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Abstract  
The methylotrophic yeast Pichia pastoris has emerged as a powerful tool to 
produce heterologous proteins during the last years. The protein production in these 
cells is commonly controlled by the methanol-inducible aox1 promoter. However, 
the current knowledge of the changes in physiology of this yeast during the shift 
from growth on glycerol to methanol-induced protein production under industrial 
relevant conditions is still scarce. To further understand the physiological changes 
in P. pastoris during production of recombinant proteins such as human insulin 
precursor (IP) and hepatitis B virus surface antigen (HBsAg), a comprehensive 
analysis of the intracellular proteome during the cultivation combined with electron 
microscopy analysis of P. pastoris cells was performed. Proteome analysis from 
different cultivation time points was done by two-dimensional gel electrophoresis 
combined with MALDI-TOF.  
The most notable change in the proteome profile of P. pastoris cells after shift from 
glycerol to methanol was detected in the enzymes of the carbon metabolism. In 
particular, enzymes from the methanol dissimilation pathway started to dominate 
the proteome, suggesting here a potential to increase methanol incorporation into 
biomass/product through metabolic enhancement of the methanol assimilation 
pathway. In addition, the presence of alcohol dehydrogenases (ADHs) in the 
methanol-fed batch phase indicates that ADHs may play an important role in 
formaldehyde detoxification in P. pastoris. 
Two stress responses were specially investigated, the oxidative stress provoked by 
methanol oxidation in peroxisomes and the stress related to the recombinant protein 
overproduction. Up-regulation of anti-oxidant enzymes as well as the autophagy of 
the peroxisomes was observed as a response to cope with the damage caused by the 
reactive oxygen species (ROS) generated during methanol metabolism. These 
results support for the first time that peroxisome degradation in P. pastoris during 
growth on methanol is a housekeeping mechanism.  
The unfolded protein response (UPR) and endoplasmic reticulum associated 
degradation (ERAD) pathway were stimulated during the production of the 
hydrophobic HBsAg. On the other hand, the production of the small IP did not 
provoke any relevant stress to the cells. Thus, the individual physical properties of 
the heterologous protein have a significant effect on an efficient final production. 
Hence, the cell full capacity to produce a recombinant protein should be regulated 
according to the properties of the product of interest.  
A profound understanding of the nature of whole-protein networks is fundamental 
to improve the performance of P. pastoris strains in various biotechnological 
processes. Therefore, the herein presented results are a valuable contribution for 
future rational strain engineering. 
Keywords: Pichia pastoris, Recombinant protein production, Proteomics 
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Zusammenfassung 
Die methylotrophe Hefe Pichia pastoris wird immer häufiger erfolgreich als 
Werkzeug zur Produktion heterologer Proteine in der Bioprozesstechnik eingesetzt. 
Dabei wird meist der methanol-induzierbare Promoter aox1 zur regulierten 
Produktion der Fremdproteine genutzt. Trotz der weiten Anwendung ist bisher nur 
wenig über die metabolischen und physiologischen Abläufe und Veränderungen 
innerhalb der Hefezellen unter bioprozess-relevanten Umständen bekannt. Mit 
dieser Arbeit wird ein umfassender Einblick in die Physiologie zweier 
rekombinanter P. pastoris Stämme während des Kultivierungsprozesses gewährt. 
Der zweistufige Prozess setzt sich aus einer Glycerin-Batch Phase, zur Generierung 
hoher Biomasse, gefolgt von einer Methanol-Fed-Batch Phase zur Induktion des 
rekombinanten Proteins zusammen. Bevor und während der Produktion 
rekombinanter Proteine wie einem humanen Insulinvorläufer (insulin precursor, IP) 
und einem Oberflächenantigen des Hepatitis B Viruses (hepatitis B virus surface 
antigen, HBsAg) wurde das Proteom sowie die Morphologie der Zellen analysiert. 
Die Proteomanalysen der Zellen von verschiedenen Zeitpunkten der Kultivierung 
wurden mittels zwei-dimensionaler Gelelektrophorese in Kombination mit 
MALDI-TOF durchgeführt. Zur ultrastrukturellen Untersuchung der Zellen wurde 
ein Transmissionselektronenmikroskop verwendet.   
Die Proteomanalysen zeigen, dass ein Wechsel der Kohlenstoffquelle von Glycerin 
zu Methanol unter den gewählten Prozessbedingungen starke Veränderungen 
innerhalb der Enzyme des Kohlenstoffmetabolismus zur Folge hat. Dabei wird vor 
allem die Synthese von Enzymen des dissimilatorischen Methanolabbaus induziert. 
Eine gentechnische Unterstützung des assimilatorischen Abbaus könnte zur 
Steigerung der Produktivität durch den Einbau von Methanol in Biomasse/Produkt 
genutzt werden. Des Weiteren wurde die Anwesenheit von 
Alkoholdehydrogenasen (ADHs) während der Methanolphase festgestellt, was auf 
eine Rolle dieser Enzyme bei der Formaldehyd Detoxifikation in P. pastoris 
hindeutet. 
Ein besonderer Fokus wurde auf die zelluläre Stressregulation während der 
Kultivierung gelegt. Die Zellen sind zwei Arten von Stress ausgesetzt. Zum einen 
oxidativem Stress, der durch die Oxidation des Methanols in den Peroxisomen 
generiert wird und zum anderen Stress, der aus der Überexpression des 
rekombinanten Proteins resultiert. Als Antwort auf eine erhöhte Konzentration an 
reaktiven Sauerstoffspezies (reactive oxygen species, ROS), wurde die 
Hochregulation anti-oxidativer Enzyme sowie die Autophagy von Peroxisomen 
(Pexophagy) festgestellt. Der Abbau von Peroxisomen während des Wachstums 
auf Methanol, welcher vermutlich homeostatischen Nutzen bringt und somit als 
„Housekeeping Mechanismus“ bezeichnet werden kann, wird hier erstmalig für P. 
pastoris beschrieben.  
  XIII 
Die Überproduktion des hydrophoben HBsAg stimuliert sowohl die "unfolded 
protein response" (UPR) als auch den "endoplasmatic reticulum associated 
degradation pathway" (ERAD). Während der Produktion des kleinen IP-Proteins 
scheinen hingegen keine dieser Stressreaktionen ausgelöst zu werden. Hierdurch 
wird der Einfluss der physikalischen Eigenschaften des Produkts auf die 
Zellphysiologie und damit auf die Produktivität deutlich. Um die volle 
Produktionskapazität der Zellen zu erzielen, sollte der Prozess somit den 
Produkteigenschaften angepasst werden.  
Für die zukünftige Generierung leistungsfähiger und produktionsstarker P. pastoris 
Stämme ist ein grundlegendes Verständnis des gesamten Proteinnetzwerks von 
fundamentaler Bedeutung. Die vorgestellten Ergebnisse liefern hierzu einen 
wertvollen Beitrag und bieten eine gute Grundlage zum Design zukünftiger P. 
pastoris Stämme hinsichtlich einer gesteigerten Produktionsleistung. 
Stichwörter: Pichia pastoris, Rekombinante Proteinproduktion, Proteomik 
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1. Theoretical background 
Recombinant protein production in the last decades has paved a new way towards 
improvement in human health. The acquisition of profound knowledge and entire 
genome sequences of a number of expression platforms has lead to considerable 
success in production of many recombinant proteins of pharmaceutical importance. 
The biotechnology industry has grown considerably, and currently about 25% of 
commercial pharmaceuticals are biopharmaceuticals [1]. Initially, their industrial 
production has been performed in Escherichia coli, benefiting from the high 
amount of information accumulated on the genetics and biochemistry of this well-
studied organism [2]. Nevertheless, as the demand for producing more complex 
proteins developed, novel yeast strains, among them Pichia pastoris, have been 
progressively invading the field of bio-pharmaceutical protein production 
dominated by E. coli and mammalian cell expression systems. This is best 
illustrated by the recent approval of KALBITOR® (ecallantide, a peptide used for 
the treatment of hereditary angioedema), the first P. pastoris-produced protein 
therapeutic approved by the Food and Drug Administration (FDA) [3].  
Despite of being explored over the decades for protein production, P. pastoris is 
still not adequately characterized at the physiological and proteomic level, 
especially regarding the physiological responses to alleviate the stress generated 
during cultivation in bioreactor. 
1.1. Pichia pastoris as expression system 
After its first transformation reported in 1985 [4], P. pastoris became a well 
developed expression platform which has been utilized successfully to express a 
multitude of proteins for both basic research and industrial use [5-9]. P. pastoris 
includes characteristics of both prokaryotes and eukaryotes. As an unicellular 
organism, it includes ease of genetic manipulation and rapid growth on relatively 
inexpensive media similar to E. coli [10]. P. pastoris also combines unique 
characteristics of eukaryotes such as post-translational modifications, for instance 
glycosylation and disulfide bridges formation [11]. It possesses highly inducible 
and tightly regulated alcohol oxidase (aox1) promoter [12]. The aox1 promoter is 
strongly repressed in cells grown on most carbon sources; such as glycerol, but it is 
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induced over 1000-fold when cells are shifted to a medium containing methanol as 
a sole carbon source, which is an advantage if the protein is toxic to the cell [10]. In 
addition, it shows a stable integration of expression plasmids into the genome and 
the ability to grow to high cell densities (> 100 g L-1 dry cell mass) in bioreactor 
cultures [8]. Another important characteristic that makes this expression system an 
attractive choice is the efficient secretion of heterologous protein and the relative 
low levels of endogenous proteins that are secreted to the medium, which facilitates 
purification [13]. The protein concentration in the culture supernatant can exceed 
10 g L-1 [14]. Finally, diverse post-translational protein processing properties that 
include among others glycosylation and disulfide bond formation in P. pastoris are 
similar to higher eukaryotes, including humans. Consequently, heterologous 
proteins are more likely to be correctly processed, folded and assembled into 
functional molecules when produced in P. pastoris compared with S. cerevisiae or 
E. coli [5].  
In the biopharmaceutical industry, over 70% of the therapeutic proteins under 
preclinical and clinical development are glycosylated and there has been an 
increasing need for highly efficient glycoprotein expression systems [15]. 
Mammalian systems such as Chinese hamster ovary (CHO) cells have been most 
widely used since they have been extensively characterized and are capable of 
human like glycosylation [16]. However, they typically exhibit low survivability 
and low recombinant protein productivity unless sophisticated experimental 
techniques are employed [15]. On the other hand, although yeast systems typically 
produce hyper-mannosylated proteins with poor bioactivity in humans, advances in 
yeast glycoengineering, especially for P. pastoris enabled the synthesis of 
humanized glycoproteins with substantially improved bioactivity [17, 18]. 
Recently, P. pastoris was reassigned to the genus Komagataella. The commonly 
used recombinant protein production strains, such as X-33 and GS115, were 
classified as Komagataella phaffii [19]. In the present work, the earlier 
denomination (P. pastoris) is used when referring to the strains X-33 and GS115 
since at the time this study was performed all the data banks used the P. pastoris 
name as well. 
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1.2. Methanol metabolism in P. pastoris  
A limited number of yeast species is able to utilize methanol as sole energy and 
carbon source. These methylotrophs include Hansenula polymorpha (Pichia 
angusta), P. pastoris, Candida boidinii, and Pichia methanolica [20]. The enzyme 
alcohol oxidase (AOX) is responsible for the first step of methanol metabolism. 
The genome of P. pastoris contains two genes, aox1 and aox2, whereby activity of 
AOX1p is responsible for the majority (> 85%) of alcohol oxidase activity in the 
cell [21]. There are three phenotypes of P. pastoris host strains with regard to 
methanol utilization, Mut+ (methanol utilization plus) where both aox genes are 
intact and active, MutS (methanol utilization slow) which has a disruption in the 
aox1 gene and the Mut− (methanol utilization minus), which is unable to grow on 
methanol, since these strains have both aox genes deleted [22]. 
All methylotrophic yeasts use a common methanol-utilizing pathway [23]. An 
outline of methanol metabolism in methylotrophic yeasts is summarized in Figure 
1.1. Methanol is first oxidized by alcohol oxidase (AOX) to form formaldehyde 
and hydrogen peroxide, which are both highly toxic compounds. Formaldehyde is a 
central intermediate situated at the branch point between assimilation and 
dissimilation pathways [24]. In the assimilation pathway, a portion of 
formaldehyde is fixed to xylulose 5-phosphate (Xu5P) by dihydroxyacetone 
synthase (DAS) forming dihydroxyacetone (DHA) and glyceraldehyde 3- 
phosphate (GAP). DHA is phosphorylated by dihydroxyacetone kinase (DAK), 
and, subsequently, dihydroxyacetone phosphate (DHAP) and GAP form fructose 
1,6-bisphosphate which is then utilized for regeneration of Xu5P and for 
biosynthesis of cell constituents [25]. Another portion of formaldehyde is further 
oxidized to CO2 by the cytosolic dissimilation pathway. Formaldehyde generated 
by AOX reacts nonenzymatically with the reduced form of glutathione (GSH) to 
generate S-hydroxymethyl glutathione (GS-CH2OH). GS-CH2OH is then oxidized 
to CO2 through the cytosolic GSH-dependent oxidation pathway, which is 
ubiquitous in nature. NAD+-linked and GSH dependent formaldehyde 
dehydrogenase (FLD) uses GS-CH2OH as a substrate to yield S-formylglutathione 
(GS-CHO) and NADH. GS-CHO is then hydrolyzed to formate and GSH by S-
formylglutathione hydrolase (FGH). NAD+-linked formate dehydrogenase (FDH) 
is the last enzyme involved in the methanol dissimilation pathway and generates 
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CO2 and NADH through the oxidation of formate [23]. Methyl formate synthesis 
by methylotrophic yeasts during growth on methanol has also been considered to 
play a role in formaldehyde detoxification. An enzyme that catalyses methyl 
formate synthesis was isolated in C. boidinii and suggested to belong to the alcohol 
dehydrogenase (ADH) family [26]. 
GSH
CH3OH
HCOH
½ O2 + H2O H2O2
O2
DHA GAP
GS‐CH2OH
Peroxisome
DHA GAP
F6PF1,6BP
DHAP
Xu5P
Methanol
GS‐CHO HCOOH CO2
NAD+
NADH
NAD+
NADH
Cytosol
CTA AOX
FLD FGH FDH
DAS
DAK
GAP Cell constituents
Assimilation pathway
Dissimilation pathway
ATP
ADP
CH2(OH)OCH3 HCOOCH3
ADH
NAD+
NADH
?
 
Figure 1.1. Methanol metabolism. Enzymes: AOX, alcohol oxidase; CTA, catalase; DAS, 
dihydroxyacetone synthase; DAK, dihydroxyacetone kinase FLD, formaldehyde 
dehydrogenase; FGH, S-formylglutathione hydrolase; FDH, NAD(+)-dependent formate 
dehydrogenase and ADH, alcohol dehydrogenase. Abbreviations: DHA, dihydroxyacetone; 
DHAP, dihydroxyacetone phosphate; F6P, fructose 6-phosphate; FBP, fructose 1,6-
bisphosphate; GAP, glyceraldehyde 3-phosphate; GS-CH2OH, S-hydroxymethyl glutathione; 
GS-CHO, S-formylglutathione; GSH, reduced form of glutathione; GSSG, oxidized form of 
glutathione; Xu5P, xylulose 5-phosphate. This picture was made based on [23, 25, 26]. 
 
The methanol pathway has been under rigorous research due to the extensive use of 
methanol-inducible promoters for commercial production of recombinant proteins 
[27]. The tightly regulated aox1 promoter is the most widely utilized in P. pastoris 
for recombinant protein production [22]. P. pastoris strains with an engineered 
methanol utilization pathway have been recently reported [28]. Some key enzymes 
of the methanol pathway, FLD and DAS, were co-expressed in a producing P. 
pastoris strain and the effect on the growth rate, methanol uptake and productivity 
was analyzed [28]. The co-expression of DAS increased 2 to 3-fold the conversion 
of the substrate methanol into product, although the volumetric productivity was 
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reduced. Nevertheless, the co-expression of FLD not only increased the conversion 
of methanol to product 2-fold, but also showed an equivalent volumetric 
productivity compared to the non-engineered strain, pointing a target to improve 
recombinant protein production [28]. Therefore, it is essential to better elucidate 
the overall mechanism of methanol metabolism for further application. The 
methanol metabolic pathway has been attracting scientists also as a source of 
cofactors, such as NADH, for use in the chemical and drug industry. The 
improvement of the cofactor regeneration has been reported in S. cerevisiae, C. 
boidinii and most recently in P. pastoris strains with an engineered methanol 
oxidation pathway [29]. 
Another important area regarding this pathway is the crucial role of the 
peroxisomes in the methanol metabolism. In the first step of methanol oxidation, 
which occurs inside the peroxisomes, hydrogen peroxide (H2O2) is produced, 
increasing the intracellular reactive oxygen species (ROS) levels [30]. Although 
H2O2 has no unpaired electrons and thus is not a radical, it is also often qualified as 
ROS because it can easily convert into the highly reactive hydroxyl radical (•OH) 
[30-32]. The peroxisomal antioxidant enzymes are required to prevent the cell 
damage caused by these toxic molecules. Thus, when the methylotrophic yeasts are 
grown on methanol as the sole carbon and energy source, not only the enzymes 
involved in methanol metabolism are strongly induced, but the membrane-bound 
organelles, peroxisomes, which contain key enzymes of methanol metabolism, 
proliferate massively [23]. This means that the regulation of methanol metabolism 
can be accomplished in part, through control of peroxisome homeostasis. This 
feature has made methylotrophic yeasts useful model organisms for the study of 
peroxisome biogenesis and degradation [33, 34]. 
1.3. Autophagy: adaptation response to nutrient 
conditions 
Autophagy is the process through which proteins and organelles are sequestered 
and delivered to the vacuole for breakdown and recycling [35, 36]. One of its 
primary roles is to regulate intracellular homeostasis and to adjust organelle 
numbers in response to stress such as changes in nutrient availability [35]. 
Autophagy is a process which is conserved from yeast to man [37]. Autophagic 
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research has increased significantly in the last years, especially due to the 
connection with cancer, neurodegenerative disease and various human 
developmental processes [37, 38]. Autophagy also appears to play an important 
role in filamentous fungi [37, 39]. The discovery of many of the autophagy genes 
(termed ATGs) and autophagy mechanisms were made in S. cerevisiae [40]. 
For a long time, starvation-induced autophagy has been considered a non-selective 
pathway [35]. However, numerous recent observations revealed that autophagy can 
also selectively eliminate specific proteins, protein complexes and organelles [41, 
42]. Nonselective autophagy involves random uptake of portions of the cytoplasm 
(cytosol and organelles) in the vacuole for recycling [43] and during selective 
autophagy, a specific cargo is exclusively sequestered into the autophagosomes 
[35]. 
Autophagy of several organelles has been reported in the last years in yeast. Under 
starvation conditions, mitochondria [43] and ribosomes [44] were detected in the 
interior of autophagosomes in yeast cells; fragments of the ER were also 
enwrapped into autophagosomes and subsequently degraded in the vacuole [45]. 
The specific degradation of ribosomes is called ribophagy [46]. It has been recently 
shown that ribosomes are turned over through a selective type of autophagy [35]. 
Accurate examination of ribosome fate under nutrient starvation conditions in yeast 
S. cerevisiae has revealed that these structures are more rapidly degraded compared 
to other cytoplasmic components, supporting the notion of a selective degradation 
process [35]. Ribosome biogenesis and protein translation are among the most 
energy-consuming cellular processes, and it is therefore not surprising that these 
pathways are tightly controlled upon nutrient limitation [47]. 
1.3.1. Pexophagy: autophagic degradation of peroxisomes 
Peroxisomes are organelles involved in many aspects of lipid metabolism and the 
elimination of peroxides. These organelles can be induced or turned over based on 
the needs of the cell [35]. The balance between biogenesis and degradation is 
tightly regulated and excess or damaged peroxisomes are degraded by an 
autophagy-related process called pexophagy [48]. 
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Two forms of autophagy have been described: macroautophagy and 
microautophagy [32, 49, 50]. During macroautophagy, individual organelles (e.g., 
peroxisomes) are surrounded by double-membrane structures known as 
autophagosomes, which fuse with vacuole to deliver autophagic bodies into the 
vacuole lumen for degradation and recycling [32]. In microautophagy, clusters of 
organelles (e.g., cluster of peroxisomes) are engulfed by vacuolar sequestering 
membranes (VSMs), without prior formation of an autophagosome. This occurs 
either by direct invagination or through formation of finger-like protrusions that 
sequester cytoplasmic components. Once the engulfment is complete, the 
membrane and the sequestered material are degraded (Figure 1.2) [32]. 
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Figure 1.2. Degradation of peroxisomes in yeast by macro- and micropexophagy. Left: 
Macroautophagy involves sequestration and degradation of peroxisomes by engulfment into 
autophagosomes. After sequestration is complete, the outer layer of the now formed 
pexophagosome (Px) fuses with the vacuolar membrane. Upon entry into the vacuole, the 
resulting pexophagic body (PB) will be degraded by vacuolar hydrolases. Right: 
Micropexophagy is morphologically characterized by vacuolar extensions (vacuolar 
sequestration membranes, VSM) and the cup-shaped micropexophagy apparatus (MIPA) that 
capture the peroxisome cluster. P, peroxisomes; Px, pexophagossomes; PB; pexophagic 
body. This picture was made based on [32, 40, 49]. 
 
In P. pastoris, peroxisomes can be induced when cells are grown in media 
containing methanol, oleate or amines. Transferring cells grown in methanol to 
ethanol or from oleate or methylamine to glucose without nitrogen induces 
macropexophagy. Shifting cells from methanol to glucose medium induces 
micropexophagy [36]. Intriguingly, the two modes of pexophagy can be triggered 
by different experimental conditions in different yeasts. In H. polymorpha 
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macropexophagy is induced rather than micropexophagy when cells are shifted 
from methanol medium to glucose [36]. In P. pastoris, the choice between 
induction of either micro- or macropexophagy was suggested to be determined by 
ATP levels in the cell [51]. High levels of ATP induce micropexophagy while 
lower levels activate macropexophagy. One explanation for this observation may 
be that the massive vacuolar re-arrangement during micropexophagy and formation 
of the MIPA may be a more energy-intensive process than formation of the 
pexophagosome and thus may demand more energy in the form of ATP from the 
cell [51]. Some autophagy-related proteins (ATG26, 28 and 30) are required for 
both micro- and macropexophagy in P. pastoris [52-54]. However, ATG35 from P. 
pastoris is specifically required for micropexophagy [55]. 
Pexophagy has emerged recently as an important process for the vitality of several 
fungi under different growth conditions. For example, H. polymorpha peroxisomes 
are constitutively degraded by autophagy during the growth of cells in methanol 
medium despite the continuous induction of peroxisome proliferation [56]. Some of 
these peroxisomes have decreased activity of peroxisomal catalase that is 
associated with increased cellular levels of reactive oxygen species (ROS) [56]. 
Peroxisomal proteolysis and constitutive autophagy of peroxisomes might 
represent two independent mechanisms protecting cells from accumulation of 
peroxisomal protein aggregates and ROS under peroxisome proliferation 
conditions [40]. 
Despite the advantages of the methylotrophic yeast P. pastoris, studies of 
pexophagy frequently use the model of baker’s yeast S. cerevisiae. In baker’s yeast, 
peroxisome proliferation is induced only by oleate, while in P. pastoris, both oleate 
and methanol induce peroxisome proliferation; being methanol able to induce 
much larger peroxisomes [57]. Furthermore, P. pastoris possesses two types of 
peroxisome degradation, macropexophagy and micropexophagy; micropexophagy 
is induced by glucose in P. pastoris. Only macropexophagy is known for baker’s 
yeast [57]. In addition, P. pastoris has been frequently used as a model to study the 
autophagy of peroxisomes during glucose adaptation and ethanol adaptation [58]. 
However, little is known about peroxisomes biosynthesis and degradation in P. 
pastoris during growth on methanol. 
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1.4. Stress responses due to recombinant protein 
production  
It is well-known nowadays that the utilization of yeast for recombinant protein 
production may expose them to several stress conditions and consequently 
influence the final yield [59]. Regarding the methylotrophic yeasts, oxidative stress 
caused by methanol degradation is an important issue. Oxidative stress can be 
simply defined as a state where there is a relative imbalance within cells between 
generation and removal of reactive oxygen species (ROS) [60]. The methanol 
metabolism leads to high oxygen consumption resulting in ROS generation which 
could have detrimental effects on cells in case they can not remove these 
molecules. To reduce the ROS level in the cell, anti-oxidant enzymes are required 
and the degradation of peroxisomes also plays a role as previously described. 
Additionally, the overexpression of recombinant protein can overburden the cell 
ability to fold them in the endoplasmic reticulum (ER). The resulting accumulation 
of misfolded or unfolded proteins will elicit the unfolded protein response (UPR) 
and ER-associated protein degradation (ERAD). 
1.4.1. Protein folding and unfolded protein response (UPR) 
Protein folding takes place in three main subcellular compartments, cytosol, 
endoplasmic reticulum (ER) and mitochondria [61]. Each organelle is equipped 
with a specific set of folding assistants [61]. 
The ER is the cradle of all cell surface proteins and proteins that are secreted to the 
extracellular space [62]. Such proteins are synthesized on ER-bound ribosomes and 
translocated into ER lumen where they attain their native conformation [61]. Most 
of the proteins leave the organelle once they are fully folded [62]. The ER folding 
factory sustains a special set of covalent modifications, which include signal 
sequence processing, disulfide bond formation and N-glycosylation [63]. The 
mature proteins which could fold into correct structure are coated by transport 
vesicles, delivered to the secretion pathway of the Golgi apparatus and 
subsequently transported to the extracellular space, vacuoles or other organelles 
(Figure 1.3) [64]. 
Theoretical background   23 
Meanwhile, misfolded proteins get accumulated in the ER lumen and are 
recognized by the quality control (QC) system. As a reaction, many cellular 
responses are activated simultaneously in a process called “unfolded protein 
response” (UPR) [61]. In the ER, folding and disulfide bond formation rate is 
increased by up-regulating chaperones and foldases. Oxidative stress response 
genes are also activated due to the increased disulfide bond formation activity and 
the subsequent reactive oxygen species generated [65]. Glycosylation processing 
elements of the ER and Golgi are also up-regulated to increase processing capacity 
of the secretory pathway. Trafficking components used in COPI, COPII, and post-
Golgi vesicles are up-regulated. The metabolic pathways for lipid and inositol are 
also up-regulated, to increase the amount of membrane. Membranes, while often 
not considered to be an active component of the secretory pathway, provide 
essential surface area that is essential for almost all secretory pathway processes 
[66]. 
The initial description and major progress in understanding the molecular 
mechanisms of the UPR was done using the yeast S. cerevisiae. Specifically, this 
yeast was used for the molecular cloning of the UPR transducer IRE1 and the 
UPR-specific transcription factor HAC1 [67].  
A schematic overview of the protein folding process and unfolded protein stress 
response in yeast is presented in Figure 1.3.  
Under non stress condition, IRE1 is a monomeric protein closely associated with 
the ER chaperone binding protein (KAR2), IRE1 is then stabilized in an inactive 
state [68]. KAR2 is the yeast homologue of mammalian BiP, an ER-resident 
member of the HSP70 family and the expression of KAR2 gene is up-regulated by 
the UPR [69]. KAR2 recognizes hydrophobic regions of peptides that are usually 
buried inside native proteins [70]. IRE1 is a transmembrane protein oriented with 
the N-terminal in the ER lumen and the C-terminal in the cytosol [68]. When the 
unfolded protein accumulates in the ER lumen, KAR2 dissociates from IRE1 in 
order to bind to unfolded proteins [68]. This allows IRE1 to dimerize, be 
autophosphorylate and to activate its endonuclease activity [68]. The activated 
IRE1 transmits a signal to cut HAC1 mRNA at two sites, removing the introns. 
After the splicing, HAC1 mRNA is efficiently translated. HAC1 is a transcriptional 
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activator that up-regulates expression of UPR target genes by binding to the 
promoter of genes encoding ER-resident chaperones and other proteins [67]. HAC1 
is known to activate or repress over 100 genes, including KAR2, PDI and ERO1 in 
S. cerevisiae [71]. HAC1 mRNA is constitutively expressed, but because of the 
secondary structure of the intron, no protein is produced when the mRNA remains 
unspliced [72]. The HAC1 gene and splice event was recently characterized in P. 
pastoris [73]. Nascent glycoproteins are bound by CNE1, a S. cerevisiae 
homologue of the mammalian calnexin [74], which mediates the correct folding 
and processing of the N-glycans. Prolonged binding to either calnexin or the KAR2 
complex targets the polypeptides to degradation [75]. 
HSP70, HSP40,
HSP104
Cytosol
ER lumen
Folded protein
Accumulation of 
misfolded protein
Post‐translation 
modification
P‐ ‐P
UPR
ROS
Failed folding
ERAD
UPR
IRE1
KAR2
SH
SH
Cell surface
Organelles
Extracellular space
Golgi complex
Foldases
Chaperones
HAC1
UPR target genesHAC1 splicing
HAC1 mRNA
HAC1
Nucleus
Sorting
COPII
Secretory vesicles
S-S
e-
e-
e-
ERO1
FAD
PDI
O2
Degradation by 
proteasome
CDC48
Polyubiquitin chain
E1, E2, E3
Sec61
PDI
KAR2
Ribosome
Calnexin
 
Figure 1.3. Schematic diagram representing folding protein and the unfolded protein 
response (UPR) in yeast. This picture was made based on [67, 76-79]. 
 
The formation of disulfide bonds is an important step in the maturation of the 
extracellular domains of both membrane and secreted proteins. Protein disulfide 
bonds are formed in the ER of eukaryotes and this process involves two proteins: 
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oxidoreductin 1 (ERO1) and protein disulfide isomerase (PDI) [80]. PDI is a 
multifunctional protein resident in the ER lumen which is responsible for the 
correct formation of disulfide bonds during oxidative folding and the isomerisation 
of incorrectly folded disulfides [78]. The disulfide bonds formation requires the 
transference of electrons from cysteine to PDI which in turn passes the electrons to 
FAD-bound ERO1 [81]. Finally, ERO1 passes electrons to molecular oxygen, 
resulting in the production of ROS [76]. The rate of protein folding is dependent 
upon the complexity of the protein to be folded, the availability of chaperones to 
assist folding and ATP used by chaperones [76, 81]. This mechanism forms 
disulfide bridges randomly, and the correct pairings must be found by a trial and 
error process, involving the repeated oxidation/reduction of cysteines by PDI [66]. 
If protein repair by ER chaperones is unsuccessful, aberrant proteins are cleared 
from the ER by a mechanism termed ER-associated degradation (ERAD) [77]. 
During ERAD, misfolded proteins are translocated, through the ER-membrane 
protein Sec61, back to the cytosol where they are conjugated to ubiquitin and 
directed to proteasomal degradation [77]. Ubiquitination is a modification carried 
out by a set of three enzymes, E1 (ubiquitin-activating enzymes), E2 (ubiquitin-
conjugating enzymes) and E3 (ubiquitin ligase) [82]. Retro-translocation of ERAD 
substrates and their delivery to the proteasome can be catalyzed by a chaperone-
like AAA ATPase, known as CDC48, the highly conserved homologue of 
mammalian p97 in S. cerevisiae [83]. As a multiubiquitin-binding protein, it was 
proposed that CDC48 recognizes multiubiquitin moieties on many proteins, 
including ERAD substrates and targets them to the proteasome for degradation 
[83]. The chaperone KAR2 and the isomerase PDI are also important components 
of the retro-translocation machinery [79]. Prior to the retro-translocation to the 
cytosol PDI reduces the disulfide bonds present in the protein [84]. KAR2 was 
suggested to maintain the solubility of ERAD substrates [85]. 
The degradation of misfolded ER membrane proteins requires a different set of 
chaperones as compared to ER lumenal proteins, due to the exposure of protein 
misfolded domain to the cytosol [79]. SSA1, a cytosolic HSP70 in yeast, is 
required for the ERAD of several membrane proteins [77, 86]. SSA1 probably 
maintains the solubility of misfolded cytosolic domains on at least some integral 
membrane ERAD substrates, which would facilitate their delivery to and 
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degradation by the proteasome [77]. It is also unclear how precisely chaperones act 
as “decision makers” for the ER quality control system [87]. Distinct chaperone 
classes have unique effects depending upon the ERAD substrate. For example, 
BiP/Jem1/Scj1 are required not only for the folding of carboxypeptidase Y (CPY), 
but also for the degradation of the ERAD target CPY [87]. It has become clear in 
recent years, that chaperones play a central role in the elimination process of 
proteins that are either damaged, terminally misfolded or do not fold in a certain 
time frame [79]. The interaction between chaperone and the unfolded protein keeps 
the unfolded protein soluble and helps to acquire a native structure [79]. The 
clearest picture is presently available for the chaperones of the HSP70 family 
members with their HSP40 co-chaperones [79]. What specifically these chaperones 
recognize and how they decide whether a protein is properly folded or will be 
degraded is still unknown [79, 87].  
1.4.1.1. Environmental impact on protein folding and secretion  
The impact of environmental factors on the productivity of P. pastoris cells has 
been investigated in the past years and the changes in the proteins involved in 
folding and degradation were always an object to better understand their effect on 
the final product yield. Among environmental factors that affect protein folding 
and secretion, especially temperature, high osmolarity and oxidative stress may 
play important roles [78].  
Temperature has a profound impact on cell metabolism and regulation of folding 
related genes/proteins [78]. The decrease of the cultivation temperature from 30 to 
20°C led to a down-regulation of chaperones from the HPS70 family, such as 
SSA4 and SSB1, as well HSP60 and HSP82. KAR2 was also down-regulated while 
the PDI did not show any change at lower temperatures [88]. At 20°C, the specific 
productivity of the human antibody Fab fragment increased 3 fold [88]. The lower 
temperature may lead to a higher stability of protein and a reduced demand for 
protein refolding or degradation, resulting in a higher secretion capacity [88].  
Although oxygen limitation affects the core metabolism by causing energy 
deprivation [89], it was shown recently that very low oxygen supply enhances the 
secretion rate of heterologous proteins in P. pastoris [90]. Besides affecting growth 
and protein production, oxygen also plays a role in cellular redox reactions which 
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are closely connected with protein folding reactions within the cell [81]. When P. 
pastoris cells were exposed to severe oxygen limitation the stress response was 
highly activated, which was demonstrated by the up-regulation of the chaperones 
SSA4 and TSA1 at protein level. At transcript level HAC1, PDI1 and ERO1 were 
significantly increased by hypoxia, while the transcription of KAR2 and IRE1 was 
not affected [89]. It was assumed that the significant induction of some UPR genes 
under hypoxia could benefit protein folding and secretion, probably by reducing 
the ROS generation [89].  
Response to hyperosmolarity in yeast has also been analyzed in the last years. The 
adjustment of protein folding machinery in different yeasts was previously reported 
upon high osmolarity [91, 92]. Proteins from the HSP70 family, such as KAR2, 
and PDI were found to be up-regulated in a high salt concentration medium as part 
of a mechanism which alleviates the damaging effects of high salt on protein 
folding in the yeast Rhodotorula mucilaginosa [93]. On the other hand, the heat 
shock protein SSB was found to be down-regulated in the same study [93]. The 
major impact of osmolarity on the P. pastoris proteome was reported to be on 
proteins involved in energy metabolism and protein folding [94]. An increased 
level of some proteins from UPR, such as KAR2, PDI, SSC1, HSP60 and SSA4, 
was observed in a medium at high osmolarity in a non producing strain, while no 
change was observed in the producing strain. It has been previously reported that 
osmotic stress applied prior to induction of protein secretion resulted in higher 
level of scFv antibody in P. pastoris [95], due to the UPR-like response, which 
makes the cells already conditioned for a better folding response compared to the 
untreated cells [94].  
1.4.1.2. Overcoming folding stress in recombinant protein production 
As a straightforward strategy, overexpression of multiple chaperones, PDIs and 
other folding helpers seemed to be an effective approach [63]. The co-expression of 
S. cerevisiae and more recently P. pastoris HAC1 has been used successfully as a 
tool to improve the recombinant protein production [73, 96]. The overexpression of 
S. cerevisiae PDI proved to be functional in P. pastoris by enabling the increase of 
the antibody fragment Fab production level by 1.3-fold [96] and facilitating the 
secretion of the human parathyroid hormone [97]. The co-expression of KAR2 is 
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reported to enhance cell growth as well as the production of antithrombic hirudin 
[98] and, the secretion of human erythropoietin [99] in S. cerevisiae. On the other 
hand, the co-expression of KAR2 could also decrease the yield of the recombinant 
protein [100]. The effect of coexpression of chaperone and foldase genes strongly 
depends on the properties of the target protein and, moreover, it seems that fine-
tuned (optimal amount) overexpression of these genes is required to generate a 
functional secretory network to improve foreign protein overproduction [78]. 
Elevating expression of the chaperones, e.g., KAR2, may also facilitate target 
protein degradation via the ER-assisted degradation [100] and co-expression of 
chaperones genes could compete with target genes for transcription, translation and 
folding in the cell [101].  
As a result of a strict QC system in the ER, protein folding often has a tendency to 
become the bottleneck in heterologous protein secretion. Thus, genetic 
modification of the ER protein folding and QC system has become the most useful 
approach in the current strain engineering method to overcome the drawbacks in 
the cell specific productivities. The wide range of cell specific secretion titers for 
different proteins in yeast still raises the important question as to whether 
environment-, host- or protein-based factors limit the cell specific protein secretion 
levels [63]. Most of the data regarding stress responses come from S. cerevisiae 
studies and are not in a industrial relevant scale [59]. Therefore, there is an urgent 
demand for research on physiological response on the new yeast generation as P. 
pastoris to bring new insights on the adaptation of the host to stressful situations. 
1.5. Proteome analysis 
To date, there are only few published studies concerning the physiological 
adaptations of P. pastoris facing different environmental conditions [88, 89, 94, 
102]. Additionally, although the aox1 promoter is the most widely utilized in P. 
pastoris and this yeast has been a successful recombinant protein production 
platform for decades [11, 22], there is very little known about the intracellular 
proteome of P. pastoris in methanol-induced cultures [103]. Despite the rapid 
development of many gel-free proteomic techniques, classical combination of two-
dimensional electrophoresis (2-DE) and mass spectrometry (MS) is still the 
workhorse for quantitative proteomic studies [104]. Protein mixtures from cells are 
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separated by 2-DE. Proteins are separated by charge in the first dimension and then 
by size in the second dimension, yielding spots on a polyacrylamide gel. The gel is 
further stained, and each observed protein spot is quantified by its staining 
intensity. Selected spots are excised, digested into short peptide fragments and 
analyzed by MS [105].  
The term “proteomics” was first introduced in the mid-90s by Wilkins and 
colleagues [106], and defined as the study of the proteome. After the 
“transcriptomic era”, the field of proteome analysis has gained popularity in 
various research areas [104]. Although the measurement of transcribed mRNA has 
proven to be very powerful in the elucidation of functional mechanisms, alone it is 
not sufficient for the characterization of biological systems as a whole [107]. 
Examples in which the mRNA and the protein production profiles show only a 
rather weak correlation are increasing [104]. In a transcriptome and proteome study 
of S. cerevisiae under oxygen deprivation, the data of glycolysis, amino-acyl-tRNA 
synthesis, purine nucleotide synthesis and amino acid biosynthesis showed a weak 
connection, leading to a strong evidence for post-transcriptional regulation of these 
key cellular processes [108]. Control of biological systems not only involves 
transcription and mRNA stability, but also control at other levels such as mRNA 
processing, nuclear export, translation and protein degradation [109]. Therefore, 
the disparities between mRNA and protein abundance are not unexpected [109]. 
Integration of transcriptome and proteome data leads to new insights into the 
physiology of growing yeast and it is fundamental to understand the entire network 
of reactions in the living cell. 
The public genome sequences of P. pastoris GS115 and DSMZ 70382 are now 
available. A total of 5,313 and 5,450 predicted ORFs were identified in GS115 and 
DSMZ 70382, respectively [110, 111]. These two databases provide a powerful 
tool to study and pinpoint global cellular responses derived from recombinant 
protein production in P. pastoris under bioprocess-relevant conditions [112]. 
One major obstacle towards directed strain engineering in alternative host systems 
seems to be the lack of detailed knowledge of host physiology, molecular biology 
and biochemistry. The aim of this work was to perform a comprehensive analysis 
of the intracellular proteome of P. pastoris GS115 and X-33 throughout fed-batch 
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cultivation, producing high level of recombinant hepatitis B virus surface antigen 
(HBsAg) and insulin precursor (IP) under the control of the methanol-regulated 
promoter (aox1). The analyses were focused on the stress caused to the cell by 
methanol degradation and recombinant protein production leading to the induction 
of oxidative stress and unfolded protein response pathway.  
The insights gained in this study will enable us to better understand the global 
cellular physiology of P. pastoris, essential for further development of metabolic 
and cellular engineering strategies.  
Aim of this work   31 
2. Aim of this work 
The yeast Pichia pastoris has been recognized as an effective host for recombinant 
protein production and has been widely used to produce high yield of proteins for 
both basic research and industrial use. Unfortunately, the current knowledge of the 
changes in physiology of this yeast under bioprocess-relevant conditions is still 
scarce. 
The aim of the present study is to analyze the physiological response of P. pastoris 
to overproduction of intracellular hepatitis B virus surface antigen (HBsAg) and 
secreted insulin precursor (IP) in large scale cultivation under the control of a 
methanol-regulated promoter (aox1). The cell adaptation facing a carbon source 
transition from glycerol (growth phase) to methanol (production phase), as well as 
stress responses such as oxidative stress and unfolded protein response will be 
analyzed. Additionally, autophagic responses of the cells to nutrient conditions 
throughout cultivation processes will be also investigated in this work. The new 
insights into the global mechanisms connecting protein production to 
environmental conditions gained in this study can serve as a valuable basis for 
future rational strain engineering. 
For this purpose, samples from two different cultivations of P. pastoris producing 
the HBsAg and IP will be analyzed. Sample at different time points will be 
collected and the protein identification and analysis of changes in the proteome will 
be done using 2D gel electrophoresis combined with MALDI-TOF. Also, electron 
microscopic studies of the cells will be used in order to analyze the adaptation 
response, such as autophagy, to the environmental nutrient conditions. 
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3. Physiological response of Pichia pastoris 
GS115 to methanol-induced high level 
production of the Hepatitis B surface antigen: 
catabolic adaptation, stress responses, and 
autophagic processes 
In the first part of this work the proteome profile of Pichia pastoris GS115 
producing high level of the hepatitis B surface antigen (HBsAg) under the control 
of aox1 promoter was analyzed. 2D gel electrophoresis was employed to measure 
the relative changes in protein abundance during the cultivation. These results were 
combined with electron microscopy to better understand the physiological response 
of the cell under a relevant bioprocess condition. The stress caused to the cell by 
protein overproduction as well by using methanol as a carbon source during the 
induction phase are described in the published work integrated in this thesis.  
The present chapter is reprinted from the following article [113] and it is a courtesy 
of BioMed Central. It is an open acess publication. 
Vanz AL, Lünsdorf H, Adnan A, Nimtz M, Gurramkonda C, Khanna N, Rinas U. 
Physiological response of Pichia pastoris GS115 to methanol-induced high level 
production of the Hepatitis B surface antigen: catabolic adaptation, stress 
responses, and autophagic processes. Microb Cell Fact 2012, 11(1):103 
 
3.1. Abstract 
Background 
Pichia pastoris is an established eukaryotic host for the production of recombinant 
proteins. Most often, protein production is under the control of the strong 
methanol-inducible aox1 promoter. However, detailed information about the 
physiological alterations in P. pastoris accompanying the shift from growth on 
glycerol to methanol-induced protein production under industrial relevant 
conditions is missing. Here, we provide an analysis of the physiological response 
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of P. pastoris GS115 to methanol-induced high-level production of the Hepatitis B 
virus surface antigen (HBsAg). High product titers and the retention of the protein 
in the endoplasmic reticulum (ER) are supposedly of major impact on the host 
physiology. For a more detailed understanding of the cellular response to 
methanol-induced HBsAg production, the time-dependent changes in the yeast 
proteome and ultrastructural cell morphology were analyzed during the production 
process. 
Results 
The shift from growth on glycerol to growth and HBsAg production on methanol 
was accompanied by a drastic change in the yeast proteome. In particular, enzymes 
from the methanol dissimilation pathway started to dominate the proteome while 
enzymes from the methanol assimilation pathway, e.g. the transketolase DAS1, 
increased only moderately. The majority of methanol was metabolized via the 
energy generating dissimilatory pathway leading to a corresponding increase in 
mitochondrial size and numbers. The methanol-metabolism related generation of 
reactive oxygen species induced a pronounced oxidative stress response (e.g. 
strong increase of the peroxiredoxin PMP20). Moreover, the accumulation of 
HBsAg in the ER resulted in the induction of the unfolded protein response (e.g. 
strong increase of the ER-resident disulfide isomerase, PDI) and the ER associated 
degradation (ERAD) pathway (e.g. increase of two cytosolic chaperones and 
members of the AAA ATPase superfamily) indicating that potential degradation of 
HBsAg could proceed via the ERAD pathway and through the proteasome. 
However, the amount of HBsAg did not show any significant decline during the 
cultivation revealing its general protection from proteolytic degradation. During the 
methanol fed-batch phase, induction of vacuolar proteases (e.g. strong increase of 
APR1) and constitutive autophagic processes were observed. Vacuolar enclosures 
were mainly found around peroxisomes and not close to HBsAg deposits and, thus, 
were most likely provoked by peroxisomal components damaged by reactive 
oxygen species generated by methanol oxidation. 
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Conclusions 
In the methanol fed-batch phase P. pastoris is exposed to dual stress; stress 
resulting from methanol degradation and stress resulting from the production of the 
recombinant protein leading to the induction of oxidative stress and unfolded 
protein response pathways, respectively. Finally, the modest increase of methanol 
assimilatory enzymes compared to the strong increase of methanol dissimilatory 
enzymes suggests here a potential to increase methanol incorporation into 
biomass/product through metabolic enhancement of the methanol assimilatory 
pathway. 
Keywords 
Pichia pastoris, Proteome, Aox1 promoter, Carbon metabolism, ER stress, 
Autophagy 
 
3.2. Background 
The methylotrophic yeast Pichia pastoris is nowadays a well-established 
eukaryotic host for the heterologous production of technical enzymes and also for 
protein pharmaceuticals [10, 114]. P. pastoris naturally possesses two different 
genes (aox1 and aox2) encoding alcohol oxidases for oxidation of methanol, the 
first step in methanol degradation [115]. Aox1 is highly expressed during growth on 
methanol, thus the strong aox1 promoter is utilized most often to drive the 
production of foreign proteins. Another attempt to enhance the yield of the target 
protein is to increase its chromosomal gene dosage which - up to a certain target-
protein dependent extent - can further increase product levels [116-119]. However, 
increasing the gene copy number beyond a target protein-dependent threshold can 
have a severe impact on cell growth and viability including a reduced level of the 
target protein [117, 120-122]. In particular, overburdening the cellular protein 
export machinery for production of extracellular proteins can cause severe stress 
responses [78]. The passage of export-destined proteins through the secretory 
pathway often presents a bottleneck leading in many cases to partial retention of 
the target protein in the endoplasmic reticulum (ER) and a transcriptional up-
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regulation of the Unfolded Protein Response (UPR) and the ER-Associated 
Degradation (ERAD) pathway [123, 124]. 
In this study we investigated the physiological changes accompanying the 
methanol-induced high-level production of HBsAg, the major surface antigen of 
the Hepatitis B virus (HBV) employed for vaccination against HBV, in P. pastoris 
under industrially relevant conditions. The antigen is a very stable and also a very 
hydrophobic protein and not secretable in yeast expression systems [125]. Thus, 
production occurs as intracellular protein in P. pastoris GS115 carrying 8 copies of 
the gene encoding mature HBsAg without employing yeast-derived secretory 
signals [116]. Cells are grown on defined medium in a controlled fed-batch 
procedure maintaining the methanol concentration at 6 g L-1 through continuous 
methanol feeding during the production phase [126]. Although not destined for 
export the HBsAg is translocated into the ER where it is retained leading to a 
bulging of the ER into cloud-shaped irregular formations [125]. The very 
hydrophobic HBsAg is not further passaged in the secretory pathway but assembles 
into well-ordered multi-layered lamellar structures in the ER which are 
transformable into virus-like particles (VLPs) during down-stream processing 
[125]. The high-level production and the retention of the protein in the ER are 
supposedly of major impact on the cell physiology. For a more detailed 
understanding of the cellular response to methanol-induced high level HBsAg 
production, we followed the changes in the yeast proteome and the ultrastructural 
cell morphology during the HBsAg production process. 
 
3.3. Results and discussion 
The physiological alterations accompanying the adaption of recombinant Pichia 
pastoris to methanol-induced high-level production of HBsAg were followed by 
proteome analysis and electron microscopy. Cells were grown initially on glycerol, 
and after depletion of glycerol, methanol was added to a final concentration of       
6 g L-1 to initiate HBsAg production. This methanol concentration was kept 
constant through appropriate methanol feeding for the remaining fed-batch phase 
of the cultivation [126]. After an initial growth arrest and a short period of 
adaptation to methanol (~3-4 h), cells started to consume methanol and the biomass 
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increased from 60 to 100 g L-1 cell dry mass during the first 90 - 100 h of the 
methanol feeding phase [126]. During this period, the intracellular HBsAg levels 
increased strongly reaching a final maximum of 6 - 7 g L-1 (thereof 30% soluble 
HBsAg competent for assembly into VLPs). Beyond this period, cell viability 
declined concomitant with a decrease of the soluble fraction of HBsAg [126]. 
Thus, this production process is characterized by four distinct phases: i. glycerol 
batch phase, ii. adaptation phase to methanol, iii. production phase, and iv. decline 
phase. From all these phases representative samples were taken for proteome 
analysis. The complete list of all identified proteins with their corresponding 
changes and classified into functional categories and a 2D gel image indicating all 
identified proteins are found in the Additional file 1. Moreover, cell physiological 
changes were also followed by ultrastructural analysis using transmission electron 
microscopy. 
3.3.1. Carbon metabolism: cell adaptation to carbon source 
change from glycerol to methanol 
The intracellular proteome of Pichia pastoris exhibited a dramatic change in 
response to the shift from growth on glycerol to production and growth on 
methanol (Figure 3.1 A and B). 
3.3.1.1. Methanol metabolism 
In particular, proteins required for methanol utilization which were only present in 
minor amounts during growth on glycerol started to dominate the proteome after 
the onset of the methanol feeding phase. Surprisingly, a major protein which 
accumulated during growth on methanol was identified as alcohol oxidase 1 
(AOX1) (Figures 3.1 A-C, 3.2 and Additional file 2). This HBsAg producing strain 
was first classified as Muts [116], hence the presence of aox1 and the accumulation 
of AOX1 unexpected. A comprehensive analysis verified the formation of AOX1 
as well as the presence of the intact encoding gene aox1 (for details please refer to 
Additional file 2). Thus, high level recombinant protein production may lead to 
impaired growth on methanol despite the presence of functional aox1. 
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Figure 3.1. Change of the intracellular proteome of P. pastoris GS115 in response to 
methanol-induced high-level production of the Hepatitis B surface antigen. Sections of 
2D gels representing parts of the intracellular proteome (A) at the end of the glycerol batch 
phase and (B) 114 hours after the onset of methanol feeding. For encircled protein spots 
(dark lines) time-dependent changes are given below. Magnified 2D gel sections from 
samples taken at the end of the glycerol batch phase and 4, 16, 72 and 114 hours after the 
onset of methanol feeding with representative proteins involved in (C) methanol metabolism 
and (D) oxidative and (E) ER stress responses (including also vacuolar degradation). 
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In addition to AOX1 also the NAD+-dependent formate dehydrogenase (FDH1), 
the enzyme catalyzing the last step in the methanol dissimilation pathway increased 
to very high levels in the methanol feeding phase (Figures 3.1 A-C and 3.2). The 
other two enzymes of the methanol dissimilation pathway, the S-(hydroxymethyl)-
glutathione dehydrogenase (FLD1) and S-formylglutathione hydrolase (FGH1), 
also increased strongly but not as pronounced as AOX1 and FDH1 (Figures 3.1 A-
C and 3.2). 
Interestingly, AOX1 already accumulated to high levels during the adaption phase 
to methanol (Phase II), while the subsequent enzymes of the methanol dissimilation 
pathway reached their highest concentrations in the production phase (Phase III) or 
even later in the decline phase (Phase IV) (Figure 3.1 A-C). Methanol is not only 
oxidized by Pichia pastoris in the dissimilation pathway for potential energy 
generation through reoxidation of NADH in the respiratory chain but can also be 
incorporated into biomass in the assimilation pathway. In this case, formaldehyde, 
which is formed through oxidation of methanol by AOX1 (or AOX2), is not further 
converted to carbon dioxide, but condensed with xylulose 5-phosphate (Xu5P), 
through the action of dihydroxyacetone synthase (DAS1), a special transketolase 
which converts formaldehyde and Xu5P into the central C3-compounds 
dihydroxyacetone (DHA) and glyceraldehyde 3-phosphate (GAP) [25] (Figure 
3.2). 
In contrast to the strong increase of the enzymes from the methanol dissimilation 
pathway, the level of DAS1 increased only moderately during the production phase 
(Figures 3.1 A, B and 3.2) suggesting that the majority of methanol is processed 
through the dissimilation pathway leading to the generation of NADH and carbon 
dioxide. In fact, a carbon mass balance analysis revealed that 70 - 80% of the 
methanol metabolized is converted into carbon dioxide in the methanol fed-batch 
phase (data not shown). Interestingly, the mitochondrial area within cellular cross 
sections increased significantly during the methanol fed-batch phase (Figure 3.3) 
probably as a result of the elevated NADH supply from methanol dissimilation and 
the enhanced energy demand for growth, production and cell maintenance (e.g. 
repair and recycling). 
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Figure 3.2. Simplified carbon metabolic network. Identified enzymes from pathways 
involved in glycerol and methanol metabolism, from the glycolytic and pentose phosphate 
pathway, and TCA cycle and their changes in response to the shift from growth on glycerol 
to growth and HBsAg production on methanol. The red arrow (↑) indicates an increasing and 
the green arrow (↓) a decreasing amount of the enzyme in the methanol fed-batch phase. An 
orange dash (−) indicates no significant change. One arrow indicates small (0.6-1 log2 
change), two arrows strong (1–4 log2 change) and three arrows very strong changes (> 4 
log2 change). Abbreviations (enzymes): AOX1, alcohol oxidase 1; CTA1, catalase; PMP20, 
peroxiredoxin; FLD1, formaldehyde dehydrogenase; FGH1, S-formylglutathione hydrolase; 
FDH1, NAD(+)-dependent formate dehydrogenase; ADH, alcohol dehydrogenase; DAS1, 
transketolase (dihydroxyacetone synthase); TPI1, triose phosphate isomerase; FBA1, 
fructose 1,6-bisphosphate aldolase; TDH1, glyceraldehyde-3-phosphate dehydrogenase; 
PGK1, 3-phosphoglycerate kinase; GMP1, tetrameric phosphoglycerate mutase; ENO2, 
enolase; 6PGD, 6-phosphogluconate dehydrogenase; RKI1, 1- ribose-5-phosphate ketol-
isomerase; ACO1, aconitase; IDH2, subunit of mitochondrial NAD(+)-dependent isocitrate 
dehydrogenase; FUM1, fumarase; MDH1, mitochondrial malate dehydrogenase. 
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Figure 3.3. Mitochondrial morphology and size changes during methanol-induced high-
level production of the Hepatitis B surface antigen. Transmission electron micrographs of 
P. pastoris GS115 (A) at the end of the glycerol batch phase and (B) 112 hours after the 
onset of methanol feeding. White arrow heads indicate mitochondria. (C) Quantification of 
the average total mitochondrial area within the cross sectional average cell area. The vertical 
bars encompass individual cell variance, e.g. the lowest and highest total mitochondrial area 
observed in a single cell in each growth phase; (left column) at the end of the glycerol batch 
phase and (right column) 112 hours after the onset of methanol feeding. 
 
3.3.1.2. Glycolysis, pentose phosphate pathway, and tricarboxylic acid 
(TCA) cycle 
In contrast to the strong increase of the enzymes from the methanol utilizing 
pathways, in particular enzymes from the methanol dissimilation pathway, the 
enzymes from the glycolytic and the pentose phosphate pathway either decreased 
during the methanol fed-batch phase or did not show significant changes (Figure 
3.2). A more pronounced decrease was observed for the triose phosphate isomerase 
(TPI1), the glycolytic enzyme required for channeling glycerol into the central 
carbon metabolic pathways (Figures 3.1 A, B and 3.2 and Additional file 1). The 
enzymes of the TCA cycle did not show significant changes except for the 
mitochondrial malate dehydrogenase (MDH1) which increased strongly during the 
methanol feeding phase (Figures 3.1 A, B and 3.2 and Additional file 1). MDH1 
was already a prominent component of the intracellular proteome during growth on 
glycerol but increased even further in the methanol feeding phase (Figure 3.1 A 
and B). Interestingly, the corresponding homolog in A. niger was also identified as 
major part of the intracellular proteome in well-aerated bioreactor cultures [127]. 
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3.3.1.3. Ethanol metabolism 
P. pastoris is generally classified as Crabtree-negative yeast and glycerol and 
methanol are not considered as fermentable carbon sources. However, two alcohol 
dehydrogenases (ADH and mitochondrial ADHIII) were identified in the proteome 
during growth on glycerol with ADHIII as a prominent component of the 
intracellular proteome (Figure 3.1 A and C). The presence of alcohol 
dehydrogenases indicated the formation of ethanol in the glycerol batch phase 
which was confirmed by gas chromatography (1.3 g L-1 ethanol at the end of the 
glycerol batch phase). Previous reports also documented ethanol formation by P. 
pastoris during growth on excess glycerol [128, 129]. Surprisingly, the amount of 
both enzymes increased even further in the methanol fed-batch phase (Figure 3.1 
A-C; ethanol concentration: 0.3 g L-1 after 112 hours of growth on methanol) 
indicating a potential involvement in metabolic activities beyond ethanol 
metabolism. In fact, it has been suggested that proteins of the ADH family from 
other methylotrophic yeasts (e.g. C. boidinii) are involved in fomaldehyde 
detoxification through formation of methyl formate [26]. A similar role may be 
also attributable to ADHs in P. pastoris. 
3.3.2. Stress responses 
In the methanol fed-batch phase the cells are exposed to dual stress; stress resulting 
from methanol degradation and stress resulting from the production of the 
recombinant protein. The first, AOX catalyzed step during methanol utilization 
generates formaldehyde and hydrogen peroxide, both toxic compounds [25]. The 
delayed accumulation of formaldehyde processing enzymes compared to the rapid 
accumulation of AOX after the onset of methanol feeding (cf. preceding paragraph 
and Figure 3.1 A-C) suggests a considerable negative impact of formaldehyde on 
the cells, in particular in the beginning of the methanol fed-batch phase. 
3.3.2.1. Oxidative stress response 
Methanol metabolism is mainly localized in the peroxisomes, membrane 
surrounded organelles which harbor the enzymes required for the initial steps of 
methanol metabolism (e.g. AOX, DAS1). During oxidation of methanol reactive 
oxygen species such as hydrogen peroxide but also peroxidated molecules are 
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generated which need to be removed to prevent or minimize corresponding cell 
damage. At least two peroxisomal enzymes which are involved in the removal of 
reactive oxygen species, catalase (CTA1), which removes hydrogen peroxide [25, 
30, 130], and a glutathione peroxidase or peroxiredoxin (PMP20), which removes 
peroxidated molecules, e.g. lipid hydroperoxides [25, 130, 131], increased strongly 
in the methanol fed-batch phase (Figures 3.1 D and 3.2). CTA1 was already present 
in significant amounts during growth on glycerol and increased further in the 
adaptation and production phases (Figures 3.1 A, B, D and 3.2). In contrast to 
CTA1, PMP20 was virtually absent during growth on glycerol but increased 
immediately in the methanol adaptation phase (Figures 3.1 A, B, D and 3.2) 
indicating a more important role in methanol-related detoxification of reactive 
oxygen species. In fact, deletion of pmp20 was more deleterious than deletion of 
cta1 in methylotrophic yeast knockout strains (C. boidinii and P. pastoris) exposed 
to methanol [131, 132]. It has been suggested that the presence of PMP20 is 
essential for maintaining peroxisomal membrane integrity during growth on 
methanol through removal of oxidized lipids [133]. Cyclophilin B, a cytoplasmic 
peptidyl-prolyl cis-trans isomerase (Cpr1), reported as environmental (oxidative)-
stress responsive protein in Saccharomyces cerevisiae [134], also increased 
immediately in the methanol adaptation phase (Additional file 1) suggesting a 
stress-responsive function also for P. pastoris. 
3.3.2.2. Induction of UPR and ERAD pathway 
HBsAg is a very stable and also a very hydrophobic protein able to form VLPs 
during downstream processing [126]. The VLPs are further stabilized by intra- and 
intermolecular disulfide bonds [135]. During its methanol-induced high-level 
production HBsAg is translocated into the ER but not further processed in the 
secretory pathway [125]. The accumulation of HBsAg in the ER is leading to an 
expansion of the ER which bulges into cloud-shaped irregular formations. Thus, an 
induction of the UPR and a corresponding increase of ER resident chaperones or 
foldases would not be surprising. In fact, the amount of the UPR-inducible and ER-
resident disulfide isomerase (PDI) increased strongly in the methanol fed-batch 
phase (Figure 3.1 A, B, and E). Moreover, other UPR-induced proteins such as the 
mitochondrial chaperone SSC1 [136] also increased significantly during HBsAg 
production (Additional file 1). In addition, two cytosolic chaperones and members 
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of the AAA ATPase superfamily (ClpB=hsp104 and the AAA ATPase 
PAS_FragD_0026=Cdc48) also revealed a strong increase in the methanol fed-
batch phase (Figure 3.1 A, B, E and Additional file 1) indicating an activation of 
the ERAD pathway. In S. cerevisiae, the homologs of both proteins have been 
identified as ER-stress responsive proteins, which participate in energy-driven 
disaggregation and degradation of ERAD substrates [137-139]. Hsp104 cooperates 
with hsp70 and hsp40 in disassembling protein aggregates for either proper 
refolding or degradation [137, 139, 140]. The AAA ATPase Cdc48 operates on the 
cytosolic part of the ER membrane actively involved in dragging misfolded 
proteins from the ER for subsequent degradation by the proteasome [83, 141, 142]. 
Here, their increase in response to ER stress was also verified for P. pastoris. 
3.3.2.3. Induction of other degradation pathways and autophagic 
processes 
Moreover, a strong increase of the vacuolar aspartyl protease APR1 (PEP4 in S. 
cerevisiae) was observed in the methanol fed-batch phase (Figure 3.1 A, B, E and 
Additional file 1) suggesting the induction of vacuolar degradation pathways in 
addition to ERAD. An electron microscopic examination of the cells revealed a 
drastic change in vacuole morphology after the start of the methanol fed-batch 
phase (Figure 3.4). At the end of the glycerol batch phase, the majority of cells 
possessed large spherical vacuoles of which many contained autophagic bodies. 
The appearance of spherical vacuoles with autophagic bodies indicate the onset of 
nutrient limiting conditions and the accompanying recycling of cell material [143]. 
After the start of methanol feeding, the number of cells with spherical vacuoles 
declined strongly and, instead, cells with irregularly shaped vacuoles increased in 
number (Figure 3.4).  
A closer electron microscopic examination revealed invagination of vacuoles 
(Figure 3.5) as is typically observed during peroxisome degradation by 
microautophagy (micropexophagy) [36, 144]. Micropexophagy requires high levels 
of ATP [51] most likely available in the methanol fed-batch phase through 
primarily dissimilatory methanol catabolism. Interestingly, vacuolar enclosure was 
mainly related to peroxisomes (for details see Figure 3.5) and not to HBsAg 
deposits suggesting that vacuolar degradation pathways were not induced by 
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Figure 3.4. Vacuole morphology changes in P. pastoris GS115 during methanol-induced 
high-level production of HBsAg. Time-dependent change in the percentage of cells 
containing large spherical vacuoles with autophagic bodies (AB, ●), cells containing large 
spherical vacuoles without autophagic bodies (○), cells containing irregular vacuole (▲), 
cells with small vacuoles (∆), cells without any visible vacuoles (■), and apoptotic cells (□). 
The bar in the electron micrographs of representative cells corresponds to 500 nm. 
 
HBsAg accumulation but most likely by damaged peroxisomes. In other cases, 
activation of autophagic processes have been reported in S. cerevisiae and 
mammalian cells upon induction of ER stress through addition of reducing agents 
[42] and tunicamycin and thapsigargin [145], respectively. Moreover, the analysis 
of the interactome of a degradation-prone and secreted Fab fragment in P. pastoris 
revealed mainly proteasomal degradation but also degradation via vacuolar 
pathways [64]. Also, analysis of the effects of producing folded-state stability 
Pichia pastoris GS115 producing HBsAg             45 
variants of human lysozyme on the activation of stress responsive pathways 
revealed a reverse correlation of protein stability versus activation of degradative 
processes such as ERAD and ER-phagy, apparent through enhanced expression of 
e.g. sec61 and e.g. atg1, respectively [123]. However, in our case invaginated 
vacuoles were either closely connected to peroxisomes (Figure 3.5) or otherwise 
did not show any clear connection to other organelles (e.g. mitochondria or ER).  
Autophagy of peroxisomes (pexophagy) has been previously reported for P. 
pastoris upon shifting from methanol to ethanol or glucose but not during growth 
on methanol. Our findings suggest that constitutive autophagic recycling of 
peroxisomes might be part of the house-keeping machinery of Pichia pastoris also 
under methanol growth conditions helping cells to deal with damage caused by 
reactive oxygen species created through methanol oxidation. Vacuolar enclosure of 
peroxisomes was already apparent in the middle of the production phase (Figures 
3.4 and 3.5 D) and increased further during the ongoing methanol fed-batch phase 
(Figure 3.4 and 3.5). Indeed, it has been shown for the methylotrophic yeast 
Hansenula polymorpha that constitutive pexophagy is vital during growth on 
methanol as mutant cells with defects in autophagy displayed reduced vitality [56] 
and damaged peroxisomes are rapidly subjected to autophagic degradation in H. 
polymorpha [146]. Thus, the strong increase in the vacuolar protease APR1 during 
the methanol fed-batch phase might not be related to HBsAg production but to 
vacuolar degradation of damaged peroxisomes. 
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Figure 3.5. Peroxisome sequestration via micropexophagy during methanol-induced 
high-level production of HBsAg. (A-C) Representative transmission electron micrographs 
of ultrathin sectioned cells of P. pastoris GS115 growing for 112 hours on methanol. (D-F) 
Close-up views of vacuoles sequestering peroxisomes in cells growing for (D) 48 and (E, F) 
112 hours on methanol. Abbreviations: V, vacuole; P, peroxisome. 
 
3.4. Conclusions 
The shift from growth on glycerol to growth and production on methanol leads to a 
drastic change in the yeast proteome. In particular, enzymes from the methanol 
dissimilation pathway start to dominate the proteome while enzymes from the 
methanol assimilation pathway, e.g. the transketolase DAS1, only show a moderate 
increase during the production phase suggesting this pathway as a potential target 
for metabolic engineering to enhance methanol assimilation, e.g. though enhanced 
expression of genes from the methanol assimilatory pathway [28]. Moreover, the 
strong increase of alcohol dehydrogenases, ADHs, in the methanol-fed batch phase 
indicate that ADHs may play an important role in formaldehyde detoxification in 
P. pastoris. 
The accumulation of HBsAg in the ER of P. pastoris leads to the induction of the 
UPR and the ERAD pathway suggesting that potential degradation of HBsAg may 
proceed via the ERAD pathway and through the proteasome. On the other hand, 
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there is no significant decrease in the concentration of HBsAg even after prolonged 
cultivation [126] suggesting that the (lamellar) HBsAg deposits in the ER [125] are 
well protected from proteolytic degradation. Electron microscopic investigations 
revealed autophagic processes mainly related to peroxisome degradation and not to 
degradation of HBsAg deposits. Thus, the activation of autophagic processes also 
by ER-derived misfolded proteins as reported for mammalian [145] but also for 
fungal systems [147] might depend on specific protein properties and also on 
environmental conditions. During methanol-induced production of HBsAg in P. 
pastoris, autophagic processes are clearly related to peroxisome turnover most 
likely provoked by peroxisomal proteins and components damaged by reactive 
oxygen species. 
 
3.5. Methods 
3.5.1. Strain and growth conditions 
The construction of the P. pastoris strain GS115 carrying 8-copies of the HBsAg 
structural gene under the control of the aox1 promoter and displaying a MutS 
phenotype was described before [116]. Cells were grown on defined medium in a 
fed-batch procedure as described earlier [126]. High-level production of HBsAg 
was started after batch growth on glycerol through the addition of methanol to a 
final concentration of 6 g L-1. This methanol concentration was kept constant by 
continuous methanol feeding throughout the entire production phase [126]. 
3.5.2. Sample preparation 
Cells were harvested by centrifugation and washed with phosphate buffered saline 
to remove extracellular proteins and other contaminants. The remaining pellet was 
resuspended in extraction buffer (20 mmol L-1 Tris–HCl, pH 7.6, 10 mmol L-1 
NaCl, 0.5 mmol L-1 deoxycholate, 1 μg mL-1 pepstatin). Cell disruption was 
accomplished by grinding in liquid nitrogen using a Mortar Grinder (RM 100, 
Retsch Gmbh & Co. KG, Germany). The cell debris was removed by centrifugation 
(22 000 × g, at 4°C for 30 min) and 1 mL of the subsequent supernatant treated for 
15 min with 7 μL of nuclease mix (0.5 mg mL-1 DNase, 0.25 mg mL-1 RNase, 50 
mmol L-1 MgCl2). Protein was precipitated with 30% TCA. Finally, the protein 
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pellets were air-dried and dissolved in a solubilization buffer containing 7 mol L-1 
urea, 2 mol L-1 thiourea, 4% (w/v) CHAPS, 1% (w/v) dithiothreitol (DTT), 20 
mmol L-1 Tris, and 1% (v/v) Pharmalyte™ pH 3–10 (Amersham Biosciences). The 
total soluble protein concentration was determined using the BIO-RAD protein 
assay (BIO-RAD Lab., Hartfordshire, USA). The solubilized proteins were stored 
at −70°C until further analysis. 
3.5.3. Two-dimensional gel electrophoresis 
Two-dimensional (2-D) gel electrophoresis was essentially carried out as described 
previously [127]. Briefly, the first-dimension using isoelectric focusing (IEF) was 
run with the IPGphor™ Isoelectric Focusing System (Amersham Biosciences) 
loading 300 μg protein sample onto Immobiline DryStrip gels of pH 3–10 (IPG 
strips, Amersham Biosciences) by in-gel rehydration. IEF was performed with the 
following setting: 30 V×12 h, 300 V×3 h, 600 V×2 h, 1000 V×1 h, gradient from 
1000 V to 5000 V within 2 h, 5000 V×2 h, gradient from 5000 V to 8000 V within 
2 h, then 8000 V×10 h. Prior to the second dimension (SDS-PAGE), the IPG strips 
were equilibrated and then transferred onto lab cast SDS-polyacrylamide gels 
(DALT multiple gel caster and DALT gradient maker, Amersham Biosciences). 
Proteins were separated on 12-16% linear gradient gels using the vertical 
separation unit Hoefer™ System (Amersham Biosciences). Subsequently, gels 
were stained using colloidal Coomassie Blue G-250 according to the “Blue silver” 
protocol [148]. The gels were then scanned (ScanMaker 9800 XL, Umax System 
GmbH, Germany) at 300 dpi resolution. Image analysis, namely protein spot 
detection, matching and quantification were performed using Proteomweaver™ 3.0 
(Definens AG, Germany). 
3.5.4. In-gel trypsin digestion and peptide extraction 
The intracellular proteome was analyzed at different cultivation time points by 2-D 
gel electrophoresis combined with MALDI-TOF analysis. A total of 136 protein 
spots were excised manually from Coomassie brilliant Blue stained 2-D gels, each 
spot was washed several times with 200 μl water, dehydrated in 50 μl acetonitrile, 
and dried in a vacuum concentrator (Eppendorf ® Vacufuge Concentrator 5301, 
Eppendorf AG, Hamburg). The gel pieces were treated with 100 mmol L-1 
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ammonium bicarbonate containing 20 mmol L-1 DTT at 56°C for 30 min and then 
with 100 mmol L-1 ammonium bicarbonate containing 55 mmol L-1 iodoacetamide 
in the dark at room temperature for 30 min. Acetonitrile was added in between the 
treatments to dehydrate the gel pieces. Finally, the gel pieces were washed twice 
with 100 mmol L-1 ammonium bicarbonate, dehydrated with acetonitrile and dried 
in the vacuum concentrator. In-gel digestion was carried out by incubation with 2 
ng μL-1 trypsin (sequencing grade modified, Promega Corp.) in 50 mmol L-1 
ammonium bicarbonate at 37°C overnight. Obtained peptides were extracted and 
then desalted with reversed-phased C-18 ZipTips (Millipore, Billerica, MA, USA) 
before application to the MALDI-TOF sample plates. 
3.5.5. MALDI-TOF MS analysis 
Matrix-assisted laser desorption ionization time-of-flight mass spectrometry 
(MALDI-TOF MS) was employed to obtain the peptide mass fingerprint of a given 
protein. The concentrated peptide solution was mixed (1:1, v/v) with the MALDI 
loading solution (10 mg α-cyano-4-hydoxycinnamic acid, 400 μL acetonitrile and 
600 μL 0.1% trifluoroacetic acid), loaded on the target and dried at room 
temperature. The molecular masses of the tryptic peptides were determined on a 
Bruker Ultraflex time-of-flight mass spectrometer (Bruker Daltonics GmbH, 
Germany). 
3.5.6. Data analysis 
Peptide mass fingerprints obtained by the MALDI-TOF MS were processed using 
FlexAnalysis 2.0 (Bruker Daltonics GmbH, Germany) and used to search NCBInr 
database by using Mascot 2.10 software (http://www.matrixscience.com). The 
parameters used for the search were as follows: taxonomy: other Fungi, tryptic 
digestion, modifications were allowed for carbamidomethylation of cysteine (fixed 
modification) and methionine oxidation (variable modification), one missed 
cleavage site was allowed, all peptides monoisotopic, peptide tolerance at 100 ppm. 
Mascot scores (probability based MOWSE scores) and expect values were 
generated from the Mascot search program. All proteins with a Mowse score ≥ 70 
were regarded as significant (p <0.05). Protein identification was based on the 
recently annotated P. pastoris GS115 genome sequence [110] and the gene name 
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used in this study is according to Pichia pastoris strain GS115 
(http://www.uniprot.org/). If no gene name was given for this strain the gene name 
is according to Pichia pastoris strain ATCC 76273 / CBS 7435 / CECT 11047 / 
NRRL Y-11430 / Wegner 21–1 or general Pichia pastoris (yeast) in case of 100% 
sequence identity (http://www.uniprot.org/). Image analysis from the scanned gels, 
namely protein spot detection, matching and quantification were performed using 
Proteomweaver™ 3.0 (Definiens AG, Germany). The spot volumes were computed 
and normalized for each spot on each gel in relation to the total spot volume of 
each 2D gel. To obtain comparable data, spot intensities were normalized using the 
log2 ratio of induced samples versus uninduced sample. Log2 fold changes above 
0.6 (equivalent to a 1.5 fold changes) were considered significant. 
3.5.7. Ethanol analysis 
Ethanol concentrations were determined by gas chromatography (Shimadzu 14B 
GC, Kyoto, Japan) using a column packed with Carbograph 1AW (20/120; 5% 
carbowax 20 M) (Alltech Associates Inc., Deerfield, IL, USA), column temperature 
160°C, detector: flame ionization detector. 
3.5.8. Electron microscopy and image analysis 
Electron microscopic studies were carried out essentially as described previously 
[125]. Mitochondrial and total cell area were determined from randomly chosen 
cells at the end of the glycerol batch phase (in total: 55 mitochondria in 12 cells) 
and after 112 hours of growth on methanol (in total: 67 mitochondria in 8 cells) 
using Image J Software (National Institutes of Health, Bethesda, Maryland, USA). 
For analysis of vacuolar morphology, 520 cells were randomly chosen for analysis 
(224 cells at the end of the glycerol batch phase, 160 cells 48 hours and 136 cells 
112 hours after the onset of methanol feeding). 
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Appendix I 
Additional file 1 All identified intracellular proteins. The complete list of all 
identified proteins classified into functional categories and their log2 changes in 
response to methanol-induced high-level production of the HBsAg and a 
representative 2D gel image indicating the spots of all identified proteins are given. 
Appendix II  
Additional file 2 Identification of AOX1 in P. pastoris GS115 with a “Muts 
phenotype”. Unexpectedly AOX1 was identified in the supposedly Muts strain of 
P. pastoris GS115 producing high levels of HBsAg. Background information on 
AOX1 identification and discussion about MutS behavior of Mut+ strain is given
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4. Pichia pastoris cellular response to 
overproduction of secretory insulin precursor 
under methanol induction: morphological and 
proteomic analysis  
 
4.1. Background 
The secretion of properly folded proteins is one of the major factors taken into 
account when considering yeast as the preferred host for recombinant protein 
production [11, 13, 149]. Secretion requires the presence of a signal sequence at the 
N-terminus of the foreign protein to target it to the secretory pathway. The 
secretion signal sequence from the S. cerevisiae α-factor-prepro peptide, which is 
located downstream of the aox1 promoter and upstream of the heterologous protein 
gene, has been used with success to facilitate the secretion of numerous 
heterologous proteins [22, 150], including proinsulin [10]. The S. cerevisiae α-
factor prepro-leader consists of a 19-residue signal (pre) sequence followed by a 
66-residue pro-sequence containing three consensus N-linked glycosylation sites 
and a dibasic Kex2 endoprotease (an endopeptidase processing S. cerevisiae α-
factor precursor) processing site [151]. 
In the methylotrophic yeast Pichia pastoris, heterologous proteins can either be 
produced intracellular or secreted into the medium. Since P. pastoris secretes only 
a small amount of endogenous proteins, the secreted product of interest can 
comprise more than 80% of the total protein in the medium [11]. Thus, secretion 
serves as a major first step in purification and eliminates the need for high-cost and 
low-yielding cell disruption or refolding processes [152].  
However, not all recombinant proteins can be efficiently secreted in yeast, and 
endoplasmic reticulum (ER) retention of highly expressed proteins is still a 
problem [112]. The successful high level secretion of recombinant protein can be 
limited by a number of different steps, such as folding, disulfide bridge formation, 
glycosylation, transport within the cell and release from the cell [124]. The 
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physical properties of the target protein can also play an important role on the final 
protein yield [63]. As reviewed in the introduction chapter, the accumulation of 
unfolded proteins in the ER is sensed and leads to initiation of the unfolded protein 
response (UPR) and the ER-associated degradation (ERAD) process. In the yeast S. 
cerevisiae, nearly 400 genes are transcriptionally affected by the UPR and a similar 
proportion of genes has been also reported to be affected by the UPR in other 
yeasts and filamentous fungi [153]. To explore this complex field involving protein 
secretion and degradation, yeasts such as P. pastoris have been used as model 
organism [124, 154].  
Insulin is synthesized as preproinsulin in the pancreatic β-cells and is composed of 
two polypeptide chains, A (21 amino acids) and B (30 amino acids), with three 
disulfide bonds [155]. In this work, the expression of insulin precursor in P. 
pastoris was performed in the following configuration: α-factor leader – KR – 
spacer - insulin precursor, where KR is the Kex2 dibasic endoprotease processing 
site [156]. The Kex2 endoprotease cleaves the leader-insulin precursor fusion 
protein in the late secretory pathway and the folded insulin precursor is secreted to 
the culture supernatant. The spacer peptide (EEAEAEAEPK) localized between the 
leader and the insulin precursor was integrated to optimize Kex2 endoprotease 
processing and insulin precursor yield [157]. The mature insulin precursor is 
secreted as a single-chain N-terminally extended proinsulin-like polypeptide 
consisting of the insulin A chain with 21 amino acids and B chain with 29 amino 
acids (lacking the C terminal B30 threonine) linked via a short synthetic C peptide 
(AAK). It is predicted to be 63 amino acids long with a molecular weight of ~ 7 
kDa [156]. After purification of the insulin precursor and proteolytic removal of 
spacer and C-peptides with trypsin, the amino acid ThrB30 can be added to LysB29 
by trypsin-mediated transpeptidation to generate insulin [156-158]. 
In this study, the intracellular proteome of P. pastoris was analyzed combined with 
ultrastructural analysis to better understand the response of the cell factory forced 
to produce the recombinant secreted insulin precursor (IP) under the control of the 
aox1 promoter. Besides the unfolded protein response, other cell 
responses/adaptation to the carbon feeding condition, such as autophagy, were also 
analyzed throughout the cultivation.  
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4.2. Results and discussion 
To evaluate the cell response to production of the secreted synthetic insulin 
precursor in P. pastoris strain X-33, the global intracellular protein production 
profile combined with electron micrographs was analyzed. The recombinant strain 
was grown to high-cell density in a batch procedure using a defined medium with 
low salt and high glycerol concentrations [156]. Following batch growth, the 
production of IP was carried out by addition of 1.0 g L-1 of methanol. After the first 
pulse, the methanol concentration was increased to 1.5 g L-1 and further to a final 
concentration of 2 g L-1, which was kept constant throughout the remaining 
production phase. Samples for proteomic analysis were taken at 0 h (immediately 
before induction), and at 6, 18, 48 and 120 hours after methanol induction. 
4.2.1. Evaluation of the P. pastoris intracellular proteome 
Glycerol and methanol were the only carbon sources during the growth and 
production phase, respectively. As expected, the proteins related to carbon 
metabolism showed the most relevant changes upon methanol induction. The 
global view of the protein profile changes upon the shifting from glycerol to 
methanol is schematically represented in Figure 4.1. All identified proteins 
according its functionality and log2 fold change in response to methanol-induced 
high-level production of the IP are detailed in Appendix III. 
The enzymes related to methanol metabolism were significantly up-regulated after 
induction with methanol. Most of the enzymes from methanol pathway, such as 
AOX1, CTA1, DAS1, DAK, FLD1, FGH1 and FDH1 were identified and 
represent the majority of the produced proteins during the production phase 
(Appendix III). Some protein spots were identified as being fragments of the full-
length proteins AOX1 and FDH1 (see details in Appendix III). These proteins 
fragments showed an increase in abundance along the production phase. The 
enzymes from the dissimilation pathway showed a significant up-regulation already 
at 6 h after induction with methanol and increased its level along the cultivation 
(e.g., FDH1, 10.7 and 12.3 log2 fold change at 6 and 120 h after induction with 
methanol, respectively). Whereas, the abundance level of the enzymes from 
assimilation pathway were much lower during whole methanol phase (e.g., DAK, 
6.5 and 8.7 log2 fold change at 18 and 120 h after induction with methanol, 
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respectively). According to the mass balance analysis the majority of methanol 
(~70%) was metabolized through the dissimilation pathway and converted into 
carbon dioxide in the methanol fed-batch phase (data not shown).   
In line with the previous chapter, the alcohol dehydrogenase (ADHIII) was 
detected in the proteome of P. pastoris X-33 during growth on glycerol and 
throughout the entire methanol fed-batch phase (Appendix III). The ADH 
abundance was slightly lower than observed during HBsAg cultivation. This is 
probably due to the lower methanol concentration used for IP production in 
comparison to that for HBsAg. This data support the idea about the involvement of 
alcohol dehydrogenases on methanol metabolism as part of the formaldehyde 
detoxification process [26].  
The proteins related to the glycerol, pentose phosphate pathway and TCI cycle 
were mostly down-regulated or kept their level constant after induction with 
methanol (Figure 4.1 and for details see Appendix III).  
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Figure 4.1. The global view of the intracellular proteome profile change upon shifting 
from glycerol to methanol in P. pastoris X-33 producing secretory insulin precursor. 
The red arrow (↑) indicates an increasing and the green arrow (↓) a decreasing amount of the 
enzymes in the methanol fed-batch phase. An orange dash (−) indicates no significant 
change. One arrow indicates small (0.6-1 log2 change), two arrows strong (1–4 log2 change) 
and three arrows very strong changes (> 4 log2 change). The arrows correspond to the 
average of log2 fold change from each functional group. The position of the arrows is 
according to the proteins location in the cell. Only some proteins from each functional group 
are indicated in this figure. The complete list of the identified protein is in Appendix III. 
Abbreviations: TCA, tricarboxylic acid cycle; PPP, pentose phosphate pathway; ERAD, 
endoplasmic reticulum associated degradation; UPR, unfolded protein response; P, 
peroxisome; R, ribosome; ER, endoplasmic reticulum; V, vesicle; M, mitochondria; N, 
nucleus; G, Golgi complex.   
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4.2.1.1. Cellular response to secretory insulin precursor production in P. 
pastoris  
Most of the identified proteins involved in ER stress showed a down-regulation 
throughout the IP production phase (Figure 4.2). Two ER-resident chaperones, 
KAR2 and PDI were identified. The KAR2, also known as BiP in mammalian 
cells, is the central player in folding assistance in the ER. KAR2 plays a role in all 
known functions of the ER, including gating the translocon, folding nascent 
proteins, targeting misfolded proteins for degradation and regulating the unfolded 
protein response [63, 159]. The cytosolic chaperones from the HSP70 family 
(SSA1, SSA3 and SSB), HSP90 and members of the AAA ATPase superfamily 
(ClpB and the AAA ATPase PAS_FragD_0026, named as HSP104 and CDC48 in 
S. cerevisiae, respectively), as well the mitochondrial chaperones CPNA (HSP60 
family) and SSC1 (HSP70 family), which are classical UPR targets [136], were 
also identified and showed a down-regulation during the production phase. The 
ubiquitin-activating enzyme, also known as E1 enzymes (UBA1), which catalyzes 
the first step in the ubiquitination reaction and targets a protein for degradation via 
a proteasome [82] also showed a down-regulation. Additionally, one protein spot 
identified as fragment of the heat shock protein SSA3 with a molecular weight of 
approximately 25 kDa showed a significant increasing level along the cultivation. 
This fragment is probably derived from a degradation process. 
Comparable results were also observed in a second bioreactor cultivation 
performed at similar conditions (Figure 9.1, Appendix III).  
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Figure 4.2. Changes of the intracellular proteome of P. pastoris X-33 in response to 
secretory insulin precursor production containing most of the identified ERAD and 
UPR related proteins. The proteome analysis was done using duplicate 2D gel 
electrophoresis and the average of each spot intensity was calculated. Here only one of the 
duplicate gels used for the analysis is shown. (A) Sections of 2D gels representing parts of 
the intracellular proteome and containing most of ERAD and UPR related proteins, at 0, 6, 
18 and 48h after methanol induction. (B) Representative graphs of the abundance changes of 
each protein spot shown in A. The protein abundance corresponds to an average of the 
resulting value from the duplicate gels used. The bar on the columns in the graphs represents 
the standard deviation. The spot related to fragment SSA3 ~25 kDa is shown in the small 
box. The small map indicates the position of the 2D sections in the entire 2D gel. 
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Although the final yield of IP was approximately 4 g L-1 of cell-free culture 
supernatant [156], the amount of protein which could be retained into the cell was 
not analyzed up to that time. It is known that the up-regulation of ERAD and UPR 
related proteins is caused by unfolded proteins retained in the ER [67]. Since it was 
observed a down-regulation of such proteins, the amount of the IP which was 
secreted to the media and the amount which was retained inside the cells were 
evaluated. It was observed that less than 5% of the insulin precursor stacked inside 
the cell (Figure 9.2, Appendix III). This result confirms a functioning secretory 
pathway and could explain the down-regulation or no stimulation of the UPR and 
ERAD responses.  
With the purpose to compare the proteome profile of the insulin producing strain 
(X-33-IP) with the P. pastoris host strain X-33 (X-33-host), regarding specially the 
proteins related to ERAD and UPR, parallel shake flask cultivations were 
performed and the samples were analyzed by SDS-PAGE. It is important to 
highlight that most of the proteins, until now, related to unfolded protein stress 
have a high molecular weight, i.g. KAR2, 74 kDa; UBA1, 115 kDa; Hsp90, 80 kDa 
and clpB, 100 kDa. In an overview of SDS-PAGE of the crude extract of the 
intracellular proteins of the strain X-33-IP and the X-33-host it is clearly observed 
that the proteins from the upper part of the gel decreased their level during the 
production phase (Figure 4.3). To assure the identity of the referred proteins in the 
SDS-PAGE, some protein bands from the upper part of the gel were analyzed by 
MALDI-TOF. One of the protein bands was identified as clpB and it is indicated 
by the black arrow in Figure 4.3. In the previous chapter, a ER stress caused by the 
recombinant protein production was reported and the clpB showed an up-regulation 
during the production phase of the recombinant protein HBsAg [113]. In a general 
view, the insulin producing strain has a similar proteome profile comparing with 
the host strain which suffers no stress related to recombinant protein 
overproduction.  
To verify if this effect is not strain dependent, the P. pastoris host strain GS115 
(GS115-host) was also analyzed at the same conditions. The shake flask cultivation 
of the GS115 cells harbouring 4 copies of HBsAg gene and 1 copy of chimeric 
protein possessing envelope domain III of dengue virus serotype 2 fused with 
HBsAg (Den2EDIII- HBsAg) was also performed in parallel. The same proteome 
Pichia pastoris X-33 producing IP   60 
profile of strains X-33, i.e., the decreasing level of UPR related proteins, was 
observed in the strain GS115-host, confirming that this profile is not strain 
dependent (Figure 4.3). On the other hand, in the GS115-Den2EDIII-HBsAg, the 
same group of protein showed a constant or even higher level in the production 
phase compared to the growth phase. This effect is probably due to the unfolded 
protein response. 
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Figure 4.3. UPR and ERAD related proteins profile in P. Pastoris X-33 and GS115 
producing and host strains. Crude extracts of the intracellular proteins of the P. pastoris 
insulin precursor producing strain (X33-IP), X-33 host strain (X33-host), chimeric protein 
hepatitis B surface antigen with the envelope domain III of the dengue virus (GS115-Den2 
EDIII-HBsAg) and GS115 host strain (GS115-host) were analyzed by SDS-PAGE. Samples 
at the end of the growth phase directly before induction with methanol (0) and at 6, 72 and 
96 h after induction with 1% methanol were disrupted and analyzed. The black arrow 
indicates the protein clpB identified by MALDI-TOF. Marker: Thermo Scientific, Page Rule 
Plus 26619. 
 
In order to better examine the changes in abundance of these proteins from the 
growth to production phase, Western blot analysis was performed. Due to the lack 
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of specific antibodies against P. pastoris proteins, an anti-HDEL antibody was 
used. Resident proteins of the lumen of ER, such as KAR2 and PIB, carry the 
HDEL C-terminal retention signal [160] and these antibodies have been used to 
detect these proteins [88, 161]. It could clearly be demonstrated that after induction 
with methanol, the proteins recognized by the antibody, KAR2 and PDI, showed a 
lower level in both strains X-33-IP and X-33-host when compared to the growth 
phase (Figure 4.4). However, this decreasing level is stronger in the host strain 
compared to the producing strain. This is probably due to the recombinant protein 
production. On the other hand, the same proteins showed a constant level or even a 
higher level during the production phase of the GS115-Den2EDIII-HBsAg strain 
(Figure 4.4). The ER stress response caused in this strain is probably due to the 
recombinant protein production. In conclusion, although no significant ER stress 
was observed during the production of the secreted insulin precursor, the UPR 
related proteins are still required for the recombinant protein production at certain 
level.  
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Figure 4.4. Western Blot analysis with anti-HDEL. Crude extracts of the intracellular 
proteins of the P. pastoris insulin precursor producing strain (X-33-IP), X-33 host strain (X-
33-host), chimeric protein hepatitis B surface antigen with the envelope domain III of the 
dengue virus (GS115-Den2-EDIII-HBsAg) were analyzed. Samples at the end of the growth 
phase directly before induction with methanol (0) and at 72 and 96 h after induction with 1% 
methanol were disrupted and analyzed. The proteins detected by this antibody are indicated 
with arows. KAR2 has 74 kDa and PDI has 58 kDa. Marker: Fermentas, Page Rule Plus 
Prestained SM1811. 
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Secretion efficiency is not dictated solely by a signal sequence, but in part, it 
depends on the nature of the protein [10]. One limiting factor for a successful 
secretion to the medium could be the tertiary structure of the protein. The protein β-
glucosidase from Pyrococcus furious has a tetrameric nature and it was reported to 
be retained in the ER of S. cerevisiae. The possibility that such retention was 
provoked by a tetrameric missassociation was not exclude [162]. Furthermore, 
copy number was also reported to cause a bottleneck during protein secretion 
[163]. Parekh et al. [163] used bovine pancreatic trypsin inhibitor (BPTI), a small 
polypeptide with 58 aa, as a model for studying secretion and the role of folding in 
the ER. It was found that the level of protein secretion driven by multiple copies of 
the expression cassette compared to a single copy was very similar. Gene 
transcription was higher in the multicopy strain, as expected, but the binding of 
conformation-specific antibodies showed that the majority of BPTI was improperly 
folded and retained in the ER lumen. It was suggested that the limitation for the 
secretion may be the maintenance of correct tertiary structure of the recombinant 
protein or insufficient levels of ER-resident protein folding chaperones.  
Given that the produced insulin precursor is a small protein composed of 63 aa, it 
has only three disulfide bonds and it is not glycosylated, it is assumed that such non 
complicated structure facilitates protein folding, transport through the secretory 
pathway and consequently does not provoke folding stress to the cells. 
Additionally, as previously described, the IP gene sequence was constructed to 
improve the secretion of the IP to the culture supernatant with the replacement of 
the human proinsulin C-peptide with a small C-peptide (AAK) and insertion of the 
spacer peptide between leader and the insulin precursor. Moreover, the clone 
carries only one copy of insulin precursor gene which probably does not 
overburden the protein folding assistants.  
In line with the obtained data, it was recently reported the influence of the protein 
physical features, such as size and number of disulfide bonds, on the dysfunction of 
the secretory pathway in the yeast S. cerevisiae [81]. The secretion of the small 
insulin precursor was compared with the large protein α-amylase and although a 
higher level on mass basis of α-amylase was secreted, six-fold more insulin 
molecules were secreted to the medium. This result shows that the protein 
properties influence the amount of protein secretion. The oxygen and ATP 
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consumption was lower in cells producing insulin then in cells producing α-
amylase, likely because IP is shorter and has less disulfide bonds. For a successful 
recombinant protein production, the transcription should be as high as possible 
without overburding the ER folding capacity, bringing the cell to an oxidative 
stress condition. However, this optimal expression level will be different according 
to the protein, since protein folding rates will vary according to the protein size and 
structure [81].  
In addition, the higher amount of proteins related to the UPR and ERAD detected 
at the end of the growth phase when compared to the production phase (Figure 4.2, 
4.3 and 4.4, at 0h) might be related to the environmental condition. The same 
abundance level of those proteins was also observed in the middle of the growth 
phase (data not shown). For the growth phase a high amount of glycerol (95 g L-1) 
was used and the cultivation was performed at 30°C. As described previously in the 
introduction chapter, high temperature [88] and high osmolarity (140 mOsm Kg-1 
was considered a low and 1350 mOsm Kg-1 a high osmolarity) [94] result in the 
induction of proteins from UPR. Generally, the induction of the UPR may not be 
only a result of high concentration of ionic solutes but it is also triggered by high 
osmotic pressure induced by other substances [94]. It has been reported for 
mammalian cells that high hexose concentration can lead to UPR induction [164]. 
The osmolarity of the culture supernatant of the bioreactor samples was analyzed. 
It was approximately 1780 mOsm Kg-1 at the beginning of the growth phase, 822 
mOsm Kg-1 at the end of the growth phase and 560 mOsm Kg-1 at the end of 
production phase. It is assumed that the higher level of the UPR related proteins 
during the growth phase may be caused by the high osmolarity in the medium and 
the high temperature used. It has been reported that osmotic stress applied prior to 
the induction of protein secretion resulted in higher level of scFc antibody in P. 
pastoris [95]. Therefore, the presence of high amount of chaperones and folding 
helpers at the beginning of the induction phase may also explain the fine folding 
competence of the cells leading to an efficient IP production and secretion.  
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4.2.2. Autophagic processes in P. pastoris: a cell adaptation 
response 
Cells were first grown in a batch procedure on defined medium with glycerol as 
carbon substrate. After depletion of glycerol, the production of insulin precursor 
was induced by the addition of methanol in gradually increasing steps for a better 
cell adaptation [156]. First methanol was added to a final concentration of 1 g L-1. 
About 24 h after the initial methanol pulse, the concentration of methanol in the 
bioreactor was further increased to 1.5 and later (~30 h) to 2 g L-1, and it was kept 
constant for the remainder of the cultivation. At the transitional phase from 
glycerol to methanol, the cells were subjected to a short carbon starvation 
condition. With the help of electron microscopy, autophagic processes could be 
observed at the end of the growth phase. Upon nutritional deficiency, fractions of 
the cytoplasm are consumed via autophagy and the resulting catabolic products are 
used as sources of energy or as building blocks for the synthesis of new 
macromolecules [46].  
In the electron micrographs of samples at the end of growth phase, directly before 
induction with methanol, a great number of autophagic vacuoles were observed 
(Figure 4.6 A-C and E). Autophagic bodies (Figure 4.6 A and E) and multilamellar 
membrane structures (Figure 4.6 B and C) were observed inside the vacuoles which 
could be part of a degradation process. The nature of these multilamellar structures 
is not fully understood. Apparently forming autophagosomes could also be 
observed in the cytosol near to the vacuole (Figure 4.6 A and C-E). These vesicles 
seem to contain structures with similar appearance as the ribosomes from the 
cytosol (Figure 4.6 A). However, the classical double membrane of the 
autophagosome [165, 166] was not found. Considering that the cells are not in an 
extreme and long starving situation and the cell response was analyzed in a 
“normal” bioprocess condition (i.e., the autophagy was not intentionally induced), 
it is not an easy task to find autophagosomes, specially when they have a short 
half-life (5-10 min) [166]. Ribosomes entering in the vacuole were also observed 
(Figure 4.6 B). The autophagy of ribosomes, a process called ribophagy, in S. 
cerevisiae cells under nitrogen starvation condition has been reported [47]. A dense 
area was always present in the vacuole (Figure 4.6 A, C and E). Some similar  
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Figure 4.6. Representative transmission electron micrographs of ultrathin sectioned 
cells of P. pastoris X-33 in the transitional phase from glycerol to methanol. (A-E) Cells 
at the end of growth phase, directly before induction with methanol, containing autophagic 
vacuoles were observed. The red arrow in pictures A, C and E indicates the probable forming 
autophagosomes (close view in picture A). In picture A, the white arrowhead indicates an 
empty vesicle; probably the material was already digested. In picture B the white arrow 
indicates probable ribophagy as a consequence of the C-starvation condition. In pictures B 
and C, the white arrowheads indicate multilamellar structures. In picture D, the white arrow 
indicates a probable autophagosome with apparent ribosome inside. In picture F, cells are at 
48 h after methanol induction and the black arrow indicates fragments of the membrane of 
autophagic bodies. In pictures A, C and E the (* symbol) points to a dense area containg 
material for digestion. V, vacuole. 
 
structures have been already described as autophagic bodies containing ribosomes 
of high density and it was suggested they were condensed ribosomes [43]. These 
dense areas were analyzed and, in this sample, the presence of ribosomes could not 
be neither confirmed nor exluded (data not shown). Further analysis should be done 
to clarify the presence of the autophagosomes in the cytosol and its contents. At the 
beginning of the production phase (at 48 h), where the cells were being adapted to 
the new carbon source (methanol), some intact autophagic bodies were still present 
inside the vacuole, but in most of the cells fragments of autophagic bodies were 
detected representing the degradation of the vesicle membrane (Figure 4.6 F). 
An examination of ribosomes in yeast S. cerevisiae under nitrogen starvation 
conditions has revealed that these structures are more rapidly degraded compared 
to other cytoplasmic components, supporting the idea of a selective degradation 
process [47]. As ribosomes constitute about half of the total cellular protein [46], 
their degradation may be a major amino acid source under nutrient limiting 
conditions. Furthermore, by the fact that both ribosome biogenesis and protein 
translation are highly energy consuming processes, ribophagy might contribute to 
the rapid down-regulation of these processes and effectively save energy [47].  
Up to this date, most of the researches regarding ribosome degradation were based 
on S. cerevisiae under N-starvation condition. Since the typical strategy to produce 
recombinant protein in P. pastoris is based on two steps process (growth phase and 
induction phase) using glycerol and methanol as carbon source, it seems to be 
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relevant to perform further studies to elucidate how the carbon starvation period 
during this transition phase is overcame by the cells and which influences it could 
bring to cell viability and protein production.  
4.2.2.1. Pexophagy: degradation of peroxisomes 
P. pastoris is a valuable model system for the study of methanol metabolism [23, 
25], peroxisome biogenesis [34] and pexophagy [144]. In the recent ultrastructural 
analysis of P. pastoris GS115 producing high-level of intracellular HBsAg, 
pexophagy was described. In that study, cells were first grown to high-cell density 
in a batch process, using a simple defined medium and high glycerol 
concentrations. After batch growth, induction of high-level product formation was 
achieved by adding methanol to a final concentration of 6 g L-1 and keeping this 
high concentration for the remainder of the production phase [126]. From 48 h after 
methanol induction, the pexophagy process was already observed and it seemed to 
become more intense along the cultivation. Approximately 9% and 12% of the total 
cells randomly counted from overview images, at 48 h and 112 h after induction 
with methanol, respectively, showed peroxisomes clearly been engulfed by 
vacuoles in the cells producing HBsAg (Figure 4.7 A and C).  
The strategy to produce the secretory HBsAg was modified and the methanol 
amount was decreased to a final constant concentration of 2 g L-1 to produce the 
secretory IP [156]. In the ultrastuctural analysis of cells from this new condition, it 
was noticed that although the peroxisomes were already present in large amount at 
48 h after methanol induction, no peroxisome degradation was observed (Figure 
4.7 A and B). Just from the next time point analyzed, at 96 h after methanol 
induction, pexophagy could be observed (Figure 4.7 A and B). Nevertheless, 
comparing with HBsAg production, only in 6% of the total cells a clear pexophagy 
process could be observed (Figure 4.7 A). The average of the methanol 
consumption rate throughout the induction phase was lower in the cells producing 
IP (2.6 g L-1 h-1) compared to the cells producing HBsAg (4.1 g L-1 h-1). The 
difference on the initiation and intensity of pexophagy in the cells under these two 
different methanol feeding strategies is probably due to the amount of ROS 
generated related to the methanol consumption rate along the induction phase. 
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Figure 4.7. Images of recombinant P. pastoris cells growing on methanol. (A) 
Representative graph showing the (%) of the cells, of the total counted cells, in which the 
vacuole is clearly engulfing the peroxisome. Samples of P. pastoris X-33 producing IP and 
P. pastoris GS115 producing HBsAg at 48 and 100 h* after methanol induction were 
analyzed. (B) Electron microscopy of P. pastoris X-33 at 48 h and at 96 h on methanol for 
production of secretory IP. At 48 hours the peroxisomes are still in cluster near to the 
vacuole and no pexophagy is observed. At 96 h pexophagy could be observed. (C) Electron 
microscopy of P. pastoris GS115 at 48 h and at 112 h on methanol for production of HBsAg. 
Pexophagy could be already observed at 48 h. The red arrow points to the vacuole engulfing 
the peroxisomes. P, peroxisome; V, vacuole. The (*) symbol means approximately 100 h, 
(i.e., 96 h in IP and 112 h in HBsAg cultivation). 
 
In Hansenula polymorpha, the increase of ROS related to excess of methanol was 
linked with peroxisome degradation [146]. Pexophagy is considered a 
housekeeping mechanism where the peroxisomes are constantly degraded and 
regenerated in a vegetative growth condition (i.e., chemostat cultivation with the 
same carbon source) probably to prevent the accumulation of non-functional 
peroxisomal proteins [56]. However, the threshold to launch the peroxisome 
degradation is still unclear. The increase of ROS in the peroxisomes in an atg1 H. 
polymorpha mutant (atg1 is required for autophagy) was linked to catalase activity 
reduction in some peroxisomes of the mutant cells [56]. The peroxisomal 
membrane proteins, such as Pex3, have been speculated to be the signal for the 
peroxisome turnover, suggesting that the signal for degradation comes from the 
inside of the organelle [146]. It is accepted that ROS induces autophagy in general, 
and H2O2 has been implicated as a signalling molecule in various signal 
transduction pathways, including autophagy [167]. Nevertheless, how this 
oxidative signal is transmitted is still a question to be solved.  
In agreement with the previous chapter, the peroxisomes were degraded by 
micropexophagy mode (it can be observed in the close views of Figure 4.7 B at 100 
h). In micropexophagy, the vacuole membrane invaginates and engulfs the 
peroxisomal cluster directly to degrade it. This vacuolar membrane re-arrangement 
is an energy demanding process and the choice of autophagy mode was assumed to 
be controlled according to the ATP availability in the cell [51]. To control the ROS 
accumulation in the peroxisomes may help to reduce the oxidative stress to the cell 
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and may delay the initiation of pexophagy and avoid the cell energy consumption 
deviation from the final product production.  
 
4.3. Conclusions  
The presented data revealed a general down-regulation of the proteins related to 
UPR and ERAD along the production phase of the secreted insulin precursor. It 
suggests that the production of insulin precursor does not provoke any significant 
stress to the cell. The physical feature of the insulin precursor, such as its small size 
and low number of disulfide bonds, may facilitate a correct protein folding and 
consequently leads to a successful secretion of the recombinant protein. 
Additionally, the environmental condition, such as relative high temperature and 
high osmolarity during the growth phase of the cultivation, may trigger the 
induction of proteins related to UPR which could benefit and increase the folding 
competence of the cells facilitating the secretion of insulin precursor to the 
medium.  
So far, most of the studies focus on the induction of unfolded protein response in 
order to discover new bottlenecks of this pathway or the application of these 
proteins to increase the final production and secretion of the recombinant protein 
[89, 96, 136]. Protein secretion in eukaryotic cells is a complex process involving 
many interacting participants. The successful high level secretion of recombinant 
protein may be limited not only at a number of different steps, such as folding, 
disulfide bridge formation, glycosylation, transport within the cell, and release 
from the cell but also it is intimately related to the protein physical properties as 
demonstrated in this work. 
Autophagic responses to nutrient conditions during the cultivation were also 
observed. At the end of the growth phase, just before induction with methanol, the 
cells were subjected to a short carbon starvation condition. At this transition period, 
the cells have to find a source of energy and degrade its own organelles. According 
to the results, apparent degradation of ribosome, called ribophagy, was observed. 
Ribophagy is most reported in S. cerevisiae under nitrogen starvation. Here, 
ribophagy in P. pastoris as a response to the cell under carbon starvation condition 
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can be strongly suggested. During the induction phase, the degradation of the 
peroxisomes, named as pexophagy was observed. Differently from the HBsAg 
production strain, where the degradation of peroxisome was observed in the 
beginning of the production phase, in the IP cultivation the pexophagy process 
started later. This is probably due to the lower ROS generated as consequence of 
the lower methanol consumption rate during the IP production. Pexophagy seems 
to have an important role in cell maintenance during growth on methanol, making 
it essential to better understand the mechanism, the stimulus behind it and the 
influence of pexophagic process on the final protein production. This knowledge 
may help to improve final recombinant protein yields.  
 
4.4. Methods 
4.4.1. Yeast strains  
The construction of the P. pastoris host strain X-33 carrying insulin precursor gene 
under the control of the aox1 promoter and harbouring a Mut+ phenotype used for 
this study was described previously [156]. A synthetic codon-optimized gene 
encoding the IP was inserted into the polylinker of this vector, in-frame with the S. 
cerevisiae α-factor secretion signal sequence to create the expression plasmid 
pPICZα-IP, which was then integrated into the genome of P. pastoris strain X-33. 
Transformation of P. pastoris, selection and screening of transformants to identify 
clones harboring the IP inserts, the isolation of putative multicopy clones using the 
zeocin screening protocol, and the identification of the methanol utilization (mut) 
phenotype were described previously [156]. The clone GS115-Den2-EDIII-HBsAg 
(GS115 cells harbouring 4 copies of HBsAg gene and 1 copy of chimeric protein 
possessing envelope domain III of dengue virus serotype 2 fused with HBsAg) 
used as a control is from a collaboration project (ICGEB, India). The P. pastoris X-
33 and GS115 host strains, used as a control are from Invitrogen (Invitrogen, 
Carlsbad, CA). 
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4.4.2. Growth conditions 
Shake flask cultivation 
In 500 mL baffled shake flasks, 100 mL basal medium (20 g L-1 glycerol,          
13.4 g L-1 yeast nitrogen base without amino acids, 400 µg L-1 biotin in ddH2O) 
were inoculated with 100 µL glycerol stock of the respective P. pastoris clones,   
X-33 host strain, X-33 insulin producer, GS115 host strain and GS115-EDIII-
HBsAg. The cultures were grown for approximately 36 hours at 30°C and 250 rpm 
to gain an OD600 of 8 – 10. Next, 1 mL of this pre-inoculum was used to inoculate 
100 mL fresh basal medium. After approximately 20 h, when the culture reached 
an OD600 of 3 – 5, 450 mL defined medium (as described below for the bioreactor 
cultivation) were inoculated with 50 mL of inoculum in a 2 L baffled shake flask. 
The culture was grown for 30 – 40 hours at 30°C and 150 rpm. Afterwards cells 
were washed with sterile PBS and resuspended in defined medium without glycerol 
to an OD600 of 100. To induce recombinant protein production, 0.5% of methanol 
(100%) was added, which was repeated every 12 hours. Samples at different time 
points were harvested by centrifugation at 13.000 rpm at 4°C. The pellet was 
immediately frozen in liquid nitrogen and stored at -80°C.  
Bioreactor 
High-cell density cultivations were carried out in a 15 L BIOSTAT-C (B. Braun 
Biotech International, Germany) bioreactor essentially as described previously 
[126]. A 1 L preculture was transferred to the bioreactor containing 7 L growth 
medium. The growth medium contained per liter: glycerol, 95.2 g; potassium di-
hydrogen phosphate, 9.4 g; yeast trace metal (YTM) solution, 4.56 g; ammonium 
sulfate, 15.7 g; magnesium sulfate hepta-hydrate, 4.6 g; calcium chloride di-
hydrate, 0.28 g; and biotin, 0.4 mg. The YTM solution contained: potassium 
iodide, 207.5 mg L-1; manganese sulfate, 760.6 mg L-1; di-sodium molybdate, 484 
mg L-1; boric acid, 46.3 mg L-1; zinc sulfate hepta-hydrate, 5.032 g L-1; ferric 
chloride hexa-hydrate, 12.0 g L-1; and sulfuric acid, 9.2 g L-1. Foaming was 
controlled by the addition of antifoam (Ucolub N115). Temperature was 
maintained at 30°C and pH at pH 5.5 with 12.5% (v/v) NH4OH or 1 mol L-1 
H3PO4. Aeration rate was maintained at 4 L min-1 throughout the process. The 
stirrer speed was controlled between 100 to 1370 rpm aiming at dissolved oxygen 
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(DO) concentration of 20% air saturation. After consumption of glycerol, indicated 
by an increase of the DO concentration, production of recombinant IP was initiated 
by step-wise addition of a methanol solution [96.6% (w/w) methanol and 4.4% 
(w/w) YTM] to a final methanol concentration of 2 g L-1, which was maintained 
constant throughout the remainder of the induction period based on on-line 
measured methanol concentrations determined from the methanol vapor in the off-
gas using a flame ionization detector (Ratfish Instruments, Germany). Based on the 
gas liquid phase equilibrium methanol concentrations were determined in the off-
gas using two point calibrations directly before and after induction. The 
concentrations of oxygen and carbon dioxide in the exhaust gas were determined 
by paramagnetic and infrared exhaust gas analysis systems, respectively (Maihak, 
Hamburg, Germany) [156]. Cells were harvested by centrifugation and washed 
with phosphate buffered saline to remove extracellular proteins and other 
contaminants. The pellet was stored at -80°C immediately.  
Methanol consumption rate 
Methanol consumption rate (g L-1 h-1) during the methanol phase, was determined 
by dividing the total methanol consumed (g) by the cultivation time (h) and volume 
of the culture (L). The volume of the culture was assumed to be constant 10 L. 
4.4.2.1. Osmolarity analysis of the culture supernatant  
The osmolarity of the culture supernatant samples was measured by freezing-point 
depression with an Osmomat 030 (Gonotec, GmbH, Berlin, Germany). 
4.4.3. Two-dimensional gel electrophoresis  
The detailed protocol of 2D gel electrophoresis is described in Appendix IV.  
4.4.3.1. Sample preparation 
Cell pellets were washed with ice-cold 1× PBS, resuspended in 1 mL cell lysis 
buffer (7 mol L-1 urea, 2 mol L-1 thiourea, 30 mmol L-1 Tris, 4% (w/v) Triton, pH 
8.5), OD600 adjusted to a final 50 and combined with 500 μL of glass beads (0.5 
mm, Sartorius, Germany). For cell disruption, samples were treated in a Thermo 
Savant Fastprep FP120 (homogenizer) twice (speed 6.00 m/s for 30 s; cooling 
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interval of 30 s between treatments). Afterwards, cellular debris was pelleted by 
centrifugation at 13000 rpm at 4°C for 5 min, the supernatant was removed and 
protein was precipitated using chloroform and methanol. Finally the protein pellets 
were air-dried and dissolved in 500 µL of resolubilization solution (9 mol L-1 urea, 
2 mol L-1 thiourea, 4% CHAPS, 2 mg mL-1 Tris, 0.2% SDS, 0.002% bromophenol 
blue, containing IPG commercial buffer). The solubilized protein was stored at -80 
ºC until further analysis by two-dimentional gel electrophoresis.  
4.4.3.2. Isoelectric focusing and SDS-PAGE  
The first-dimensional of isoelectric focussing (IEF) was run with the IPGphorTM 
Isoelectric Focussing System (Amersham Biosciences, UK) at 20°C with a current 
of 30 µA per strip. 400 µg of each protein sample were loaded onto Immobiline 
DryStrip gels of pH 3–10 NL (IPG strips, Amersham Biosciences, UK) by in-gel 
rehydration. IEF was performed with the following setting: 0 V × 35h, 50 V × 4 h, 
gradient from 100 V to 300 V within 4h, gradient from 300 V to 1000 V within 3h, 
gradient from 1000 V to 3500 V within 4h, gradient from 3500 V to 5000V within 
3h, 5000 V × 3h, gradient 5000 V to 8000 v within 3h, then 8000 V × 10h. Before 
the second-dimension (SDS-PAGE), the IPG strips were equilibrated and then 
transferred onto 12% SDS-PAGE gel. The second-dimension was carried out using 
the vertical separation unit HoeferTM System (Amersham Biosciences) at 10°C in 
constant working voltage mode as follows: 40 V for 2 h and then 100 V overnight. 
Subsequently, gels were stained using colloidal Coomassie Blue G-250 according 
to the "Blue silver" protocol [15]. The gels were then scanned (Epson Perfection 
V750 Pro, Epson, Germany) at 300 dpi resolution to acquire the gel images.  
4.4.4. In-gel trypsin digestion and peptide extraction 
The detailed protocol of in-gel trypsin digestion is described in Appendix IV.  
Protein spots were excised manually from the stained gels, washed several times 
with 200 μL water, dehydrated in 200 μl acetonitrile, and dried in a vacuum 
concentrator (Eppendorf ® Vacufuge Concentrator 5301, Eppendorf AG, 
Hamburg). The gel pieces were treated with 100 mmol L-1 ammonium bicarbonate, 
containing 20 mmol L-1 DTT at 56°C for 30 min and then with 100 mmol L-1 
ammonium bicarbonate containing 55 mmol L-1 iodoacetamide in the dark at room 
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temperature for 30 min. Acetonitrile was added in between the treatments to 
dehydrate the gel pieces. Finally, the gel pieces were washed twice with 100 mmol 
L-1 ammonium bicarbonate, dehydrated with acetonitrile and dried in the vacuum 
concentrator. In-gel digestion was carried out by incubation with 2 ng µL-1 trypsin 
(sequencing grade modified, Promega Corp.) in 50 mmol L-1 ammonium 
bicarbonate at 37°C overnight. Obtained peptides were extracted, washed with a 
buffer for desalting (10 mmol L-1 ammonium phosphate, monobasic in 0.1% TFA) 
and then loaded to PAC (Prespotted Anchor Chip, Bruker Daltonics GmbH, 
Germany) targed for MALDI-TOF analysis. The molecular masses of the tryptic 
peptides were determined on a Bruker Ultraflex time-of-flight mass spectrometer 
(Bruker Daltonics GmbH, Germany).  
4.4.5. Database searching and identification of proteins 
Peptide mass fingerprints obtained by the MALDI-TOF MS were processed using 
FlexAnalysis 2.0 (Bruker Daltonics GmbH, Germany) and used to search NCBInr 
database by using Mascot 2.10 software (http://www.matrixscience.com). The 
parameters used for the search were as follows: taxonomy: other Fungi, tryptic 
digestion, modifications were allowed for carbamidomethylation of cysteine (fixed 
modification) and methionine oxidation (variable modification), one missed 
cleavage site was allowed, all peptides monoisotopic, peptide tolerance at 100 ppm. 
Mascot scores (probability based MOWSE scores) and expect values were 
generated from the Mascot search program. All proteins with a Mowse score 
greater than 71 were regarded as significant (p < 0.05). For most peptide mass 
fingerprints, a single significant (P<0.05) hit with probability-based Mowse score 
>71 was obtained. In rare cases the Mowse score was <71, which indicates that the 
protein was not identified with reliability above the level of significance. These 
protein spots was excluded from the results unless the identification was confirmed 
by MS/MS. Image analysis from the scanned gels, namely protein spot detection, 
matching and quantification were performed using Proteomweaver™ 3.0 
(Definiens AG, Germany). For each sample, 2D gels were made in triplicate. And 
the best two gels were analyzed. The spot volumes were computed and normalized 
for each spot on each gel in relation to the total volume spot on each 2D gel. To 
obtain comparable data, spot intensities were normalized, using the log2 ratio of 
induced samples versus uninduced samples. Log2 fold changes above 0.6 
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(equivalent to a 1.5 fold change) were considered significant. The gene name used 
is this study is according to Pichia pastoris strain GS115 (http://www.uniprot.org/). 
If no gene name is given for this strain the gene name is according to Pichia 
pastoris (strain ATCC 76273 / CBS 7435 / CECT 11047 / NRRL Y-11430 / 
Wegner 21-1) or Pichia pastoris (yeast) in case of 100% sequence identity 
(http://www.uniprot.org/). 
4.4.6. SDS-PAGE and Western Blot 
The crude extract of the samples from the shake flask cultivation, described in 
4.3.2, was analyzed by SDS-PAGE 12%. Sample at 0 h i.e., at the end of the 
growth phase directly before induction with methanol and at 72 h and 96 h after 
induction with methanol were harvested. Samples corresponding to 100 OD units 
(1 mL) were transferred and pelleted by centrifugation at 13,000 rpm for 15 min. 
Cell pellets were resuspended in cell lysis buffer (25 mmol L-1 phosphate buffer, 5 
mmol L-1 EDTA, 0.5 mol L-1 NaCl, 8% glycerol, 1 µg/mL pepstatin A, 1 mmol L-1 
PMSF, pH 8.0) and adjusted to a final OD600 30 and a final 700 mL was combined 
with 500 μL of glass beads (0.5 mm, Sartorius). For cell disruption, samples were 
treated in a Thermo Savant Fastprep FP120 (homogenizer) seven times (speed 6.00 
m/s for 30 s; cooling interval of 30 s between treatments). 
For the Western blot analysis, the intracellular proteins were separated on 12% 
SDS-PAGE and electrobloted onto a PVDF membrane (Bio-Rad, Hercules, USA) 
at 12 volts for 45 min. The membrane was blocked with 5% skimmed milk (Difco, 
France) in PBS (phosphate buffer saline) containing 0.5% Tween 20 (PBS-T 
buffer) for 2 h. After washing the membrane with PBS-T buffer, the mouse anti-
HDEL (2E7) (sc-53472; Santa Cruz Biotechnology), diluted to 1:1000 in PBS-T 
containing 2.5% skimmed milk, was added and the membrane incubated for 1 h at 
room temperature. After washing with PBS-T buffer, the secondary antibody, anti-
mouse (Calbiochem, Germany) diluted to 1:5000 was added and incubated for 1 h. 
Protein bands of Western blots were visualized using TMB (3,3´,5,5´ 
tetramethylbenzidine, Sigma, Germany) as substrate. 
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4.4.7. Quantification of insulin precursor production by reverse 
phase high performance liquid chromatography  
A HPLC system equipped with a system controller, intelligent pump L-6200A 
(Merck-Hitachi), auto sampler, column temperature control compartment and an 
UV-Vis detector IS-3702 Sama was used. The analyses were carried out on 
reversed phase ZORBAX Poroshell 300SB C8 column (Agilent Technology) (75 × 
2.1 mm, with a pore size of 300 Å). Seeing that IP doesn`t contain any tryptophan 
residue, the main contributor for absorbance at 280 nm, the detector was set at 214 
nm. Mobile phase A consisted of 0.1% (v/v) trifluoroacetic acid (TFA) (Sigma-
Aldrich, Germany) in water and mobile phase B consisted of 0.1% (v/v) TFA in 
acetonitrile (Carl Roth GmbH, Germany). The analyses were performed at a 
column temperature of 30°C and flow rate of 1.0 mL min-1. Elution was done with 
a linear gradient of increasing acetonitrile concentration (0.5% up to 29%) over 22 
min. The injection volume was 50 μL for both standard and samples. Samples were 
taken at 120 h after induction and cells were lysed with glass beads as described 
previously. Pure IP was used as control for the retention time. Sample before 
induction and GS115 host strain were used as a negative control to check if none of 
natural proteins has the same retention time. 
4.4.8. Electron microscopy and image analysis 
Electron microscopic studies were carried out essentially as described previously 
[125]. For the vacuole morphology analysis a total of 628 cells were randomly 
chosen (100 cells at the end of the growth phase, 223 cells after 48 h and 305 cells 
after 96 h of methanol induction). 
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5. Final conclusions and outlook 
The methylotrophic yeast Pichia pastoris is one of the most important expression 
systems and has been extensively used for the production of recombinant proteins. 
However, this yeast is still not adequately characterized at the physiological and 
proteomic level, especially in relation to its physiological responses to the stressful 
environment in a bioreactor. 
In this work, a comprehensive analysis of the P. pastoris cell response when forced 
to produce recombinant proteins under methanol induction in a relevant bioprocess 
condition was done at proteomic and morphological level. The response to the 
overproduction of the hydrophobic hepatitis B virus surface antigen (HBsAg) in 
strain GS115 and the secreted insulin precursor (IP) in strain X-33 was evaluated 
using 2D gel electrophoresis combined with MALDI-TOF. In parallel, 
morphological studies using transmission electron microscopy (TEM) were also 
performed to investigate autophagic processes, the auto-degradation of cellular 
components, during the cultivation as a response to nutrient conditions.  
In both cultivations, basically the same strategy was used. The cells were first 
grown in defined medium with high amounts of glycerol as carbon source. After 
depletion of glycerol, the production phase was initiated by adding a defined 
amount of methanol. For HBsAg, methanol was maintained at 6 g L-1, and for IP 
the final concentration was maintained at 2 g L-1. The most significant change in 
the intracellular proteome after methanol induction compared to the profile before 
induction was detected in the proteins from the carbon metabolism. The majority of 
methanol was metabolized via the energy generating dissimilation pathway leading 
to a corresponding increase in mitochondrial size and numbers. Although the 
energy generation is one of the roles of the dissimilation pathway during growth on 
methanol, the detoxification of formaldehyde, which is a by-product of methanol 
metabolism, is considered its main task [25, 168]. Regarding the methanol 
metabolism, the assimilation pathway is a potential target to enhance the 
assimilation of methanol into biomass and recombinant protein. Moreover, the 
presence of alcohol dehydrogenases (ADHs) in the cells during the methanol-fed 
batch phase, in both cultivations, indicates that ADHs may play an important role 
in formaldehyde detoxification in P. pastoris. 
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Due to the methanol induction, cells were subjected to oxidative stress. In addition 
to formaldehyde, the reactive hydrogen peroxide (H2O2) is also generated in the 
first step of the methanol oxidation and the up-regulation of anti-oxidant enzymes 
and degradation of peroxisomes were detected in both cultivations. The 
accumulation of the reactive oxygen species (ROS), as well as the decrease of the 
activity of some peroxisomal enzymes, has been linked to peroxisome degradation, 
also named pexophagy [56]. It was observed that the initiation of the pexophagy 
started earlier in the cells from HBsAg cultivation compared to the IP cultivation. 
This is probably a result of the higher methanol consumption rate during HBsAg 
production, which may generate and accumulate more ROS in the peroxisomes. 
However, in both cultivations, pexophagy was observed throughout the production 
phase. A housekeeping mechanism can be suggested for P. pastoris cells growing 
on methanol as was suggested for the yeast H. polymorpha [146]. Such mechanism 
may prevent the accumulation of non-functional peroxisomal proteins by degrading 
the old and regenerating new peroxisomes. Despite of its significance, several 
aspects regarding pexophagy still remain to be solved. The origin of membrane 
material for the autophagosome, the signaling for pexophagy regulation or the 
physiological roles for micro- or macropexophagy is still unclear. Moreover, to 
investigate if pexophagy has some influence on the final recombinant proteins yield 
could be an interesting point to be elucidated.  
Autophagic response was observed not only during production phase but also at the 
end of the growth phase as a consequence of nutrient limitation, as analysed in the 
IP cultivation. Before methanol induction, the cells were subjected to a short 
carbon starvation period and as a response the cells started to degrade its own 
components. Autophagic bodies were observed inside the vacuole during this 
transition period from glycerol to methanol. Structures with appearance of 
ribosomes were detected inside the autophagic bodies and also entering into the 
vacuole. Ribophagy, the degradation of ribosomes, has been reported on S. 
cerevisiae under nitrogen starvation [47]. Here, ribophagy in P. pastoris cells as a 
response to carbon starvation condition can be strongly suggested. 
The stress related to protein overproduction was also analyzed. Regarding this 
point, two different cell responses were observed depending on the protein which 
was produced. The production of HBsAg caused stress to the cells, showed by the 
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up-regulation of some proteins related to ERAD (endoplasmic reticulum associated 
degradation) and UPR (unfolded protein response). During the methanol 
production phase, high-level of HBsAg was produced and translocated into the ER 
but not further processed in the secretory pathway. The accumulation of HBsAg in 
the ER triggered the expansion of the ER which bulged into cloud-shaped irregular 
formations [125]. HBsAg contains 14 cysteines per 226 amino acid monomer, 
providing opportunity for numerous different disulfide bonds formation [169]. The 
folding stress might be provoked not only because of the physical feature of the 
recombinant protein, such as hydrophobicity, size and number of disulfide bonds, 
but also due to the high copy number of the HBsAg gene inserted into the yeast 
genome.  
On the other hand, the production of the small IP does not provoke any relevant 
unfolded protein stress response to the cells. During the production phase, the 
down-regulation of proteins related to UPR and ERAD were detected. The IP 
physical nature, such as its small size and low number of disulfide bonds, may 
facilitate protein folding and consequently the secretion to the extracellular space. 
Additionally, an elevated amount of proteins from the UPR and ERAD during the 
glycerol growth phase was observed. This is probably due to the cultivation 
conditions used, such as the high temperature and the high osmolarity. This prior 
induction of chaperones and foldases might condition the cells for a better folding 
performance and seemed to positively affect the IP folding and secretion. Further 
studies should be done to better understand the regulation of the ERAD and UPR 
related proteins during the growth phase of P. pastoris facing different 
environmental conditions, such as osmotic stress, and its influence on insulin 
precursor secretion level.  
When the folding machinery gets overloaded, the folding is slow compared to the 
disulfide bond formation and the unfolded protein may go through many futile 
redox cycles, required to fix incorrect disulfide bonds, producing excess of ROS 
[81]. For a successful production of the recombinant protein, the transcription rate 
should be as high as possible without overloading the ER folding capacity and 
sending the cell into an oxidative stressed state [81]. But this optimal condition will 
be different for different proteins. As described in this work, different cell response 
regarding unfolding protein stress was observed in P. pastoris producing HBsAg 
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and IP. Such differences might be caused because of the properties of each protein. 
To reach a balance, either the protein folding rate must be increased by expression 
of chaperones for instance [98], or the oxidation rate must be decreased by limiting 
the oxidation of ERO1, as suggested by Tyo et al. [81]. 
Improvements in the production titer of heterologous protein have been achieved 
from milligrams to grams per liter based on optimization of the fermentation 
process and strain engineering in the past decade. However, the strategies 
sometimes are useful only for a specific protein and the same engineered strain 
could not be used as a general cell factory platform for the production of a range of 
different recombinant proteins. The protein properties as well as the gene copy 
number inserted in the strain play an important role on the production efficiency. 
An increased molecular understanding of the secretory pathway of the individual 
processes can be used to guide general models for protein secretion and used for 
engineering design of new cell factories. 
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7. Appendix I 
7.1. All identified intracellular proteins 
The complete list of all identified proteins classified into functional categories, a representative 2D gel image indicating the spots of all identified 
proteins and their log2 changes in response to methanol-induced high-level production of the HBsAg are given. 
 
The complete list of all identified proteins classified into functional categories. 
NCBI 
Accession-No 1 Locus ID 
1 Gene name 2 Protein name2 MM (kDa) 3 pI 3 Mascot Score Spot No 
4 
Functional category 1               
1. Metabolism  
1.1 Carbohydrate metabolism  
      Methanol metabolism 
XP_002494271 PAS_chr4_0821 AOX1 Alcohol oxidase  74.5 6.0 109 123*, 83* 
XP_002492075 PAS_chr2-2_0131  CTA1 Catalase A 58.1 6.6 193 92*, 93* 
XP_002493065 PAS_chr3_0832 DAS1 Transketolase (Dihydroxyacetone synthase), similar to Tkl2p  79.1 6.1 137 94*, 95*, 96*, 101*, 102* 
XP_002493270 PAS_chr3_1028 FLD1 S-(hydroxymethyl) glutathione dehydrogenase  41.4 6.1 110 27*, 31* 
XP_002493100 PAS_chr3_0867 FGH1 Non-essential intracellular esterase that can function as an S-formylglutathione hydrolase 33.4 6.3 222 5* 
XP_002493171 PAS_chr3_0932  FDH1 NAD(+)-dependent formate dehydrogenase 40.4 6.6 191 2*, 3*, 4*, 29*, 30*, 85*, 103* 
      Glycolysis    
XP_002494063 PAS_chr4_0624 EMI2 Hexokinase 52.5 6.1 237 22* 
XP_002491345 PAS_chr2-1_0437 TDH1 Glyceraldehyde-3-phosphate dehydrogenase, isozyme 3 35.7 6.2 154 114*, 117* 
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NCBI 
Accession-No 1 Locus ID 
1 Gene name 2 Protein name2 MM (kDa) 3 pI 3 Mascot Score Spot No 
4 
Functional category 1               
XP_002489713 PAS_chr1-1_0072 FBA1 Fructose 1,6-bisphosphate aldolase 39.9 6.0 108 33* 
XP_002490411 PAS_chr1-4_0292 PGK1 3-Phosphoglycerate kinase  44.1 7.8 263 52* 
XP_002493191 PAS_chr3_0951 TPI1 Triose phosphate isomerase 27.1 5.7 160 50* 
XP_002493059 PAS_chr3_0826 GMP1 Tetrameric phosphoglycerate mutase  28.0 6.0 131 51* 
XP_002492293 PAS_chr3_0082 ENO2 Enolase I 46.5 5.4 181 39*, 120* 
 
      Ethanol metabolism 
CAY67035 PAS_c034_0018 ADH Alcohol dehydrogenase 38.1 6.3 195 78* 
XP_002491382 PAS_chr2-1_0472 ADH3 Mitochondrial alcohol dehydrogenase isozyme III  37.3 5.8 140 35* 
      Citrate cycle (TCA cycle) 
XP_002489444 PAS_chr1-3_0104 ACO1 Aconitase   85.0 5.7 237  15*, 16* 
XP_002491004 PAS_chr2-1_0120 IDH2 Subunit of mitochondrial NAD(+)-dependent isocitrate dehydrogenase 40.3 8.1 96 115* 
XP_002492874 PAS_chr3_0647 FUM1 Fumarase 52.8 6.4 82 24* 
XP_002491128 PAS_chr2-1_0238 MDH1 Mitochondrial malate dehydrogenase 36.5 5.3 230 34*, 46* 
      Pentose phosphate pathway 
XP_002492495 PAS_chr3_0277 6PGD [GND] 6-Phosphogluconate dehydrogenase (decarboxylating)  54.2 5.9 209 21* 
XP_002493617 PAS_chr4_0212 RKI1 Ribose-5-phosphate ketol-isomerase  23.6 6.0 226 69* 
      Sugar metabolism and others 
XP_002490557 PAS_chr1-4_0426 BGL2 Endo-beta-1,3-glucanase 34.2 4.1 108 136* 
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NCBI 
Accession-No 1 Locus ID 
1 Gene name 2 Protein name2 MM (kDa) 3 pI 3 Mascot Score Spot No 
4 
Functional category 1               
Pyruvate metabolism 
XP_002494290 PAS_chr4_0842 GLO1 Monomeric glyoxalase I  36.9 5.6 76 40* 
XP_002491701 PAS_chr2-1_0767 acsB [ACS1] Acetyl-coA synthetase isoform  74.1 5.7 88 18*, 19* 
1.2 Energy Metabolism  
      Oxidative phosphorylation 
XP_002489364 PAS_chr1-3_0028 IPP1 Cytoplasmic inorganic pyrophosphatase (PPase)  32.3 5.3 214 65*, 134* 
XP_002493409 PAS_c131_0021 [VMA2] Vacuolar ATP synthase subunit B  55.4 5.3 169 14* 
XP_002494179 PAS_chr4_0737 MCR1  Mitochondrial NADH-cytochrome b5 reductase 33.6 8.8 183 54*, 105* 
1.3 Nucleotide metabolism 
XP_002492473 PAS_chr3_0257 ADK1 Adenylate kinase  28.2 7.0 122 106* 
XP_002492154 PAS_chr2-2_0059 YNK1 Nucleoside diphosphate kinase 17.0 6.2 111 89* 
1.4 Amino acid metabolism  
XP_002489848 PAS_chr1-1_0200 AAT1 Cytosolic aspartate aminotransferase 47.9 6.7 200 28*, 25* 
XP_002492036 PAS_chr2-2_0168 [LYS12] Homo-isocitrate dehydrogenase 40.1 6.0 121 41* 
XP_002490090 PAS_chr1-1_0432 ILV5 Acetohydroxyacid reductoisomerase 44.4 7.7 94 43* 
XP_002491046 PAS_chr2-1_0160 metE [MET6] Cobalamin-independent methionine synthase 85.9 5.9 228 17*, 118* 
XP_002492638 PAS_chr3_0410  CAR2 L-Ornithine transaminase 47.5 5.9 100 26* 
XP_002493966 PAS_chr4_0974 [AAT2] Aspartate aminotransferase 42.5 7.2 174 133* 
XP_002492166 PAS_chr2-2_0048 [LPD1] Dihydrolipoamide dehydrogenase  52.6 6.3 110 119*  
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NCBI 
Accession-No 1 Locus ID 
1 Gene name 2 Protein name2 MM (kDa) 3 pI 3 Mascot Score Spot No 
4 
Functional category 1               
 
1.5 Metabolism of cofactors and vitamins       
XP_002493470 PAS_chr4_0065 THI5 Protein involved in synthesis of the thiamine precursor hydroxymethylpyrimidine (HMP) 38.7 6.3 140 116* 
XP_002493989 PAS_chr4_0550 - Pyridoxine 4-dehydrogenase  36.3 5.6 192 42* 
XP_002492582 PAS_chr3_0361 [PNC1] Nicotinamidase  24.7 5.3 126 70* 
2. Genetic information processing 
2.1 Transcription and translation 
XP_002489515 PAS_chr1-3_0172 EGD1 Subunit beta1 of the nascent polypeptide-associated complex (NAC)   17.9 4.8 76 72* 
XP_002489404 PAS_chr1-3_0068 RPP0 Conserved ribosomal protein P0 similar to rat P0, human P0, and E. coli L10e  33.7 4.6 110 63* 
XP_002493616 PAS_chr4_0211 [RPS7B] Protein component of the small (40S) ribosomal subunit.  nearly identical to Rps7Bp  21.3 9.2 90 112* 
XP_002491009 PAS_chr2-1_0812 EFT1 Elongation factor 2 93.9 6.3 83 100* 
XP_002492789 PAS_chr3_0562 TUF1 Mitochondrial translation elongation factor Tu  47.0 5.6 103 44* 
XP_002493313 PAS_chr3_1071 CAM1 Translation elongation factor EF-1 gamma  24.3 6.4 111 107*, 132* 
2.2 Sorting and degradation  
XP_002492588 PAS_chr3_0365 SSC1  Mitochondrial matrix ATPase  69.7 5.4 98 99* 
XP_002490239 PAS_chr1-4_0130 - Heat shock protein Hsp90 80.9 4.8 100 122* 
XP_002490142 PAS_chr1-4_0027 COF1 Cofilin 18.2 6.1 97 71* 
XP_002493333 PAS_chr3_1087 APR1 [PEP4] Vacuolar aspartyl protease (proteinase A)  44.5 4.6 134 86* 
XP_002490155 PAS_chr1-4_0043 SBA1 Co-chaperone that binds to and regulates Hsp90 family chaperones  22.5 4.3 77 113* 
XP_002489443 PAS_chr1-3_0102 clpB [HSP104] Heat shock protein that cooperates with Ydj1p (Hsp40) and Ssa1p (Hsp70)  100.6 5.3 160 84* 
XP_002494360.1 PAS_FragD_0026 [CDC48] ATPase in ER, nuclear membrane and cytosol with homology to mammalian p97 91.4 4.8 216 1* 
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NCBI 
Accession-No 1 Locus ID 
1 Gene name 2 Protein name2 MM (kDa) 3 pI 3 Mascot Score Spot No 
4 
Functional category 1               
XP_002492868 PAS_chr3_0640 TFS1 Carboxypeptidase Y inhibitor  29.8 7.8 155 6*, 7* 
2.3 Folding catalysts  
CAC33587 PAS_chr4_0844 PDI Protein disulfide isomerase  58.1 4.6 160 11* 
XP_002493562 PAS_chr4_0158 CPNA [HSP60] Tetradecameric mitochondrial chaperonin  60.5 5.1 180 12* 
XP_002489608 PAS_chr1-3_0264 [CPR1] Cytoplasmic peptidyl-prolyl cis-trans isomerase (cyclophilin)  18.1 6.1 103 56* 
XP_002490274 PAS_chr1-4_0163 [HSP10] 10 kDa chaperonin 11.1 9.0 82 82* 
3. Cellular processes   
3.1 Transport and catabolism  
XP_002490181 PAS_chr1-4_0071 SOD2 Mitochondrial superoxide dismutase 25.2 7.9 111 76* 
3.2 Cell growth and death  
XP_002493242  PAS_chr3_1001 TUP1 General repressor of transcription, forms complex with Cyc8p  66.3 6.0 135 20* 
XP_002490416 PAS_chr1-4_0297 [STM1] Suppressor protein STM1  29.7 9.7 102 87* 
4. Others  
4.1 Stress response   
XP_002493863 PAS_chr4_0433 - NADPH-dependent alpha-keto amide reductase  33.7 5.6 113 73* 
XP_002490683 PAS_chr1-4_0547 PMP20  Peroxiredoxin  18.4 9.5 178 9* 
XP_002493699 PAS_chr4_0284 TRX2 Cytoplasmic thioredoxin isoenzyme of the thioredoxin system  11.4 4.9 110 80* 
XP_002492079 PAS_chr2-2_0127 CCP1 Mitochondrial cytochrome-c peroxidase  42.0 6.6 197 66* 
XP_002491803 PAS_chr2-2_0382 GPX1 [HYR1] Thiol peroxidase (Glutathione peroxidase)   18.4 6.2 164 8* 
XP_002493423 PAS_chr4_0018 CYC1 Cytochrome c, isoform 1 12.2 9.6 94 81* 
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NCBI 
Accession-No 1 Locus ID 
1 Gene name 2 Protein name2 MM (kDa) 3 pI 3 Mascot Score Spot No 
4 
Functional category 1               
BAH80186  PAS_chr2-2_0480 TRR1 Thioredoxin reductase 1  35.3 5.5 141 67* 
5. Unclassified  
XP_002491489 PAS_chr2-1_0573 - Putative xylose and arabinose reductase  32.2 6.1 167 75* 
XP_002491564 PAS_chr2-1_0640 - Putative protein of unknown function  21.7 6.3 119 129* 
XP_002491418 PAS_chr2-1_0853 - Hypothetical protein 57.0 6.0 119 121* 
XP_002489760 PAS_chr1-1_0118 - Hypothetical protein  46.3 7.0 77 127* 
XP_002490519 PAS_chr1-4_0675 - Hypothetical protein  53.8 6.7 96 23* 
XP_002491208 PAS_chr2-1_0313 - Bifunctional enzyme with alcohol dehydrogenase and glutathione-dependent formaldehyde dehydrogenase  39.1 5.8 177 37* 
XP_002491071 PAS_chr2-1_0183 - Acyl-protein thioesterase responsible for depalmitoylation of Gpa1p 24.3 6.3 102 130* 
XP_002491989 PAS_chr2-2_0208 - Hypothetical protein 18.6 6.5 85 10* 
XP_002491901 PAS_chr2-2_0289 - Hypothetical protein  28.3 4.8 125 64* 
XP_002492584 PAS_chr3_0362 - Mitochondrial peculiar membrane protein 1 32.7 5.7 92 68* 
XP_002493742 PAS_chr4_0320 MYH4 Myosin-4 92.6 4.9 152 59* 
 
1  Accession numbers and locus IDs are according to the NCBI Reference Sequence database (http://www.ncbi.nlm.nih.gov/RefSeq/). Functional classifications are mostly according to KEGG 
PATHWAY database (http://www.genome.jp/kegg/metabolism.html). 
2 Gene/protein names are according to the sequenced genome of P. pastoris GS115 (http://www.uniprot.org/). If no name was found for P. pastoris GS115, a Blast search of the respective P. 
pastoris GS115 gene/protein against different P. pastoris strains was carried out in the following order: search against ATCC 76273 / CBS 7435 / CECT 11047 / NRRL Y-11430 / Wegner 21-1 
and P. pastoris (yeast). Gene/protein names from other P. pastoris strains were only adopted in case of 100% sequence identity (http://www.uniprot.org/). Gene names in brackets are from S. 
cerevisiae if the names differ for both yeasts (http://www.uniprot.org/). 
3 Theoretical molecular mass (MM) and isoelectric point (pI) not considering potential posttranslational modifications.  
4 “Spot-No” indicates the serial number of all identified protein spots of the intracellular proteome of P. pastoris GS115. Proteins appearing in multiple spots indicate the existence of isoforms which 
probably derive from posttranslational modification events such as phosphorylation, glycosylation or limited proteolysis. A representative 2D gel of the intracellular proteome from a cell sample 
taken after 114 hours of growth on methanol with the respective spot numbers is shown below. Spot numbers in this table and the following gel are marked by an asterix (*) for simplified 
searchability
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A representative 2D gel of the intracellular proteome of P. pastoris GS115 producing HBsAg. 
The sample was taken after 114 h of growth on methanol. Spot numbers correspond to numbers in the table above and are marked by an asterix 
(*) for simplified searchability. 
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Change of the intracellular proteome in response to high-level methanol-induced production of HBsAg. 
Samples before methanol addition at the end of the glycerol batch phase and 4, 16, 72 and 114 hours after the onset of methanol feeding were 
analyzed and the protein changes in response to methanol-induced HBsAg production are shown (numbers. log2 changes; n.a. not analyzable, 
color code: light orange to red, increase, light green to dark green: decrease, yellow: no significant change). 
 
 
Functional category Gene name 1 Gene ID 0h 2 4h  16h  72h  114h  
    
Carbohydrate metabolism               
Methanol metabolism  
AOX1 PAS_chr4_0821 0.0 10.8 11.6 10.8 12.0 
CTA1 PAS_chr2-2_0131  0.0 0.6 1.0 1.0 1.5 
DAS1 PAS_chr3_0832 0.0 0.5 3.8 3.2 3.1 
FLD1 PAS_chr3_1028 0.0 9.1 10.0 9.0 10.7 
FGH1 PAS_chr3_0867 0.0 2.0 3.8 4.5 4.2 
FDH1 PAS_chr3_0932  0.0 10.6 12.7 13.4 13.5 
Glycolysis  
EMI2 PAS_chr4_0624 0.0 -0.7 -1.8 -3.8 -1.8 
TDH1 PAS_chr2-1_0437 0.0 -0.2 0.4 -0.7 0.0 
FBA1 PAS_chr1-1_0072 0.0 0.1 -0.4 -0.5 -0.8 
PGK1 PAS_chr1-4_0292 0.0 0.1 -0.9 -0.7 -0.7 
TPI1 PAS_chr3_0951 0.0 -0.1 -1.3 -2.0 -1.7 
GMP1 PAS_chr3_0826 0.0 0.0 -0.2 0.1 -0.8 
ENO2 PAS_chr3_0082 0.0 -0.4 -0.5 -0.2 -0.7 
Ethanol metabolism 
ADH PAS_c034_0018 0.0 0.8 0.2 0.8 0.7 
ADH3 PAS_chr2-1_0472 0.0 0.5 0.7 1.0 0.6 
Citrate cycle (TCA) 
ACO1 PAS_chr1-3_0104 0.0 -0.3 -0.6 0.6 0.3 
IDH2 PAS_chr2-1_0120 0.0 0.3 -0.8 -0.4 -0.6 
FUM1 PAS_chr3_0647 0.0 -0.1 -0.7 -0.1 -0.7 
MDH1 PAS_chr2-1_0238 0.0 0.8 1.1 1.7 1.0 
Pentose phosphate pathway 
6PGD [GND] PAS_chr3_0277 0.0 0.0 n.a n.a -1.0 
RKI1 PAS_chr4_0212 0.0 -0.2 1.0 1.2 0.2 
Sugar metabolism BGL2 PAS_chr1-4_0426 0.0 -1.2 -1.4 -0.8 -1.3 
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Functional category Gene name 1 Gene ID 0h 2 4h  16h  72h  114h  
Pyruvate metabolism 
GLO1 PAS_chr4_0842 0.0 0.5 0.3 1.3 1.2 
acsB [ACS1] PAS_chr2-1_0767 0.0 0.0 -1.8 -1.6 -0.9 
Energy metabolism       
Oxidative phosphorylation 
IPP1 PAS_chr1-3_0028 0.0 1.1 2.9 0.4 0.0 
[VMA2] PAS_c131_0021 0.0 0.0 0.0 0.4 -0.4 
MCR1 PAS_chr4_0737 0.0 0.1 -0.4 0.9 0.4 
Nucleotide metabolism       
  
ADK1 PAS_chr3_0257 0.0 0.0 -1.1 0.0 -0.2 
YNK1 PAS_chr2-2_0059 0.0 -0.1 -1.2 -0.3 -1.2 
Amino acid metabolism   
  
AAT1 PAS_chr1-1_0200 0.0 0.3 0.9 1.3 1.1 
[LYS12] PAS_chr2-2_0168 0.0 -0.3 -0.6 1.0 -0.4 
ILV5 PAS_chr1-1_0432 0.0 0.0 -0.4 0.1 -0.5 
metE [MET6] PAS_chr2-1_0160 0.0 0.2 -4.2 -5.2 -1.8 
CAR2 PAS_chr3_0410  0.0 0.0 0.2 -0.1 n.a 
[AAT2] PAS_chr4_0974 0.0 1.0 0.6 0.9 1.2 
[LPD1] PAS_chr2-2_0048 0.0 0.5 -1.1 -0.1 -0.5 
Metabolism of cofactors and vitamins   
  
THI5 PAS_chr4_0065 0.0 1.1 1.0 -1.0 -0.3 
- PAS_chr4_0550 0.0 -0.2 -0.2 -0.1 -0.7 
[PNC1] PAS_chr3_0361 0.0 -1.3 -1.2 -0.2 -0.7 
Genetic information processing       
Transcription and translation 
EGD1 PAS_chr1-3_0172 0.0 0.5 0.4 0.5 -0.5 
RPP0 PAS_chr1-3_0068 0.0 7.9 6.9 7.6 7.0 
[RPS7B] PAS_chr4_0211 0.0 -0.3 -0.3 -0.5 n.a 
EFT1 PAS_chr2-1_0812 0.0 n.a -3.4 n.a -0.8 
TUF1 PAS_chr3_0562 0.0 0.0 -0.4 -0.1 -1.9 
CAM1 PAS_chr3_1071 0.0 -1.4 -1.3 0.7 0.8 
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Functional category Gene name 1 Gene ID 0h 2 4h  16h  72h  114h  
Sorting and degradation 
SSC1  PAS_chr3_0365 0.0 0.3 1.0 1.0 -0.3 
- PAS_chr1-4_0130 0.0 0.7 0.4 1.0 1.2 
COF1 PAS_chr1-4_0027 0.0 0.0 -0.3 0.3 -0.5 
APR1 [PEP4] PAS_chr3_1087 0.0 -0.1 2.5 3.4 3.2 
SBA1 PAS_chr1-4_0043 0.0 -0.8 -0.3 -0.1 -1.0 
clpB [HSP104] PAS_chr1-3_0102 0.0 8.2 5.7 n.a 7.1 
[CDC48] PAS_FragD_0026 0.0 1.4 1.3 1.0 0.8 
TFS1 PAS_chr3_0640 0.0 0.1 -0.6 -0.1 -1.3 
Folding catalysts 
PDI PAS_chr4_0844 0.0 0.7 1.3 1.8 1.7 
CPNA [HSP60] PAS_chr4_0158 0.0 0.1 0.4 0.8 0.1 
[CPR1] PAS_chr1-3_0264 0.0 1.3 1.2 1.3 0.3 
[HSP10] PAS_chr1-4_0163 0.0 0.1 0.5 0.7 0.8 
Cellular processes       
Transport and catabolism SOD2 PAS_chr1-4_0071 0.0 0.5 -0.1 0.2 0.2 
Cell growth and death 
TUP1 PAS_chr3_1001 0.0 0.3 -1.2 -1.5 -1.9 
[STM1] PAS_chr1-4_0297 0.0 0.3 -0.3 0.4 -0.6 
Others       
Stress response 
- PAS_chr4_0433 0.0 -0.5 -1.5 -2.0 -1.9 
PMP20 PAS_chr1-4_0547 0.0 8.9 10.1 10.0 9.7 
TRX2 PAS_chr4_0284 0.0 0.3 0.0 0.3 -0.9 
CCP1 PAS_chr2-2_0127 0.0 0.7 0.1 0.4 -1.1 
GPX1 [HYR1] PAS_chr2-2_0382 0.0 0.6 0.3 0.6 -0.5 
CYC1  PAS_chr4_0018 0.0 0.3 -0.1 0.6 0.8 
TRR1 PAS_chr2-2_0480 0.0 0.2 -0.3 -0.4 -1.3 
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Functional category Gene name 1 Gene ID 0h 2 4h  16h  72h  114h  
Unclassified 
- PAS_chr2-1_0573 0.0 0.0 0.4 1.1 0.7 
- PAS_chr2-1_0640 0.0 -0.1 -0.7 -0.5 -1.8 
- PAS_chr2-1_0853 0.0 1.0 1.0 -0.2 2.6 
- PAS_chr1-1_0118 0.0 -1.6 -1.0 -0.2 -1.3 
- PAS_chr1-4_0675 0.0 -0.4 -1.7 -2.5 -1.1 
- PAS_chr2-1_0313 0.0 -0.1 -0.5 -0.4 0.3 
- PAS_chr2-1_0183 0.0 0.4 1.8 1.9 2.0 
- PAS_chr2-2_0208 0.0 1.8 2.5 1.0 1.1 
- PAS_chr2-2_0289 0.0 -0.2 -1.6 0.2 -1.2 
- PAS_chr3_0362 0.0 -1.1 -0.8 0.6 -0.1 
MYH4 PAS_chr4_0320 0.0 -0.3 -2.0 -0.1 -1.5 
 
1. Gene names in brackets are from S. cerevisiae if the names differ for both yeasts (http://www.uniprot.org/). 
2. When no protein spot was detectable at the end of the glycerol batch phase (methanol metabolism), a virtual number of 0.001 was taken for the spot intensity to allow the calculation of log2 
values (spot intensities were normalized using the log2 ratio of induced samples versus uninduced sample). 
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8. Appendix II   
8.1. Identification of AOX1 in P. pastoris GS115 with a 
“Muts phenotype” 
8.1.1. Results and discussion 
The HBsAg producing strain was originally identified as a Muts (methanol 
utilization slow) strain devoid of the aox1 gene [1]. Thus, the identification of 
AOX1 in the intracellular proteome of P. pastoris GS115 after methanol-induced 
production of HBsAg by MALDI-TOF MS was unexpected (Figure 8.1). To 
confirm the presence of AOX1 and exclude a misidentification of AOX2, peptides 
which sequence differences in AOX1 and AOX2 were selected for sequencing by 
MS/MS. These results confirmed the correct identification of AOX1 (Figure 8.1). 
Finally, the presence of the entire aox1 gene in the genome was confirmed by PCR 
analysis (Figure 8.2). The first attempt to verify the presence of the entire aox1 
gene by PCR with external primers using the Taq DNA polymerase failed; only the 
multicopy HBsAg gene was amplified under the applied conditions (Figure 8.2 A, 
lane 1). However, the presence of aox1 or at least parts of the aox1 gene was 
confirmed by using internal primers (Figure 8.2 A, lane 2). Finally, the presence of 
the entire aox1 gene in the genome was confirmed by PCR analysis using a high 
performance DNA polymerase and a modified PCR protocol (see Materials and 
Methods for details). 
Our results clearly show that a Muts phenotype, namely slow growth on methanol, 
does not necessarily prove the absence of a functional aox1 gene. For example, 
slow growth on methanol was also observed with of an aox1+ strain carrying 
multiple copies of a gene encoding a porcine insulin precursor [2]. Thus, high level 
expression of foreign genes can result in a metabolic burden and cellular stress 
response which may lead to impaired growth on methanol despite the presence of 
functional aox1.  
Moreover, the absence of a visible aox1 PCR product using external aox1 primers 
does not necessarily proof the absence of aox1. It is advised to use internal aox1 
primers to allow selective aox1 amplification this way preventing interference 
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through selective amplification of multiple copies of shorter foreign DNA 
fragments. Alternatively, PCR protocols can be optimized to allow simultaneous 
amplification of aox1 and the foreign DNA fragment. 
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Figure 8.1. MALDI-TOF MS spectra obtained from an AOX1 protein spot. The red arrows indicate peptide peaks which are only present in AOX1 and not in AOX2. 
Three of these peptides (indicated in spectra A) were additionaly submitted to MS/MS for sequence analysis. 
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Figure 8.2. Agarose gel electrophoresis of PCR amplified aox1 and HBsAg using aox1 
external and internal primers and HBsAg internal primer. (A) Represents the results for the 
first PCR experiment with Taq DNA polymerase and (B) the results of the second PCR 
experiment using the high performance polymerase, longer elongation time and higher 
annealing temperature. Gel A: M, 100bp DNA ladder (Fermentas); lane 1, aox1 external 
primer (only HBsAg visible~900 bp), lane 2, aox1 internal primer (aox1 internal sequence 
507 bp) and lane 3, HBsAg internal primer (HBsAg internal sequence 447pb). The band 
indicated by the arrow was subjected to sequencing and verified as aox1. Gel B: M, 1Kb 
DNA ladder (Fermentas); lane 1, with aox1 external primer now 2 bands visible 
corresponding to aox1 2105 bp and HBsAg ~900bp.  
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Query 1   MAIPEEFDILVLGGGSSGSCIAGRLANLDHSLKVGLIEAGENNLNNPWVYLPGIYPRNMK 60  
          MAIPEEFDILVLGGGSSGSCIAGRLANLDHSLKVGLIEAGENNLNNPWVYLPGIYPRNMK 
Sbjct 1   MAIPEEFDILVLGGGSSGSCIAGRLANLDHSLKVGLIEAGENNLNNPWVYLPGIYPRNMK 60 
 
Query  61 LDSKTASFYTSNPSPHLNGRRAIVPCANVLGGGSSINFMMYTRGSASDYDDFQAEGWKTK 120 
          LDSKTASFYTSNPSPHLNGRRAIVPCAN+LGGGSSINFMMYTRGSASDYDDF+AEGWKTK 
Sbjct  61 LDSKTASFYTSNPSPHLNGRRAIVPCANILGGGSSINFMMYTRGSASDYDDFEAEGWKTK 120 
 
Query 121 DLLPLMKKTETYQRACNNPDIHGFEGPIKVSFGNYTYPVCQDFLRASESQGIPYVDDLED 180 
          DLLPLMKKTETYQRACNNP+IHGFEGPIKVSFGNYTYPVCQDFLRA+ESQGIPYVDDLED 
Sbjct 121 DLLPLMKKTETYQRACNNPEIHGFEGPIKVSFGNYTYPVCQDFLRATESQGIPYVDDLED 180 
 
Query 181 LVTAHGAEHWLKWINRDTGRRSDSAHAFVHSTMRNHDNLYLICNTKVDKIIVEDGRAAAV 240 
          LVTAHGAEHWLKWINRDTGRRSDSAHAFVHSTMRNHDNLYLICNTKVDKIIVEDGRAAAV 
Sbjct 181 LVTAHGAEHWLKWINRDTGRRSDSAHAFVHSTMRNHDNLYLICNTKVDKIIVEDGRAAAV 240 
 
Query 241 RTVPSKPLNPKKPSHKIYRARKQIVLSCGTISSPLVLQRSGFGDPIKLRAAGVKPLVNLP 300 
          RTVPSKPLN KKP+HK+YRAR QIVLSCGTISSPLVLQRSGFGDPIKLRAAGVKPLVNLP 
Sbjct 241 RTVPSKPLNAKKPTHKVYRARTQIVLSCGTISSPLVLQRSGFGDPIKLRAAGVKPLVNLP 300 
 
Query 301 GVGRNFQDHYCFFSPYRIKPQYESFDDFVRGDAEIQKRVFDQWYANGTGPLATNGIEAGV 360 
          GVGRNFQDHYCFFSPYRIKPQYESFDDFVRGDA IQK+VFDQWYANGTGPLATNGIEAGV 
Sbjct 301 GVGRNFQDHYCFFSPYRIKPQYESFDDFVRGDANIQKKVFDQWYANGTGPLATNGIEAGV 360 
 
Query 361 KIRPTPEELSQMDESFQEGYREYFEDKPDKPVMHYSIIAGFFGDHTKIPPGKYMTMFHFL 420 
          KIRPTPEELSQMDESFQEGYREYFEDKPDKPVMHYSIIAGFFGDHTKIPPGKYMTMFHFL 
Sbjct 361 KIRPTPEELSQMDESFQEGYREYFEDKPDKPVMHYSIIAGFFGDHTKIPPGKYMTMFHFL 420 
 
Query 421 EYPFSRGSIHITSPDPYAAPDFDPGFMNDERDMAPMVWAYKKSRETARRMDHFAGEVTSH 480 
          EYPFSRGSIHITSPDPYA PDFDPGFMNDERDMAPMVW+YKKSRETAR+MDHFAGEVTSH 
Sbjct 421 EYPFSRGSIHITSPDPYATPDFDPGFMNDERDMAPMVWSYKKSRETARKMDHFAGEVTSH 480 
 
Query 481 HPLFPYSSEARALEMDLETSNAYGGPLNLSAGLAHGSWTQPLKKPTAKNEGHVTSNQVEL 540 
          HPLFPYSSEARA EMDLETSNAYGGPLNL+AGLAHGSWTQPLKKP  +NEGHVTSNQVEL 
Sbjct 481 HPLFPYSSEARAYEMDLETSNAYGGPLNLTAGLAHGSWTQPLKKPAGRNEGHVTSNQVEL 540 
 
Query 541 HPDIEYDEEDDKAIENYIREHTETTWHCLGTCSIGPREGSKIVKWGGVLDHRSNVYGVKG 600 
          HPDIEYDEEDDKAIENYIREHTETTWHCLGTCSIGPREGSKIVKWGGVLDHRSNVYGVKG 
Sbjct 541 HPDIEYDEEDDKAIENYIREHTETTWHCLGTCSIGPREGSKIVKWGGVLDHRSNVYGVKG 600 
 
Query 601 LKVGDLSVCPDNVGCNTYTTALLIGEKTATLVGEDLGYSGEALDMTVPQFKLGTYEKTGL 660 
          LKVGDLSVCPDNVGCNTYTTALLIGEKTATLVGEDLGY+GEALDMTVPQFKLGTYEKTGL 
Sbjct 601 LKVGDLSVCPDNVGCNTYTTALLIGEKTATLVGEDLGYTGEALDMTVPQFKLGTYEKTGL 660 
 
Query 661  ARF  663 
           ARF 
Sbjct 661  ARF  663 
Identities = 644/663 (98%), positives = 656/663 (99%), gaps = 0/663 (0%) Query 1= AOX1 Sbjct 1= 
AOX2 
 
Figure 8.3. Sequence differences between AOX1 and AOX2. Amino acid sequences of 
AOX1 and AOX2 are from the Uniprot database (accession number Q9URI8 and Q9URI7, 
respectively). Protein homologies were determined using NCBI BLAST program via NCBI 
web-server. Amino acids with green background represent the differences between AOX1 
and AOX2. 
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8.1.2. Material and methods 
8.1.2.1. MALDI-TOF MS and MS/MS analysis  
MALDI-TOF MS and MS/MS analysis and sample preparation were carried out as 
described in the main manuscript. AOX1 was identified from several gels with 
samples from different cultivations (shake flask and bioreactor) using the same 
transformant [1, 3, 4]. Three peptides, which reveal sequence differences in AOX1 
and AOX2, were sequenced by MS/MS (Figure 8.1). The theoretical mass of 
AOX1 and AOX2 and corresponding peptides were predicted using 
[http://web.expasy.org/peptide_mass/]. The amino acid sequence of AOX1 and 
AOX2 are given in Figure 8.3. 
8.1.2.2. PCR analysis and DNA sequencing 
Cells were lysed in TRIzol reagent (Invitrogen, Carlsbad, CA) and the DNA 
isolated for PCR analysis according to the manufacturer´s instruction 
(www.invitrogen.com). The following primers were employed for PCR: AOX1 
external primer, AOX1 internal primer and HBsAg internal primer (sequence given 
below). Two PCR protocols were used: the first PCR was carried out using the Taq 
DNA polymerase (TakaraTM, Japan) and the following conditions: initial 
denaturation at 95°C for 30 sec; annealing at 55°C for 30 sec and extension at 72°C 
for 30 sec with 35 cycles of amplification. The second PCR was carried out using a 
high performance polymerase (Ex Taq DNA polymerase, TakaraTM, Japan) and the 
following conditions: initial denaturation at 95°C for 30 sec; annealing at 57°C for 
30 sec and extension at 72°C for 1 min with 35 circles of amplification. The second 
protocol allowed the simultaneous amplification of the shorter HBsAg and the 
longer aox1 sequence. The PCR products were separated by agarose 
electrophoresis, the DNA extracted and subjected to sequence analysis. The 
identity of aox1 was confirmed by sequencing (Eurofins MWG GmbH) (data not 
shown). 
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DNA sequence of aox1 from P. pastoris strain GS115 with 5’ promoter 
and 3’ terminator 
 
AGATCTAACATCCAAAGACGAAAGGTTGAATGAAACCTTTTTGCCATCCGACATCCACAGGTCCATTCTCACA
CATAAGTGCCAAACGCAACAGGAGGGGATACACTAGCAGCAGACCGTTGCAAACGCAGGACCTCCACTCCTC
TTCTCCTCAACACCCACTTTTGCCATCGAAAAACCAGCCCAGTTATTGGGCTTGATTGGAGCTCGCTCATTCCA
ATTCCTTCTATTAGGCTACTAACACCATGACTTTATTAGCCTGTCTATCCTGGCCCCCCTGGCGAGGTTCATGTT
TGTTTATTTCCGAATGCAACAAGCTCCGCATTACACCCGAACATCACTCCAGATGAGGGCTTTCTGAGTGTGGG
GTCAAATAGTTTCATGTTCCCCAAATGGCCCAAAACTGACAGTTTAAACGCTGTCTTGGAACCTAATATGACAA
AAGCGTGATCTCATCCAAGATGAACTAAGTTTGGTTCGTTGAAATGCTAACGGCCAGTTGGTCAAAAAGAAAC
TTCCAAAAGTCGGCATACCGTTTGTCTTGTTTGGTATTGATTGACGAATGCTCAAAAATAATCTCATTAATGCT
TAGCGCAGTCTCTCTATCGCTTCTGAACCCCGGTGCACCTGTGCCGAAACGCAAATGGGGAAACACCCGCTTTT
TGGATGATTATGCATTGTCTCCACATTGTATGCTTCCAAGATTCTGGTGGGAATACTGCTGATAGCCTAACGTT
CATGATCAAAATTTAACTGTTCTAACCCCTACTTGACAGCAATATATAAACAGAAGGAAGCTGCCCTGTCTTAA
ACCTTTTTTTTTATCATCATTATTAGCTTACTTTCATAATTGCGACTGGTTCCAATTGACAAGCTTTTGATTTTAA
CGACTTTTAACGACAACTTGAGAAGATCAAAAAACAACTAATTATTCGAAACGATGGCTATCCCCGAAGAGTT
TGATATCCTAGTTCTAGGTGGTGGATCCAGTGGATCCTGTATTGCCGGAAGATTGGCAAACTTGGACCACTCCT
TGAAAGTTGGTCTTATCGAAGCAGGTGAGAACAACCTCAACAACCCATGGGTCTACCTTCCAGGTATTTACCC
AAGAAACATGAAGTTGGACTCCAAGACTGCTTCCTTCTACACTTCTAACCCATCTCCTCACTTGAATGGTAGAA
GAGCCATTGTTCCATGTGCTAACGTCTTGGGTGGTGGTTCTTCTATCAACTTCATGATGTACACCAGAGGTTCT
GCTTCTGATTACGATGACTTCCAAGCCGAGGGCTGGAAAACCAAGGACTTGCTTCCATTGATGAAAAAGACTG
AGACCTACCAAAGAGCTTGCAACAACCCTGACATTCACGGTTTCGAAGGTCCAATCAAGGTTTCTTTCGGTAA
CTACACCTACCCAGTTTGCCAGGACTTCTTGAGGGCTTCTGAGTCCCAAGGTATTCCATACGTTGACGACTTGG
AAGACTTGGTTACTGCTCACGGTGCTGAACACTGGTTGAAGTGGATCAACAGAGACACTGGTCGTCGTTCCGA
CTCTGCTCATGCATTTGTCCACTCTACTATGAGAAACCACGACAACTTGTACTTGATCTGTAACACGAAGGTCG
ACAAAATTATTGTCGAAGACGGAAGAGCTGCTGCTGTTAGAACCGTTCCAAGCAAGCCTTTGAACCCAAAGAA
GCCAAGTCACAAGATCTACCGTGCTAGAAAGCAAATCGTTTTGTCTTGTGGTACCATCTCCTCTCCATTGGTTT
TGCAAAGATCCGGTTTTGGTGACCCAATCAAGTTGAGAGCCGCTGGTGTTAAGCCTTTGGTCAACTTGCCAGGT
GTCGGAAGAAACTTCCAAGACCACTACTGTTTCTTCAGTCCTTACAGAATCAAGCCTCAGTACGAGTCTTTCGA
TGACTTCGTCCGTGGTGATGCTGAGATTCAAAAGAGAGTCTTTGACCAATGGTACGCCAATGGTACTGGTCCTC
TTGCCACTAACGGTATCGAAGCTGGTGTCAAGATCAGACCAACACCAGAAGAACTCTCTCAAATGGACGAATC
CTTCCAGGAGGGTTACAGAGAATACTTCGAAGACAAGCCAGACAAGCCAGTTATGCACTACTCCATCATTGCT
GGTTTCTTCGGTGACCACACCAAGATTCCTCCTGGAAAGTACATGACTATGTTCCACTTCTTGGAATACCCATT
CTCCAGAGGTTCCATTCACATTACCTCCCCAGACCCATACGCAGCTCCAGACTTCGACCCAGGTTTCATGAACG
ATGAAAGAGACATGGCTCCTATGGTTTGGGCTTACAAGAAGTCTAGAGAAACCGCTAGAAGAATGGACCACTT
TGCCGGTGAGGTCACTTCTCACCACCCTCTGTTCCCATACTCATCCGAGGCCAGAGCCTTGGAAATGGATTTGG
AGACCTCTAATGCCTACGGTGGACCTTTGAACTTGTCTGCTGGTCTTGCTCACGGTTCTTGGACTCAACCTTTGA
AGAAGCCAACTGCAAAGAACGAAGGCCACGTTACTTCGAACCAGGTCGAGCTTCATCCAGACATCGAGTACG
ATGAGGAGGATGACAAGGCCATTGAGAACTACATTCGTGAGCACACTGAGACCACATGGCACTGTCTGGGAA
CCTGTTCCATCGGTCCAAGAGAAGGTTCCAAGATCGTCAAATGGGGTGGTGTTTTGGACCACAGATCCAACGT
TTACGGAGTCAAGGGCTTGAAGGTTGGTGACTTGTCCGTGTGCCCAGACAATGTTGGTTGTAACACCTACACC
ACCGCTCTTTTGATCGGTGAAAAGACTGCCACTTTGGTTGGAGAAGATTTAGGATACTCTGGTGAGGCCTTAGA
CATGACTGTTCCTCAGTTCAAGTTGGGCACTTACGAGAAGACCGGTCTTGCTAGATTCTAATCAAGAGGATGTC
AGAATGCCATTTGCCTGAGAGATGCAGGCTTCATTTTTGATTACTTTTTTATTTGTAACCTATATAGTATAGGAT
TTTTTTTGTCATTTTGTTTCTTCTCGTACGAGCTTGCTCCTGATCAGCCTATCTCGCAGCTGATGAATATCTTGTG
GTAGGGGTTTGGGAAAATCATTCGAGTTTGATGTTTTTCTTGGTATTTCCCACTCCTCTTCAGAGTACAGAAGA
TTAAGTGAGACGTTCGTTTGTGC 
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Color code: 
 
Red underlined – 5’ promoter, 940 bp (1-940 bp) 
Black – aox1 gene, 1992bp (941- 2932 bp) 
Purple underlined – 3’ terminator, 338 bp (2865 – 3193 bp) 
Green background – External primer binding sites, 2105 bp between primers (855-
875, 2939-2959) 
Primers used for PCR 
f aox1 external – 5´ GACTGGTTCCAATTGACAAGC  3´ 
r aox1 external – 5´ GCAAATGGCATTCTGACATCC  3´ 
Blue background – Internal primer binding sites, 507bp between primers (996-
1015, 1483-1502) 
Primers used for PCR 
f aox 1 internal – 5´  CCTGTATTGCCGGAAGATTG  3´ 
r aox1 internal – 5´  CAGCACCGTGAGCAGTAACC  3´ 
Yellow background – sequence difference of aox1 and aox2 within the two 
internal primers 
 
 
HBsAg sequence 
ATG GAG AAC ATC ACA TCA GGA TTC CTA GGA CCC CTG CTC GTG TTA CAG GCG GGG TTT TTC TTG TTG 
ACA AGA ATC CTC ACA ATA CCG CAG AGT CTA GAC TCG TGG TGG GCT TCT CTC AAT TTT CTA GGG GGA 
TCA CCC GTG TGT CTT GGC CAA AAT TCG CAG TCC CCA ACC TCC AAT CAC TCA CCA ACC TCC TGT CCT 
CCA ATT TGT CCT GGT TAT CGC TGG ATG TGT CTG CGG CGT TTT ATC ATA TTC CTC TTC ATC CTG CTG 
CTA TGC CTC ATC TTC TTA TTG GTT CTT CTG GAT TAT CAA GGT ATG TTG CCC GTT TGT TCT CTA ATT 
CCA GGA TCA ACA ACA ACC AGT ACG GGA CCA TGC AAA ACC TGC ACG ACT CCT GCT CAA GGC AAC 
TCT ATG TTT CCC TCA TGT TGC TGT ACA AAA CCT ACG GAT GGA AAT TGC ACC TGT ATT CCC ATC CCA 
TCG TCC TGG GCT TTC GCA AAA TAC CTA TGG GAG TGG GCC TCA GTC CGT TTC TCT TGG CTC AGT TTA 
CTA GTG CCA TTT GTT CAG TGG TTC GTA GGG CTT TCC CCC ACT GTT TGG CTT TCA GCT ATA TGG ATG 
ATG TGG TAT TGG GGG CCA AGT CTG TAC AGC ATC GTG AGT CCC TTT ATA CCG CTG TTA CCA ATT TTC 
TTT TGT CTC TGG GTA TAC ATT TAA 
 
Color code: 
Blue underlined – start codon 
Black – HBsAg gene  
Red underlined – stop codon 
Green background – HBsAg internal primer binding sites, 447bp between primers 
(162-183, 588-608) 
Primers used for PCR 
f HBsAg internal – 5´  GTCCCCAACCTCCAATCACTCA  3´ 
r HBsAg internal – 5´  GGCCCCCAATACCACATCATC  3´ 
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9. Appendix III 
9.1. All identified intracellular proteins of P. pastoris X-33 
The complete list of all identified proteins classified into functional categories, two representative 2D gels indicating the spots of all identified 
proteins and their log2 changes in response to methanol-induced high-level production of the IP are given. 
 
The complete list of all identified proteins classified into functional categories. 
NCBI 
Accession-No1 Locus ID
1 Gene name2 Protein name2 MW (KDa)3 pI
3 Mascot Score Spot No
4 
Functional category1       
1. Metabolism  
1.1 Carbohydrate metabolism  
      Methanol metabolism  
XP_002494271 PAS_chr4_0821 AOX1 Alcohol oxidase  74.5 6.0 124 14*,15*,148*, 156* (74.5 kDa),  163* (~25 kDa) 
 XP_002492075 PAS_chr2-2_0131  CTA1 Catalase A 58.1 6.6 183 18* 
XP_002493065 PAS_chr3_0832 DAS1 Transketolase (Dihydroxyacetone synthase), similar to Tkl2p  79.1 6.0 174 153*, 223*,16*  
XP_002493071 PAS_chr3_0841 DAK Dihydroxyacetone kinase 65.4 5.4 114 57*, 58* 
XP_002493270 PAS_chr3_1028 FLD1 S-(hydroxymethyl) glutathione dehydrogenase  41.4 6.1 815 24*, 25*, 28* 
 XP_002493100 PAS_chr3_0867 FGH1 Non-essential intracellular esterase that can function as an S-formylglutathione hydrolase 33.4 6.3 131 49*, 54* 
XP_002493171 PAS_chr3_0932  FDH1 NAD(+)-dependent formate dehydrogenase 40.4 6.6 119 
29*, 30*, 31*, 32*, 33* (40 kDa), 
61* (~10 kDa),  
80*, 81* (~17 kDa), 
 87*, 89* (~30 kDa) 
      Glycolysis    
XP_002494228 PAS_chr4_0783 GUT1 Glycerol kinase 68.8 5.3 104 145* 
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NCBI 
Accession-No1 Locus ID
1 Gene name2 Protein name2 MW (KDa)3 pI
3 Mascot Score Spot No
4 
Functional category1       
XP_002493103 PAS_chr3_0868 FBP1 Fructose-1,6-bisphosphatase 38.4 6.1 118 41* 
XP_002491345 PAS_chr2-1_0437 TDH1 Glyceraldehyde-3-phosphate dehydrogenase, isozyme 3 35.7 6.2 106 45*, 48*, 95*,118* 
XP_002489713 PAS_chr1-1_0072 FBA1 Fructose 1,6-bisphosphate aldolase 39.9 6.0 186 115* 
XP_002490411 PAS_chr1-4_0292 PGK1 3-Phosphoglycerate kinase  44.1 7.8 152 210*, 211* 
XP_002493191 PAS_chr3_0951 TPI1 Triose phosphate isomerase 27.1 5.7 244 112* 
XP_002493059 PAS_chr3_0826 GMP1 Tetrameric phosphoglycerate mutase  28.0 6.0 165 65* 
XP_002492293 PAS_chr3_0082 ENO2 Enolase I 46.5 5.4 102 22*, 59*, 150* 
      Ethanol metabolism  
CAY67035 PAS_c034_0018 ADH Alcohol dehydrogenase 38.1 6.3 195 78* 
XP_002491382 PAS_chr2-1_0472 ADH3 Mitochondrial alcohol dehydrogenase isozyme III  37.3 5.8 145 42*, 44*, 55*, 93*, 96* 
      Citrate cycle (TCA cycle)  
XP_002489764 PAS_chr1-1_0475 CIT1 Citrate synthase 51.9 7.8 102 27* 
XP_002489444 PAS_chr1-3_0104 ACO1 Aconitase   85.0 5.7 77 129* 
XP_002491128 PAS_chr2-1_0238 MDH1 Mitochondrial malate dehydrogenase 36.5 5.3 129 43*, 47*, 53*, 56*, 103*, 141* 
      Pentose phosphate pathway  
XP_002492495 PAS_chr3_0277 6PGD [GND] 6-Phosphogluconate dehydrogenase (decarboxylating)  54.2 5.9 116 23* 
XP_002491849 PAS_chr2-2_0337 TAL1 Transaldolase 35.7 5.1 111 109* 
      Sugar metabolism and others  
XP_002490557 PAS_chr1-4_0426 BGL2 Endo-beta-1,3-glucanase 34.2 4.1 109 158* 
XP_002493105 PAS_chr3_0870 VIG9 [PSA1] GDP-mannose pyrophosphorylase (mannose-1-phosphate guanyltransferase) 40.1 6.0 95 215* 
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NCBI 
Accession-No1 Locus ID
1 Gene name2 Protein name2 MW (KDa)3 pI
3 Mascot Score Spot No
4 
Functional category1       
      Pyruvate metabolism  
XP_002492397 PAS_chr3_0188 PDC1 Major of three pyruvate decarboxylase isozymes 61.5 5.6 118 11*, 12* 
XP_002491703 PAS_chr2-1_0769 PYK2 Pyruvate kinase 55.9 6.1 190 161* 
1.2 Energy Metabolism  
      Oxidative phosphorylation  
XP_002493409 PAS_c131_0021 [VMA2] Vacuolar ATP synthase subunit B  55.4 5.3 159 167* 
XP_002492803 PAS_chr3_0576 atpA Alpha subunit of the F1 sector of mitochondrial F1F0 ATP synthase 59.0 9.1 76 52*, 66*, 125* 
XP_002492039 PAS_chr2-2_0165 atpD Beta subunit of the F1 sector of mitochondrial F1F0 ATP synthase 54.0 5.2 83 6*, 35*, 68* 
XP_002494179 PAS_chr4_0737 MCR1 Mitochondrial NADH-cytochrome b5 reductase 33.6 8.8 151 67* 
1.3 Nucleotide metabolism  
XP_002492154 PAS_chr2-2_0059 YNK1 Nucleoside diphosphate kinase 17.0 6.2 83 121* 
1.4 Amino acid metabolism  
XP_002490090 PAS_chr1-1_0432 ILV5 Acetohydroxyacid reductoisomerase 44.4 7.7 92 37* 
XP_002491046 PAS_chr2-1_0160 metE [MET6] Cobalamin-independent methionine synthase 85.9 5.9 193 107*, 128* 
XP_002492638 PAS_chr3_0410  CAR2 L-Ornithine transaminase 47.5 5.9 249 200* 
XP_002490747 PAS_chr1-4_0608 ARO8 Aromatic aminotransferase I 54.2 5.4 172 165* 
XP_002492166 PAS_chr2-2_0048  Dihydrolipoamide dehydrogenase 52.6 6.3 113 13* 
XP_002493126 PAS_chr3_0890 SAHH S-adenosyl-L-homocysteine hydrolase 49.2 5.4 147 151* 
XP_002493112 PAS_chr3_0876 SAM2 S-adenosylmethionine synthetase 42.6 6.1 96 205* 
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NCBI 
Accession-No1 Locus ID
1 Gene name2 Protein name2 MW (KDa)3 pI
3 Mascot Score Spot No
4 
Functional category1       
 
1.5 Metabolism of cofactors and 
vitamins 
      
XP_002493470 PAS_chr4_0065 THI5 Protein involved in synthesis of the thiamine precursor hydroxymethylpyrimidine (HMP) 38.7 6.3 94 46* 
XP_002493989 PAS_chr4_0550 - Pyridoxine 4-dehydrogenase  36.3 5.6 97 138* 
XP_002492875 PAS_chr3_0648 THI4 Thiazole synthase 37.3 6.2 92 113* 
2. Genetic information processing   
2.1 Transcription and translation  
XP_002491688 PAS_chr2-1_0755 EGD2 Alpha subunit of the heteromeric nascent polypeptide-associated complex (NAC) 21.6 4.6 78
5 73* 
XP_002489404 PAS_chr1-3_0068 RPP0 Conserved ribosomal protein P0 similar to rat P0, human P0, and E. coli L10e  33.7 4.6 128 72* 
XP_002491277 PAS_chr2-1_0376 EFB1 Putative GTPase, member of the Obg family 23.2 4.3 122 108* 
XP_002490107 PAS_chr1-1_0449 PST2 Protein with similarity to members of a family of flavodoxin-like proteins 20.9 6.4 73 86* 
XP_002493447 PAS_chr4_0041 - Protein component of the large (60S) ribosomal subunit 15.1 5.8 86 94* 
XP_002489653 PAS_chr1-1_0019 SUB2 Component of the TREX complex required for nuclear mRNA export 49.6 5.4 91 166* 
XP_002490604 PAS_chr1-4_0471 RPS0 Protein component of the small (40S) ribosomal subunit, nearly identical to Rps0Bp 29.3 4.6 72 71* 
XP_002493313 PAS_chr3_1071 CAM1 Translation elongation factor EF-1 gamma  24.3 6.4 104 78*, 137* 
XP_002493749 PAS_chr4_0327 GCN1 Positive regulator of the Gcn2p kinase activity, forms a complex with Gcn20p 30.4 5.6 79 101* 
2.2 Sorting and degradation  
XP_002492588 PAS_chr3_0365 SSC1 Mitochondrial matrix ATPase  69.7 5.4 152 106* 
XP_002490239 PAS_chr1-4_0130 HSP90 Heat shock protein Hsp90 80.9 4.8 81 1*, 2* 
XP_002489443 PAS_chr1-3_0102 clpB [HSP104] Heat shock protein that cooperates with Ydj1p (Hsp40) and Ssa1p (Hsp70)  100.6 5.3 140 315* 
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NCBI 
Accession-No1 Locus ID
1 Gene name2 Protein name2 MW (KDa)3 pI
3 Mascot Score Spot No
4 
Functional category1       
XP002494360.1 PAS_FragD_0026 [CDC48] ATPase in ER, nuclear membrane and cytosol with homology to mammalian p97 91.4 4.8 108 146* 
CCA38590 PP7435Chr2-0908 AAP1 Aminopeptidase N 23.0 4.7 142 316* 
XP_002493087 PAS_chr3_0856 UBA1 Ubiquitin activating enzyme (E1) 115.6 5.0 142 325* 
2.3 Folding catalysts  
CAC33587 PAS_chr4_0844 PDI Protein disulfide isomerase  58.1 4.6 161 134* 
XP_002493562 PAS_chr4_0158 CPNA [HSP60] Tetradecameric mitochondrial chaperonin     60.5 5.1 115 4* 
XP_002489608 PAS_chr1-3_0264 [CPR1] Cytoplasmic peptidyl-prolyl cis-trans isomerase (cyclophilin)     18.1 6.1 99 92* 
XP_002493991 PAS_chr4_0552 HSP70-HSA1 [SSA1] 
ATPase involved in protein folding and nuclear localization signal (NLS)-
directed 69.7 4.1 89 207* 
XP_002492959 PAS_chr3_0731 HSP70 [SSB] Cytoplasmic ATPase that is a ribosome-associated molecular chaperone 66.6 5.1 100 209* 
XP_002491027 PAS_chr2-1_0140 KAR2 ATPase involved in protein import into the ER 74.2 4.8 146 133* 
XP_002492443 PAS_chr3_0230 HSP70 [SSA3] ATPase involved in protein folding and the response to stress 70.9 5.1 102 76* (70.9 KDa) 105* (~25 KDa) 
3. Cellular processes   
3.1 Transport and catabolism  
XP_002490181 PAS_chr1-4_0071 SOD2 Mitochondrial superoxide dismutase 25.2 7.9 85 216* 
XP_002493819 PAS_chr4_0391 [TOM40] Component of the TOM (translocase of outer membrane) complex 42.8 5.6 78 36* 
XP_002492446 PAS_chr3_1169 ACT1 Actin 41.9 5.3 148 21* 
3.2 Cell growth and death  
XP_002490987 PAS_chr2-1_0809 BMH1 14-3-3 protein homolog 29.1 4.8 85 75* 
XP_002492031 PAS_chr2-2_0172 NAP1 Protein that interacts with mitotic cyclin Clb2p 49.0 4.3 115 135* 
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NCBI 
Accession-No1 Locus ID
1 Gene name2 Protein name2 MW (KDa)3 pI
3 Mascot Score Spot No
4 
Functional category1       
 
4. Other 
4.1 Stress response   
XP_002491977 PAS_chr2-2_0220 TSA1 Thioredoxin peroxidase  21.5 4.9 125 77* 
XP_002490091 PAS_chr1-1_0433 PRX1 Mitochondrial peroxiredoxin (1-Cys Prx) with thioredoxin peroxidase activity 25.1 5.7 142 82*, 111* 
BAH80186  PAS_chr2-2_0480 TRR1 Thioredoxin reductase 1  35.3 5.5 93 225* 
XP_002491413 PAS_chr2-1_0502 - Thiol-specific peroxiredoxin 19.3 8.6 106 120* 
5. Unclassified  
XP_002491418 PAS_chr2-1_0853 - Hypothetical protein 57.0 6.0 84 7*, 8*, 91* 
XP_002489760 PAS_chr1-1_0118 - Laminin subunit gamma-1 46.3 7.0 73 142*, 157* 
XP_002491208 PAS_chr2-1_0313 - Bifunctional enzyme with alcohol dehydrogenase and glutathione-dependent formaldehyde dehydrogenase  39.1 5.8 92 38*, 39*, 40* 
XP_002490174 PAS_chr1-4_0063 - G-protein beta subunit and guanine nucleotide dissociation inhibitor for Gpa2p 35.0 6.3 104 116* 
XM_002490789 PAS_FragB_0024 - Inositol 2-dehydrogenase 38.0 5.7 79 139* 
 
1  Accession numbers and locus IDs are according to the NCBI Reference Sequence database (http://www.ncbi.nlm.nih.gov/RefSeq/). Functional classifications are mostly according to KEGG 
PATHWAY database (http://www.genome.jp/kegg/metabolism.html). The datas are according to databases on 01.10.12. 
2 Gene/protein names are according to the sequenced genome of P. pastoris GS115 (http://www.uniprot.org/). If no name was found for P. pastoris GS115, a Blast search of the respective P. 
pastoris GS115 gene/protein against different P. pastoris strains was carried out in the following order: search against ATCC 76273 / CBS 7435 / CECT 11047 / NRRL Y-11430 / Wegner 21-1 
and P. pastoris (yeast). Gene/protein names from other P. pastoris strains were only adopted in case of 100% sequence identity (http://www.uniprot.org/). Gene names in brackets are from S. 
cerevisiae if the names differ for both yeasts (http://www.uniprot.org/). The datas are according to database on 01.10.12. 
3 Theoretical molecular mass (MM) and isoelectric point (pI) not considering potential posttranslational modifications.  
4 “Spot-No” indicates the serial number of all identified protein spots of the intracellular proteome of P. pastoris X-33. Proteins appearing in multiple spots indicate the existence of isoforms which 
probably derive from posttranslational modification events such as phosphorylation, glycosylation or limited proteolysis. Two representative 2D gels of the intracellular proteome from cell samples 
taken at the end of glycerol phase and after 48 hours of growth on methanol with the respective spot numbers are shown below. Spot numbers in this table and the following gel are marked by 
an asterix (*) for simplified searchability. Fragments of full-length proteins, AOX1, FDH1 and SSA3, were identified and the respective Spot No and MW are indicated.  
5 Score obtained from MSMS analysis.
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Two representative 2D gels of the intracellular proteome of P. pastoris X-33 producing IP. 
The sample was taken at the end of the glycerol phase (A) and after 48 h of growth on methanol (B). Spot numbers correspond to numbers in the 
table above and are marked by an asterix (*) for simplified searchability. 
pI 3 pI 11
120Mw (kDa)
10
107*128*
35*
6*
68*
125*
66*
52*
121*
215*
77*
225*
112*
-46*-113*
48*43* 118*
109*
-166*
106*
216*
50*
-205*
151*
71*
72*
161*
86*
111*
211* 210*
134*
12*
11*
-138*
36*-
94*
76*
105*
13*7* 8*
91*
51*
120*
38* 39*
40*-
-116*
92*
142*
157*
167*
146*
139*
135*
53*
141*
47*
56*-
45*
67*
133*
37*-
1*
209*
207* 145*
65*
24*
41*
115*
59*
150*
22*
73*
108*
16*
223*
153*
18*
4*
27*
78*
75
158*
85*
165*
44*42*55*
96*
21*
129*
23*
325*
315*
316*
A
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B
120Mw (kDa)
10
pI 3 pI 11
35*
6*
68*
125*
66*
52*
121*
215*-
77*
225*
112*
-46
48*
95*
45*
118*109*
165*
106*
216*
50*
151*-
71*
72*
86*
82*
111*
210*
134*
12*
11*
-138 *
36*
94*
76*
105*
13*
7* 8*
91*
51*
120*
38* 39*
40*-
116*
92*
142*
-157*
167*
139*
135*
103* 
53*
141*
47*
56*-
43*
67*
37*
2*
1*
209*207*-
145*
65*
101*
28*
54*
-49* 87*
30* 31* 
32*
33*
61*
29*
81*
89*
41*
-115*
59*
150*
22*
73*
108*
153*
57*
58*
18*
4*
27*
137*
78*
75*
158*
85*
166*
14* -15*
156*
163*
44*42*55*
93*
96*
21*
129*
23*
16*
80*
25*24*
315*
316*
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Change of the intracellular proteome in response to IP production under methanol induction.  
Samples before methanol addition at the end of the glycerol batch phase and 6, 18, 48 and 120 hours after the onset of methanol feeding were 
analyzed and the protein changes are shown (numbers. log2 changes; n.a. not analyzable, color code: light orange to red, increase, light green to 
dark green: decrease, yellow: no significant change). 
 
 
 
Functional category Gene name1 Gene ID 0h2 6h  18h  48h  120h  
Carbohydrate metabolism 
Methanol metabolism  
AOX1  PAS_chr4_0821 0.0 7.4 9.4 9.2 9.5 
AOX1 (~25 kDa)3 0.0 7.1 7.1 8.1 8.1 
CTA1 PAS_chr2-2_0131 0.0 1.7 2.0 1.5 2.3 
DAS1 PAS_chr3_0832 0.0 0.1 0.9 -0.1 -0.2 
DAK PAS_chr3_0841 0.0 n.a 6.5 8.1 8.7 
FLD1 PAS_chr3_1028 0.0 9.4 9.9 10.7 10.8 
FGH1 PAS_chr3_0867 0.0 7.0 8.4 8.8 9.0 
FDH1  PAS_chr3_0932 0.0 10.7 11.6 12.3 12.3 
FDH1 (~30 kDa)3 0.0 6.2 8.3 10.1 10.5 
FDH1 (~17 kDa)3 0.0 0.0 8.1 9.6 10.5 
FDH1 (~10 kDa)3 0.0 0.0 7.1 9.3 9.4 
Glycolysis 
GUT1 PAS_chr4_0783 0.0 -0.4 0.1 -1.6 n.a 
FBP1 PAS_chr3_0868 0.0 0.1 0.6 0.6 0.6 
TDH1 PAS_chr2-1_0437 0.0 0.6 -0.3 -0.6 -1.1 
FBA1 PAS_chr1-1_0072 0.0 0.2 -0.6 -1.1 -1.0 
PGK1 PAS_chr1-4_0292 0.0 -1.0 n.a 1.1 0.4 
TPI1 PAS_chr3_0951 0.0 0.1 -0.4 -2.1 -2.2 
GMP1 PAS_chr3_0826 0.0 0.0 -0.2 -0.8 -1.1 
ENO2 PAS_chr3_0082 0.0 0.1 0.0 -1.1 -0.8 
Ethanol metabolism ADH3 PAS_chr2-1_0472 0.0 0.0 0.0 -0.7 -0.6 
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Functional category Gene name1 Gene ID 0h2 6h  18h  48h  120h  
Citrate cycle (TCA)  
CIT1 PAS_chr1-1_0475 0.0 1.0 0.7 0.3 0.4 
ACO1 PAS_chr1-3_0104 0.0 0.5 0.1 -1.0 -0.4 
MDH1 PAS_chr2-1_0238 0.0 0.1 -0.2 -0.1 0.5 
Pentose phosphate pathway 6PGD [GND] PAS_chr3_0277 0.0 0.9 0.3 -0.5 -0.9 
TAL1 PAS_chr2-2_0337 0.0 1.1 0.4 -1.0 -0.4 
Sugar metabolism BGL2  PAS_chr1-4_0426 0.0 0.2 -0.1 -1.0 -0.9 
VIG9 [PSA1] PAS_chr3_0870 0.0 0.4 -0.9 -0.9 n.a 
Pyruvate metabolism PDC1 PAS_chr3_0188 0.0 0.0 -0.5 -1.4 -2.0 
PYK2 PAS_chr2-1_0769 0.0 0.6 -0.5 -2.3 -1.9 
Energy metabolism 
Oxidative phosphorylation  
[VMA2] PAS_c131_0021 0.0 -0.1 -1.0 -1.2 -1.6 
atpA PAS_chr3_0576 0.0 0.8 0.3 0.4 1.1 
atpD PAS_chr2-2_0165 0.0 -0.2 0.4 -0.7 0.1 
MCR1 PAS_chr4_0737 0.0 0.2 0.9 0.2 1.2 
Nucleotide Metabolism     
  YNK1 PAS_chr2-2_0059 0.0 -0.2 -0.6 -1.0 -1.4 
Amino Acid Metabolism 
  
ILV5 PAS_chr1-1_0432 0.0 0.2 -0.1 -0.7 -0.1 
metE [MET6] PAS_chr2-1_0160 0.0 0.8 -0.7 n.a n.a 
CAR2 PAS_chr3_0410 0.0 0.1 -0.3 n.a -0.3 
ARO8  PAS_chr1-4_0608 0.0 1.3 0.6 -0.1 0.5 
 - PAS_chr2-2_0048 0.0 0.6 -0.4 -0.7 -0.2 
SAHH PAS_chr3_0890 0.0 0.0 -0.5 -1.6 -0.4 
SAM2 PAS_chr3_0876 0.0 0.9 -0.3 0.4 -0.1 
Metabolism of cofactors and vitamins 
  
 - PAS_chr4_0550 0.0 0.0 -0.7 -0.6 -1.2 
THI5 PAS_chr4_0065 0.0 1.5 2.3 1.0 -0.8 
THI4 PAS_chr3_0648 0.0 1.9 2.3 0.5 0.1 
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Functional category Gene name1 Gene ID 0h2 6h  18h  48h  120h  
Genetic information processing 
Transcription and translation  
EGD2 PAS_chr2-1_0755 0.0 -0.3 -0.9 -0.3 -0.2 
RPP0 PAS_chr1-3_0068 0.0 0.7 -0.1 -0.4 -0.2 
EFB1 PAS_chr2-1_0376 0.0 -0.3 -0.4 -0.9 -1.0 
PST2 PAS_chr1-1_0449 0.0 0.3 0.3 -0.8 -0.5 
 - PAS_chr4_0041 0.0 0.1 -0.4 -0.1 -1.0 
SUB2  PAS_chr1-1_0019 0.0 0.6 0.0 0.1 1.2 
RPS0 PAS_chr1-4_0471 0.0 -0.3 -0.4 -0.2 -2.5 
CAM1 PAS_chr3_1071 0.0 0.8 2.2 3.5 2.5 
GCN1  PAS_chr4_0327 0.0 n.a 7.4 7.1 6.5 
Sorting and Degradation  
SSC1 PAS_chr3_0365 0.0 -0.3 -1.3 -2.6 -1.0 
Hps90 PAS_chr1-4_0130 0.0 -0.6 -1.6 -0.9 n.a 
cIpB [HSP104] PAS_chr1-3_0102 0.0 0.5 -1.2 -2.2 n.a 
[CDC48] PAS_FragD_0026 0.0 -0.5 -1.4 -3.6 -3.4 
AAP1 PP7435_Chr2-0908 0.0 -0.5 -0.5 -0.8 -0.6 
UBA1 PAS_chr3_0856 0.0 -0.5 -1.5 n.a n.a 
Folding catalysts 
PDI PAS_chr4_0844 0.0 -0.2 -1.2 -2.7 -1.7 
CPNA [HSP60] PAS_chr4_0158 0.0 0.0 -0.5 -1.5 -0.2 
[CPR1] PAS_chr1-3_0264 0.0 -0.2 -0.7 -1.3 -1.4 
HSP70-HSA1 [SSA1] PAS_chr4_0552 0.0 -0.7 -1.5 -2.9 -2.9 
HSP70 [SSB] PAS_chr3_0731 0.0 0.1 -0.8 -2.5 -2.2 
KAR2 PAS_chr2-1_0140 0.0 0.1 -1.5 n.a -1.4 
HSP70 [SSA3]  PAS_chr3_0230 0.0 -0.4 -1.0 -2.7 -2.2 
HSP70 [SSA3] (~ 25 KDa)3 0.0 0.3 1.4 1.8 2.4 
Cellular processes 
Transport and catabolism 
SOD2 PAS_chr1-4_0071 0.0 0.3 0.0 -0.1 0.2 
[TOM] PAS_chr4_0391 0.0 0.4 -0.1 -1.0 1.1 
ACT1 PAS_chr3_1169 0.0 0.1 0.2 0.0 -0.2 
Cell Growth and death BMH1 PAS_chr2-1_0809 0.0 -0.1 0.0 -0.8 -0.9 
NAP1 PAS_chr2-2_0172 0.0 -0.7 -0.5 -0.4 -1.4 
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Functional category Gene name1 Gene ID 0h2 6h  18h  48h  120h  
Others     
Stress response 
TSA1  PAS_chr2-2_0220 0.0 -0.2 0.4 -0.1 0.6 
PRX1 PAS_chr1-1_0433 0.0 0.0 0.3 -0.1 0.4 
TRR1 PAS_chr2-2_0480 0.0 0.3 -0.1 -1.8 -1.2 
 - PAS_chr2-1_0502 0.0 0.3 -0.4 -1.4 -1.3 
Unclassified 
 
 - PAS_chr2-1_0853 0.0 0.5 0.1 -0.1 0.6 
 - PAS_chr1-1_0118 0.0 0.5 -0.1 -0.7 -0.4 
 - PAS_chr2-1_0313 0.0 -0.1 -0.3 -0.7 -0.3 
 - PAS_chr1-4_0063 0.0 1.3 0.6 0.1 -0.4 
 - PAS_FragB_0024 0.0 0.2 -0.4 -1.4 -1.2 
 
1. Gene names in brackets are from S. cerevisiae if the names differ for both yeasts (http://www.uniprot.org/). 
2. When no protein spot was detectable at the end of the glycerol batch phase (methanol metabolism), a virtual number of 0.001 was taken for the spot intensity to allow the calculation of log2 
values (spot intensities were normalized using the log2 ratio of induced samples versus uninduced sample). 
3. Fragments of full-length proteins, AOX1, FDH1 and SSA3, were identified and the respective log2 fold changes are given. 
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Figure 9.1. Changes of the intracellular proteome of P. pastoris X-33 in response to 
secretory insulin precursor production containing most of the identified ERAD and 
UPR related proteins. (A) Sections of 2D gels representing parts of the intracellular 
proteome and containing most of ERAD and UPR related proteins at 0, 5, 16 and 72h after 
induction with methanol. (B) Representative graphs of the abundance changes of each 
protein spot shown in A. The spot related to fragment SSA3 ~25 kDa is shown in the small. 
This cultivation was done in almost the same conditions as described in the Chapter 4, 
Methods 4.3.2. Only the induction with methanol was directly started with 2 g L-1, instead to 
use the initiations pulses. The small map indicates the position of the 2D sections in the 
entire 2D gel. 
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Figure 9.2. Chromatogram of intracellular and secreted insulin precursor. Quantification of intracellular and secreted insulin precursor was done by reverse phase 
high performance liquid chromatography (RP-HPLC). The injection volume was 50 μL for both standard and samples. Samples were taken at 120 h after induction. 
Pure IP (pink line-Control IP) was used as control for the retention time. Sample before induction (red line) and GS115 host strain (GS115-host) (blue line) were used 
as a negative control to check if none of natural proteins has the same retention time. The intracellular IP is represented by the green line and the secreted IP is 
represented by the turquoise line. The details of the analysis are described in the Chapter 4, Methods 4.3.2. 
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10. Appendix IV 
10.1. Protocol for P. pastoris two-dimensional gel 
electrophoresis  
This protocol is based on manufacturer's instruction (GE Healthcare, UK) and on 
the PhD thesis, Metabolic balance during protein production with recombinant 
Escherichia coli, Zhaopeng Li, 2012, Hannover University, with some modification 
for this study.  
10.1.1. Sample preparation 
10.1.1.1. Cell harvesting  
Collect a certain volume of the cell culture to always bring the OD600 to 40. 
Centrifuge at 4oC, 13300 rpm for 3 min, discard the supernatant, freeze the final 
cell pellets in liquid nitrogen and store at -80oC. 
10.1.1.2. Cell disruption  
Wash the pellet with ice-cold 1× PBS, resuspend in 1 mL cell lysis buffer (7 mol L-
1 urea, 2 mol L-1 thiourea, 30 mmol L-1 Tris, 4% (w/v) Triton X-100, pH 8.5) and 
adjust to OD600 ~50. Combine with 500 μL of glass beads (0.5 mm, Sartorius AG, 
Goettingen, Germany). For cell disruption, samples are treated in a Fastprep FP120 
homogenizer (Thermo Savant, Holbrook, NY) twice (speed 6.00 m/s for 30 s; 
cooling interval of 30 s between treatments). Afterwards, cellular debris is pelleted 
by centrifugation at 13000 rpm at 4°C for 5 min. 
10.1.1.3. Precipitation with chloroform/methanol  
In order to separate the protein from the contaminating species, such as salts, 
nucleic acids, lipids, etc, the precipitation was done as described below. Prepare 
each sample in triplicate in order to run triplicate 2D gels. For each sample prepare 
one water control group, substituting the cell lysate for Milli-Q water. 
1- Transfer 100 µL of lysate cells (or Milli-Q water for the control) into a 2 mL 
microcentrifuge tube. 
2- Add 800 µL of methanol and vortex for 10 seconds. 
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3- Add 200 µL of chloroform and vortex for 10 seconds. 
4- Add 600 µL of Milli-Q water and vortex for 10 seconds. 
5- Centrifuge at 13300 rpm for 7 min at 4°C. 
6- After centrifugation, a white pellet of protein should be visible. Use a pipette 
to remove the supernatant. Wash the surface of protein pellet using the upper 
layer of the control after the final centrifugation. Shake gently the tubes at 
300 rpm for 1 min (do not vortex). Without disturbing the protein pellet, 
remove as much as possible of the supernatant using a pipette. Allow the 
pellet to air dry to let the residual methanol and chloroform evaporate till 
there no smell of methanol. This drying procedure should not last more than 
10 min. Do not overdry the protein pellet. 
 
10.1.1.4. Resuspension of pellet 
After drying, resuspend the protein pellet in 500 µL of resolubilization solution 
(urea 9 mol L-1, thiourea 2 mol L-1, CHAPS 4%, Tris 2 mg/mL, SDS 0.2% and 
bromophenol blue 0.002%), 7.5 µL of IPG buffer and 7.5 µL of 1 mol L-1 DTT 
stock solution. To facilitate the resolubilization shake the sample at 1000 rpm for 3 
h at 26oC in an Eppendorf Thermomixer (Eppendorf, Germany). Freeze the final 
cell pellet in liquid nitrogen and store at -80oC for later analysis. 
10.1.2. First-dimension isoelectric focusing (IEF) 
During the isoelectric focusing the proteins are separated according to their 
isoelectric points (pI). 
The Ettan IPGphor strip holder (GE Healthcare, UK) should be clean and 
completely dry before use. For cleaning, wash with 10% SDS solution using a 
toothbrush, rinse well with Milli-Q water to remove the SDS and other residual 
contaminations and thoroughly air dry the strip holders. 
1- Take out the samples from -80oC and shake at 1000 rpm for 1.5 h at 28oC in 
an Eppendorf Thermomixer. Make sure that urea and thiourea are 
completely dissolved. Add another 7.5 µL of 1 mol L-1 DTT stock solution 
to each sample to make the final DTT concentration to 30 mmol L-1, shake 
for additional 10 min.  
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2- Centrifuge the sample at 13300 rpm for a 25 min at 25oC.  
3- Transfer 420 µL of supernatant to a new microcentrifuge tube. Final 
resolubilization solution is urea 9 mol L-1, thiourea 2 mol L-1, CHAPS 4%, 
Tris 2 mg/mL, IPG buffer 1.5% (pH gradient 3-10), DTT 30 mmol L-1, SDS 
0.2% and bromophenol blue 0.002%. 
4- Place two IEF sample application pieces (GE Healthcare, UK) in the lateral 
wells at both ends of the strip holder. Add 20 µL of rehydration solution 
(urea 9 mol L-1, thiourea 2 mol L-1, CHAPS 4%, Tris 2 mg/mL) onto each 
paper before the samples are loaded on to the strip holder.  
5- Take note of the number of the IPG strip and which sample will be loaded 
onto this IPG strip. Do not write on the IPG strip. 
6- Load 360 mL of sample into the center of a cleaned strip holder. The sample 
should be in between the two electrodes. Remove any larger bubble. 
7- Remove the protective cover foil of the IPG strip with forceps starting at the 
acidic (+) end. Place the IPG strip with the gel side down. Do not generate 
bubbles. Put the (+) (conical side) and (–) (square side) side in the correct 
position. 
8- Add 3 mL silicon oil on the plastic back of the IPG strip to minimize 
evaporation and, thus, prevent urea crystallization. Cover up the strip holder. 
9- Start the IEF according the following protocol:  
 
Procedure Program Steps 
Voltage 
(V) 
Step duration 
(h) 
Voltage 
gradient type 
Theoretical voltage 
hours 
(Vhr) 
Rehydration  0 35 Step-n-hold 0 
Isoelectric 
Focusing 
1 50 4 h Step-n-hold 200 
2 100 4 h Gradient 400 
3 300 3 h Gradient 900 
4 1000 4 h Gradient 2600 
5 3500 3 h Gradient 6750 
6 5000 3 h Gradient 12750 
7 5000 3 h Step-n-hold 15000 
8 8000 3 h Gradient 19500 
End 9 8000 10 h Step-n-hold 80000 
Temperature: 20oC, 
Current limit for each strip: 30 µA (3-10 NL strip) or 35 µA (3-10 strip) 
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10.1.3. Second dimension SDS-PAGE 
During the second dimension SDS-PAGE the proteins are separated according to 
their molecular weights.  
10.1.3.1. Preparing the electrophoresis tank 
Around 2 hours before the start, prepare the buffer and fill the tank. Turn on the 
tank and set the temperature to 10°C at the cooling unit. 
10.1.3.2. Equilibrating IPG strip  
The equilibration step saturates the IPG strip with the SDS buffer necessary for the 
second-dimension separation and is always performed immediately prior to the 
second-dimension run. 
1- With a pipette remove the silicon oil of the strip holder and use forceps to 
take out the IPG strips to a blotting paper to absorb the excess silicon oil. 
Make sure that the gel side is facing up to the air.  
2- Place one strip, gel side up, in each channel of the plexiglass tray and fill the 
channel successively with the equilibration buffer. First, add 4 mL of SDS 
equilibration buffer with 1% DTT, previously prepared and incubate with 
gentle agitation for 15 min, then decant. This buffer reduces the disulfide 
bonds. 
3- A second equilibration may be performed with iodoacetamide. Refill the 
channel with 4 mL of SDS equilibration buffer with 5% iodoacetamide, 
previously prepared and incubate again for 15 min with gentle shaking. This 
buffer alkylates the sulfhydryl groups. After equilibration pour out the SDS 
equilibration buffer with iodoacetamide to a special container. Do not 
discard iodoacetamide to the sink. 
 
10.1.3.3. Transfer of IPG strips to the SDS-PAGE gel 
1- During the IPG strip equilibration melt the agarose sealing solution in a 
microwave. Do not allow the solution to boil. The composition of the 
agarose sealing solution is: 1% agarose, 0.002% bromophenol blue, 
dissolved in SDS electrophoresis buffer. 
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2- Wash the SDS-PAGE slab gel cassettes with purified water; apply some SDS 
electrophoresis buffer to the loading space for the IPG strips to facilitate the 
transition procedure. 
3- Place the IPG strip onto the long plate with the plastic backing against the 
plate. Do not damage the gel of the IPG strip. As convention, always put the 
pointed, acidic (+) end on the same end as the gel label. Make sure that the 
IPG strip is positioned directly on top of the second dimension gel and 
centered. Overlay the strip with molten 1% agarose sealing solution. Avoid 
bubbles when sealing with agarose, they can disturb protein migration. Wait 
2 – 5 minutes to allow the agarose to solidify before proceeding.  
 
10.1.3.4. Placement of cassettes into the DALT tank 
Place the cassettes into the electrophoresis tank. The cassettes are correctly loaded 
in running orientation in the DALT tank (GE Healthcare, UK) slot with the IPG 
strips vertical along the left, or cathode (-), side and the rubber cassette hinge along 
the bottom. Do not drop the plates into the tank and onto the circulation flutes. 
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Adjust the buffer level after all the cassettes are placed and close the lid. Attach the 
electrical leads to make proper electrical contact with the power supply. Migration 
proceed toward the red (+), or right part of the chamber. Turn on the power supply 
to begin the separation. Set the power supply to 40 V constant voltage for the first 2 
h and increase to 100 V for overnight run.  
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10.1.3.5. Ending second-dimension SDS-PAGE electrophoresis  
Stop the running when bromophenol blue tracking dye reaches the edge of the 
polymerized acrylamide gel. Carefully take out of the tank and open the cassettes. 
Transfer the gels to a plastic box and incubate the gels in fixing solution for 1.5 h 
with gentle agitation. After 45 min, refresh the fixing solution and shake for 
another 45 min. After the fixation, remove all of the fixing solution and add some 
Colloidal Silver Coomassie G-250 staining solution and incubate overnight with 
gentle agitation. To destain the Coomassie stained gels use Milli-Q water. Refresh 
the water as often as necessary. After destaining, preserve the gel at 4°C with NaN3 
(Sodium Azide) (100 µL NaN3 1% in 1000 mL H20). 
 
10.2. Protocol for MALDI analysis  
10.2.1. Trypsin digestion  
1. Excision of protein spot from polyacrylamide gels 
1.1. Wash SDS-PAGE gel with Milli-Q water. Excise the gel spot of interest and 
put them into microcentrifuge tube. Do not touch the gel with fingers. 
Always wear gloves. 
1.2. Wash the gel pieces 5 times with 1 mL Milli-Q water.  For every washing 
step, very gently shake for 5 min. At the last washing step, use a small 
pipette tip to cut gel spots into small pieces. Withdraw water and be careful 
to not suck out and lose any piece of gel spots. 
1.3. Dehydrate. Add 200 µL acetonitrile (ACN) for 10 min. Withdraw ACN 
completely. 
 
2. Carbamidomethylation  
2.1. Add 50 µL of DTT solution [20 mmol L-1 DTT (3.1 mg/mL) in 0.1 mol L-1 
NH4HCO3] to each sample and incubate for 30 min at 56°C on a Eppendorf 
thermomixer (do not shake). This step is done to reduce the protein. 
Remove the DTT solution from each sample completely (be careful to not 
suck out any piece of gel spots). 
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2.2. Dehydrate with acetonitrile (see step 1.3 above).  
2.3. Add 50 µL of iodacetamide solution [55 mmol L-1 iodacetamide (10.2 
mg/mL) in 0.1 mol L-1 NH4HCO3] to each sample. Incubate for 30 min at 
room temperature in the dark. Withdraw iodacetamide solution completely. 
2.4. Dehydrate with acetonitrile (see step 1.3 above). 
 
3. Buffering 
3.1. Add 200 µL of 0.1 mol L-1 NH4HCO3. Incubate for 15 min at room 
temperature. Withdraw NH4HCO3. 
3.2. Dehydrate with acetonitrile (see step 1.3 above).  
3.3. Dry the gel pieces in a vacuum centrifuge (about 10 min). 
 
4. In gel trypsin digestion 
4.1. Preparation of the trypsin solution. To one vial of 20 µg trypsin (Promega) 
add 100 µL of resuspension buffer (Promega) and incubate for 30 min at 
room temperature. Add 900 µL of 0.1 mol L-1 NH4HCO3. After mixing, 
aliquot 50 µL into 0.5 mL microcentrifuge tube and store at –20°C. Before 
using, thaw and add 450 µL Milli-Q water to make 500 mL of trypsin 
working solution. 
4.2. Add about 30 µL of trypsin working solution to each gel spot. Incubate the 
sample overnight at 37°C.  
 
10.2.2. Sample preparation for MALDI using ZipTips (C18) 
5. Peptide extraction 
5.1. Add 30 µL of acetonitrile (ACN) to the gel spot and mix on a Eppendorf 
thermomixer for 15 min at 37°C and 800 rpm. 
5.2. Transfer supernatant of each sample into another Eppendorf tube. 
5.3. Add 30 µL of 5% formic acid to each gel spot and mix on an Eppendorf 
thermomixer for 15 min at 37°C and 800 rpm. 
5.4. Add 30 µL of ACN to each gel spot and mix for 15 min at 37°C and 800 
rpm. 
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5.5. After 15 min, combine the supernatant with supernatant in the tube from 
step 5.2. 
5.6. Use Speedvac to dry samples (the sample combined with the supernatant 
from step 5.2 and 5.5) about 1 hour. 
5.7. After drying, add 20 µL 2% methanol, 0.5% formic acid and put samples 
into a sonication bath to sonicate for 5 min.  
 
6. Desalting with ZipTips (C18) 
6.1. Clean ZipTip 3 times with 10 µL elution solution (65% methanol, 0.5% 
formic acid). 
6.2. Equilibrate ZipTip 3 times with 10 µL washing solution (2% methanol, 
0.5% formic acid). 
6.3. Pipette sample up and down for 10 to 15 times very slow. 
6.4. Wash ZipTip 3 times with 10 µL washing solution. 
6.5. Elution for MALDI. Add 5 µL elution solution into a 0.5 mL 
microcentrifuge tube. Using the ZipTip containing sample from step 6.4, 
pipette the 5 µL elution solution up and down 3 times to elute sample from  
ZipTip to elution solution. 
 
7. Loading for MALDI mass spectroscopy analysis 
Mix 1 µL of sample in elution solution from step 6.5 with 1 µL of MALDI loading 
solution (10 mg of α-cyano-4-hydroxycinnamic acid, 400 µL acetonitrile (ACN)  
and 600 µL 0.1% trifluoroacetic acid (TFA) and transfer 2 µL of this mixture onto a 
clean MALDI sample target. The mass spectroscopy analysis is preformed after the 
solution is completely evaporated. 
 
10.2.3. Sample preparation for MALDI using Prespotted 
AnchorChip target 
5.  Peptide-Extraction  
5.1. Add 30 µL of acetonitrile (ACN) to the gel spot and mix on an Eppendorf 
thermomixer for 15 min at 37°C and 800 rpm. 
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5.2. Transfer supernatant of each sample into another Eppendorf tube. 
5.3. Add 30 µL of 5% formic acid to each gel spot and mix on an Eppendorf 
thermomixer for 15 min at 37°C and 800 rpm. 
5.4. Add 30 µL of ACN to each gel spot and mix for 15 min at 37°C and 800 
rpm. 
5.5. After 15 min, combine the supernatant with supernatant in the tube from 
step 5.2. 
5.6. Use Speedvac to dry samples (the sample combined with the supernatant 
from step 5.2 and 5.5) about 1 hour. 
5.7. After drying, add 7 µL 32% methanol, 0.5% ammonium phosphate and put 
samples into a sonication bath to sonicate for 10 min.  
 
6. .Loading to PAC target for MALDI mass spectrometry analysis 
6.1. Deposit 1 µL sample solution in matrix spot. 
6.2. Allow three minutes incubation. 
6.3. Add 7 µL washing buffer (10 mmol L-1 ammonium phosphate, 0.1% TFA) 
and remove the whole droplet after 3~5 seconds. 
 
10.3. Buffers and solutions for proteomic analyses 
DTT (1 mol L-1) stock solution 
Add 0.92 g Tris in a 15 mL conical screw cap tube and add 5 mL of Milli-Q water 
to bring the final volume to 6 mL. After completely dissolution, aliquot 75 µL of 
this solution to several PCR tubes and store at -80oC. 
 
Tris (1 mol L-1) stock solution 
Add 0.24 g Tris in a 2 mL microcentrifuge tube and add 1.7 mL of Milli-Q water to 
bring the final volume to 2 mL. After complete dissolution, store at 4oC. This 
solution is only Tris base solution, the pH does not need to be adjusted. 
 
Bromophenol blue stock solution 
Composition: 1% bromophenol blue and 50 mmol L-1 Tris base 
Add 100 mg of bromophenol blue and 60 mg of Tris base to a 15 mL centrifugation 
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tube and add Milli-Q water to bring the final volume to 10 mL. Vortex till it is 
completely dissolved and aliquot 1.2 mL of this solution to several microcentrifuge 
tubes and store at 4 oC. 
 
Tris-HCl (1.5 mol L-1), pH 8.8 stock solution (4× resolving gel buffer 
solution) 
Add 181.71 g of Tris base, 600 mL of Milli-Q water to a glass beaker and dissolve 
the Tris base. Adjust the pH value of this solution to 8.8 using 1 mol L-1 HCl. Add 
Milli-Q water to bring the final volume to 1000 mL and check the pH value of the 
final solution. Filter this solution through a 0.20 µm membrane to an autoclaved 
glass bottle.  
 
Lysis buffer  
Composition: 7 mol L-1 urea, 2 mol L-1 thiourea, 30 mmol L-1 Tris and 4% (w/v) 
Triton X-100, pH 8.5.  
Add 42 g urea, 15.2 g thiourea, 0.36 g Tris, 4 g Triton X-100 in 100 mL Milli-Q 
water. Adjust the pH to 8.5. 
 
Rehydration solution  
Only for dampening IEF sample application pieces in IPGphor Strip holder 
Composition: 9 mol L-1 urea, 2 mol L-1 thiourea, 4% CHAPS and 0.2 mg/mL Tris 
Add 10.81 g urea, 3.04 g thiourea and 0.8 g CHAPS, 37 µL 1 mol L-1 Tris (only 
Tris base solution, pH not adjusted) to a 20 mL glass beaker and add about 10 mL 
of Milli-Q water to bring the final volume to 20 mL. After complete dissolusion, 
aliquot 0.4 mL of this solution to several 2 mL microcentrifuge tubes and store at -
20oC. 
 
Resolubilization solution (for resolubilization of protein pellets)  
Composition: 9 mol L-1 urea, 2 mol L-1 thiourea, 4% CHAPS, 0.2 mg/mL Tris, 
0.2% SDS and 0.002% bromophenol blue. 
Add 32.43 g urea, 9.13 g thiourea and 2.4 g CHAPS, 111 µL 1 mol L-1 Tris (only 
Tris base solution, pH not adjusted), 1.2 mL of 10% SDS stock solution and 120 µL 
of 1% bromophenol blue stock solution to a 100 mL glass beaker and add about 30 
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mL of Milli-Q water to bring the final volume to 60 mL. Dissolve the solution 
completely. Aliquot 1.5 mL in microcentrifuge tubes and store at -20oC.  
 
SDS (10%) stock solution 
Add 100 g of SDS powder in a 1 L plastic beaker, and add Milli-Q water to bring 
the final volume to 1 L. Add magnetic stirring bar for mixing. After the SDS have 
been completely dissolved, filter this solution through a 0.20 µm filter to two 
autoclaved 0.5 L glass bottles.  
 
SDS equilibration buffer  
Composition: 50 mmol L-1 Tris-HCl pH 8.8, 6 mol L-1 urea, 30% (v/w) glycerol 
and 2% (v/w) SDS.  
Add 108.15 g of urea, 60 mL of 10% SDS stock solution, 103.5 mL (126.3 g) of 
glycerol (86% w/w), and add some Milli-Q water and 10 mL 1.5 mol L-1 Tris-HCl, 
pH 8.8 stock solution (4× resolving gel buffer solution) into a 500 mL glass bottle. 
Bring the final volume to 300 mL with Milli-Q water and dissolve this solution. 
Store in 13 mL aliquots in 15 mL of centrifugation tube at -20oC. 
Prepare it at least 3 hours before run the gels.  
In one Falcon containing SDS equilibration buffer add 1% (w/v) (10 mg in 1 mL) 
of DTT. In another Falcon containing SDS equilibration buffer add 5% (w/v) (50 
mg in 1 mL) of iodoacetamide. Gently shake to dissolve the DTT and 
iodoacetamide. At this step, avoid to make bubbles in the SDS equilibration buffer. 
 
SDS electrophoresis buffer for agarose sealing solution (without SDS) 
Composition: 24 mmol L-1 Tris-base and 0.2 mol L-1 glycine.  
Add 2.9 g of Tris-base, 15.01 g of glycine, in a 1L glass bottle. Add Milli-Q water 
to bring the final volume to 1 L. Filtrate this solution through a 0.20 µm membrane 
to an autoclaved 1 L glass bottle. SDS should not been added to this solution. Store 
this solution at 4oC. 
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Agarose sealing solution  
Composition: 1% agarose, 0.002% bromophenol blue stock solution and 0.1% 
(w/v) SDS.  
Add 0.5 g of agarose to a 100 mL glass bottle; add 50 mL of SDS electrophoresis 
buffer (24 mmol L-1 Tris-base and 0.2 mol L-1 glycine) using a graduated cylinder 
in this bottle. Add 100 µL 1% bromophenol blue stock solution and 500 µL of 10% 
SDS stock solution. Heat in a microwave on low power until the agarose is 
completely dissolved. 
 
Tank electrophoresis buffer  
Composition of 20 L tank electrophoresis buffer (for at least 6 gel cassettes): 24 
mmol L-1 Tris-base, 0.2 mol L-1 glycine and 0.1% (w/v) SDS.  
Add 58 g of Tris-base, 300 g of glycine, 200 mL of 10% SDS stock solution in the 
electrophoresis tank and add Milli-Q water to bring the final volume to 20 L. Use 
the circulating pump to dissolved the buffer components. After complete 
dissolution, put the two barrier combs back to their original position. This buffer 
can be used for about 3 runs of SDS-PAGE electrophoresis. 
 
Fixing solution  
Composition: 10% acetic acid and 30% ethanol. 
Add 600 mL of ethanol (or 857 mL of 70% ethanol) to a 2 L glass bottle and add 
Milli-Q water to bring the volume to 1.8 L. Finally, add 200 mL acetic acid and 
mix the solution.  
 
Colloidal Silver Comassie G-250 staining  
Composition: 8.5% H3PO4, 10% (NH4)2SO4, 0.1% Coomassie Blue G-250 and 20% 
(w/v) methanol. 
Firstly, add 250 mL Milli-Q water to a glass bottle and add 250 mL of 85% H3PO4 
and mix. Secondly, add 250 g of (NH4)2SO4 to a 500 mL glass breaker and then add 
Milli-Q water to bring to a final volume of 500 mL. Add a magnetic stirring bar for 
complete mixing. Thirdly, add 2.5 g Coomassie Blue G-250 to a 500 mL glass 
beaker and then add Milli-Q water to bring to a final volume of 500 mL. Add a 
magnetic stirring bar for complete mixing. After the (NH4)2SO4 and Coomassie 
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Blue G-250 is completely dissolved, mix then add 500 mL Milli-Q water to bring 
the volume to 2 L. Mix at high stir speed over night. After complete dissolution, 
add 400 mL of methanol to complete this solution. It is better to store this solution 
in a brown bottle. 
 
Displacing solution for casting gradient gels 
Composition: 0.375 mol L-1 Tris-HCl pH 8.8, 43% (w/w) glycerol and 0.001% 
bromophenol blue. 
Add 100 mL (122 g) of glycerol (86% w/w) 50 mL Milli-Q water, 50 mL 1.5 mol 
L-1 Tris-HCl, pH 8.8 (4× resolving gel buffer solution) and 200 µL of 1% 
bromophenol blue stock solution to an appropriate and clean container. 
 
APS (10%) for casting gels 
For 12 gels: add 1 g ammonium persulfate (APS) to a 15 mL centrifugation tube. 
Then add Milli-Q water to bring the final volume to 10 mL and vortex for complete 
mixing.  
 
TEMED (10%) for casting gels 
For 12 gels: add 150 µL of TEMED and 1350 µL of Milli-Q water to a 2 mL 
microcentrifuge tube. Vortex for complete mixing. 
 
SDS (0.1%)  
Add 5 mL of 10% SDS stock solution to a 500 mL graduate cylinder, and add 
Milli-Q water to bring the final volume to 500 mL. After mixing, pour this solution 
to a bottle. 
 
Gel storage solution 
Composition: 0.375 mol L-1 Tris-HCl pH 8.8 and 0.1% SDS. 
Add 20 mL of 10% SDS stock solution, 500 mL of 4× resolving gel buffer solution 
(1.5 mol L-1 Tris-HCl, pH 8.8) to a 2 L glass bottle. After then add Milli-Q water to 
bring the final volume to 2 L and store this solution at 4oC.  
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Solution for casting gels 
Composition of solution for 12 gels (1200 mL): 480 mL acrylamide stock solution 
Rotiphorese Gel 30 (37,5:1) 30%, 300 mL Tris-HCl 1.5 mol L-1, pH 8.8, 394 mL 
Milli-Q water, 12 mL 10% SDS, 12 mL 10% APS, 2 mL 10% TEMED. Add APS 
and TEMED only before cast the gel. 
 
NH4CO3 (0.1 mol L-1) 
Add 3.95 g NH4HCO3 to a 500 mL graduate cylinder, and add Milli-Q water to 
bring the final volume to 500 mL. Filter this solution through a 0.2 μm membrane 
to an autoclaved glass bottle. Store at 4°C. 
 
NH4CO3 (0.1 mol L-1) with DTT 
Add 31 mg DTT into a 15 mL conical tube and add 10 mL 1 mol L-1 NH4HCO3 
solution to bring the final volume to 10 mL. 
 
NH4CO3 (0.1 mol L-1) with iodoacetamide 
Add 102 mg iodoacetamide into a 15 mL conical tube and add 10 mL 1 mol L-1 
NH4HCO3 solution to bring the final volume to 10 mL. 
 
Trypsin working solution (2 µg/mL) 
One vial of 20 µg trypsin (sequencing grade modified trypsin, Promega) is 
combined with 100 μl trypsin resuspension buffer (Promega) and incubated 30 min 
at room temperature. Then add 900 μl 1 mol L-1 NH4HCO3 solution. After mixing, 
aliquot 50 μl into 0.5 mL microcentrifuge tubes and store at −80°C. Before using, 
thaw and add 450 μl Milli-Q to make 500 mL trypsin working solution. 
 
Formic acid (5%) 
Add 25 mL formic acid to 500 mL graduate cylinder, and add Milli-Q water to 
bring the final volume to 500 mL. Store at 4°C. 
 
 
 
 
Appendix   144  
 
Wash solution for Zip Tip 
Composition: 2% methanol, 0.5% formic acid 
Add 2 mL methanol and 0.5 mL formic acid to a 100 mL graduate cylinder, and 
add Milli-Q water to bring the final volume to 100 mL. Store at 4°C. 
Elution solution for Zip Tip 
Composition: 65% methanol, 0.5% formic acid 
Add 65 mL methanol and 0.5 mL formic acid to a 100 mL graduate cylinder, and 
add Milli-Q water to bring the final volume to a 100 mL. Store at 4°C. 
 
PAC target washing buffer 
Add 1 mL trifluoroacetic acid (TFA) to 1 L graduate cylinder, and add Milli-Q 
water to bring the final volume to 1 L to make 0.1% TFA solution. Add 23 mg 
NH4H2PO4 and 20 mL 0.1% TFA solution to a glass bottle Store at 4°C. 
 
Saturated matrix solution 
Composition: 0.06% TFA, 40% acetonitrile and 10 mg/mL α-Cyano-4-
hydroxycinnamic acid 
Add 1 mL trifluoroacetic acid (TFA) to 1 L graduate cylinder, and add Milli-Q 
water to bring the final volume to 1 L to make a 0.1% TFA solution. Add 10 mg α-
Cyano-4-hydroxycinnamic acid, 400 μl acetonitrile and 600 μl 0.1% TFA solution 
into a 1.5 mL microcentrifuge tube. Vortex for mixing. Store at 4°C. 
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10.4. List of reagents 
Table 10.1 Chemicals 
Chemical  Annotation  Manufacturer  
Acetic acid  CH3CO2H Carl Roth GmbH + Co. KG., Germany 
Acetonitrile  CH3CN  Carl Roth GmbH + Co. KG., Germany 
Acrylamide and 
bisacrylamide stock solution  Rotiphorese® Gel 30 (37,5:1)  Carl Roth GmbH + Co. KG., Germany 
Agarose  Biozym LE GP agarose  Biozym Scientific GmbH, Germany 
Ammonium hydrogen 
carbonate  NH4HCO3  Merck KgaA, Germany 
Ammonium persulfate  (NH4)2S2O8  Sigma-Aldrich GmbH,  Germany 
Ammonium sulfate  (NH4)2SO4  Carl Roth GmbH + Co. KG., Germany 
Bromophenol Blue  3′,3′′,5′,5′′Tetrabromophenolsulfonephthalein  Sigma-Aldrich GmbH,  Germany 
CHAPS  
3-((3-Cholamidopropyl)-di- 
methylammonio)-1-propane- 
sulfonate  
Biomol GmbH, Germany 
Coomassie Blue G250  Coomassie brilliant blue G-250  Merck KgaA, Germany 
DTT  DL-Dithiothreitol  Sigma-Aldrich GmbH, Germany 
Ethanol  Ethanol (96%)  Merck KGaA , Germany 
Formic acid  HCOOH  J.T.Baker Chemical Company, USA  
Glycerol  Glycerol (86%)  Carl Roth GmbH + Co. KG., Germany 
Glycine  C2H5NO2  Carl Roth GmbH + Co. KG., Germany 
Iodoacetamide  ICH2CONH2  GE Healthcare, United Kingdom 
Methanol  CH3OH  Carl Roth GmbH + Co. KG., Germany 
Phosphoric acid  H3PO4 (85%)  Carl Roth GmbH + Co. KG., Germany 
Potassium phosphate dibasic  K2HPO4  Carl Roth GmbH + Co. KG., Germany 
Potassium phosphate 
monobasic  KH2PO4  Carl Roth GmbH + Co. KG., Germany 
SDS  Sodium dodecyl sulfate  Bio-Rad Laboratories GmbH, Germany 
Silicon M100 Polydimethyl siloxane Carl Roth GmbH + Co. KG.  
TEMED  N,N,N′,N′-Tetramethylethylenediamine  Sigma-Aldrich GmbH, Germany  
TFA  Trifluoroacetic acid  Merck KgaA, Germany 
Thiourea  Thiocarbamide  Sigma-Aldrich GmbH,  Germany 
TMB 3,3´,5,5´tetramethylbenzidine Sigma-Aldrich GmbH,  Germany 
Tris  Tris(hydroxymethyl)  aminomethane  Carl Roth GmbH + Co. KG., Germany 
Triton X-100 polyethylene glycol p-(1,1,3,3-tetramethylbutyl)-phenyl ether Sigma-Aldrich GmbH, Germany  
Urea  Carbamide  Sigma-Aldrich GmbH,  Germany 
α-Cyano-4-hydroxycinnamic acid  Sigma-Aldrich GmbH,  Germany 
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Table 10.2. Commercial buffer and other materials 
Chemical  Annotation  Manufacturer  
IPG buffer pH 3-10 NL  GE Healthcare, United Kingdom 
IPG strip pH 3-10 NL Immobiline DryStrip pH 3-10 NL, 18 cm GE Healthcare, United Kingdom 
Trypsin Sequencing grade modified  Promega Corporation, USA 
Ziptips C18  Millipore Corporation, USA 
Anti-HDEL (2E7) Sc-53472 Santa Cruz Biotechnology, USA 
Anti-mouse (secondary 
antibody) HRP conjugated Calbiochem, Germany 
PVDF membrane Polyvinylidene difluoride Bio-Rad Laboratories GmbH, Germany 
PAC target  Prespotted AnchorChip target Bruker Daltonics GmbH, Germany 
Glass beads 0.5 mm Sartorius AG, Germany 
 
 
 
10.5. List of abbreviations 
Abbreviation of protein names are given in Appendix I and III. 
Abbreviation Full name  
2D-GE Two-dimensional gel electrophoresis  
ATP  Adenosine triphosphate  
EM Electron microscopy  
ER Endoplasmatic reticulum  
ERAD Endoplasmatic reticulum associated degradation  
GC  Gas chromatography  
HBsAg Hepatitis B surface antigen  
HPLC High performance liquid chromatography  
IP Insulin precursor  
IPG Immobiline DryStrip gel  
MALDI-TOF MS   Matrix assisted laser desorption ionization time-of-flight mass spectrometry     
MS Mass spectrometry  
NADH Nicotinamide adenine dinucleotide  
NADPH Nicotinamide adenine dinucleotide phosphate  
PPP Pentose phosphate pathway  
PTM(s) Post-translational modification(s)  
ROS Reactive oxygen species  
SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel electrophoresis  
TEM Transmission electron microscopy  
TFA Trifluoroacetic acid  
TCA Tricarboxylic acid  
UPR Unfolded protein response  
VLP Virus like particle  
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